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Abstract
Intrauterine growth restriction (IUGR) is a pathological condition characterized
by low birth weight and poor organ development. Growth of the fetal liver is often
compromised at the expense of other vital organs, thereby leading to hepatic
hyperlipidemia in the affected offspring. As such, epidemiological studies suggest a
relationship between birth weight and long-term metabolic health, while the occurrence
of postnatal catch-up growth can exacerbate this relationship. Animal studies have shown
that IUGR offspring exhibit impaired mitochondrial function, which likely contributes to
the later development of metabolic pathologies. That said, the molecular mechanisms by
which mitochondria are affected remain unknown. In this thesis, I aimed to characterize
the molecular mechanisms by which hepatic mitochondrial dysfunction occurs in growthrestricted offspring with catch-up growth. To do this, we utilized two different rodent
models of IUGR: (1) the maternal protein restriction (MPR) model of undernutrition, and
(2) gestational exposure to D9-tetrahydrocannabinol (D9-THC). Offspring from both
models underwent hepatic catch-up growth by three weeks of age, while adult male
offspring from both models exhibited hepatic hyperlipidemia. I demonstrated that male
offspring further display aberrant markers of oxidative stress and mitochondrial
dysfunction, including elevated p66Shc, 4-hydroxynonenol, and various antioxidant
enzymes. These changes occurred exclusively following catch-up growth, suggesting that
rapid postnatal weight gain is detrimental to mitochondrial metabolism and long-term
metabolic health. I further found that the expression of microRNA-29 was significantly
altered in the livers of adult male IUGR offspring from both models. My in vitro studies
determined that miR-29 may be regulated by mitochondrial-induced oxidative stress, as
treatment of HepG2 cells with rotenone and thapsigargin led to increased transcript
abundance of miR-29. In addition, mRNA levels of fatty acid translocase (CD36), a
membrane transporter protein involved in fatty acid uptake that is also a target of miR-29,
was increased alongside miR-29. Overall, our data suggest that hepatic catch-up growth
has great impact on mitochondrial function in growth-restricted offspring, and that this
may occur in a sex-specific manner.
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Summary for Lay Audience
Intrauterine growth restriction (IUGR) is a condition that affects 4–7% of all
pregnancies. IUGR often occurs due to a poor maternal environment, and it results in low
birth weight and poor fetal development. This can lead to increased fat storage within the
liver, resulting in high risk for obesity, diabetes, and cardiovascular disease. This risk is
worsened through a process called catch-up growth, whereby IUGR babies gain weight
quickly during infancy and early childhood. Studies have found that the function of
mitochondria, the major energy producers of the cell, becomes impaired with IUGR and
contributes to the progression of disease. However, the role of catch-up growth in this
process is not well understood. In this study, we used two different rodent models to
study the effects of catch-up growth on mitochondria in the IUGR rat liver. In our first
model, pregnant rats were fed a low protein diet, and followed by induction of catch-up
growth after birth. In our second model, pregnant rats were injected with D9tetrahydrocannabinol (D9-THC), the major component of cannabis that affects the brain.
Both models resulted in IUGR, as offspring had low birth weight and small livers.
Following catch-up growth, adult offspring from both models had elevated levels of fat in
the liver. We believe that this occurs due to changes in (1) proteins responsible for fat
production, and (2) mitochondrial proteins that control energy production and the
production of toxic molecules. We also found that poor mitochondrial function leads to
altered regulatory mechanisms of gene expression. Overall, these studies provide insight
into the molecular causes of IUGR, and they may contribute to the development of
therapies used in clinical practice during prenatal and postnatal life.
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Chapter I
1

Introduction

Excerpts of this chapter have been previously published in the following works:
Oke, Shelby L. and Hardy, Daniel B. (2017). Effects of protein deficiency on perinatal
and postnatal health outcomes. The Handbook of Famine, Starvation, and Nutrient
Deprivation, 1–23.
Reproduced here with permission from Springer Nature.

Oke, Shelby L. and Hardy, Daniel B. (2021). The role of cellular stress in intrauterine
growth restriction and postnatal dysmetabolism. International Journal of Molecular
Sciences, 22 (13), 6986.
Ownership of copyright for this publication is assigned to the authors of the manuscript.

2

1.1 Overview
1.1.1

Intrauterine Growth Restriction
Intrauterine growth restriction (IUGR) is a pathological condition that affects

approximately 4–7% of all pregnancies (Romo et al., 2009; Creasy et al.). IUGR is
defined as the decreased rate of fetal growth relative to that of the general population,
culminating in fetal weight below the 10th percentile for gestational age (Suhag and
Berghella, 2013; Sharma et al., 2016). Although IUGR infants are defined as being small
for gestational age (SGA), there is a distinction between pathological IUGR and healthy
SGA fetuses (Sharma et al., 2016). SGA fetuses are not exposed to an adverse uterine
environment, but rather are genetically programmed to be small based on parental
genotype (Vandenbosche and Kirchner, 1998; Sharma et al., 2016). These fetuses exhibit
proportional organ growth in utero, and they have normal organ function in postnatal life
(Brites, 2002; Baschat, 2004). Conversely, the diminished growth of IUGR fetuses occurs
as a consequence of the uterine environment (Baschat, 2004; Suhag and Berghella, 2013;
Sharma et al., 2016). In cases of symmetrical IUGR, cell numbers become decreased and
fetal organ growth is reduced in a proportional manner (Suhag and Berghella, 2013;
Sharma et al., 2016). Alternatively, in cases of asymmetrical IUGR, the growth of select
fetal organs is compromised at the benefit of others (i.e., there is a brain-sparing effect;
Barker et al., 1993a). Both symmetrical and asymmetrical IUGR can occur due to uteroplacental insufficiency, whereby the placenta cannot meet metabolic requirements set by
the fetal genome (Baschat, 2004). Utero-placental insufficiency is often secondary to
insults of maternal origin, including maternal malnutrition, drug use, and infection among
others; therefore, maternal lifestyle has significant influence on offspring health (Baschat,
2004; Sharma et al., 2016). Importantly, the postnatal environment has also been
demonstrated to have an indirect role in provoking long-term metabolic dysfunction, as
offspring born into an environment that is ‘mismatched’ from that in utero are subject to
maladaptive changes in fetal programming (Hales and Barker, 2001). Despite the
divergent phenotypes associated with symmetrical and asymmetrical IUGR, infants in
both categories have increased risk for perinatal complications and the metabolic
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syndrome in later life (Romo et al., 2009; Suhag and Berghella, 2013; Sharma et al.,
2016).
Aside from fetal growth and weight, IUGR can be screened for and clinically
diagnosed during pregnancy via placental ultrasound and umbilical artery (i.e., fetoplacental) doppler ultrasound. Placental ultrasound is used to determine maximal
placental length and thickness, as placental insufficiency results in small placental size
(Baschat and Hecher, 2004). Umbilical doppler ultrasound is further used to detect
changes in blood flow and vascular resistance in the uterine artery and umbilical vessels,
because feto-placental blood flow becomes reduced in IUGR pregnancies (Baschat and
Hecher, 2004). This leads to, in part, decreased nutrient and oxygen supply to the fetus,
accounting for poor gestational growth and development. Nutrient availability is also
diminished via downregulation of placental nutrient transporters, particularly those that
mediate uptake of amino acids. IUGR placentas have decreased activity of both system L
(Jansson et al., 1998) and system A amino acid transporters (Glazier et al., 1997; Jansson
et al., 2002), along with reduced activity of the taurine transporter (Norberg et al., 1998;
Roos et al., 2004). Consequences of these reduced transporter activities are twofold,
because amino acids stimulate the production and release of fetal insulin to promote
growth and development. There is evidence to show that activity of placental lipases are
also decreased in IUGR placentas, particularly that of lipoprotein lipase (Magnusson et
al., 2004; Tabano et al., 2006; Gauster et al., 2007) and endothelial lipase (Gauster et al.,
2007). With respect to placental glucose transport, changes in glucose transporter
(GLUT) expression and activity are controversial. GLUT1 is the primary glucose
transporter present in the placenta, while GLUT3 and GLUT4 are also present at lower
levels but higher affinity for glucose. Many studies have found that placental GLUTs
remain unchanged with IUGR (Kainulainen et al., 1997; Jansson et al., 2002); however,
Janzen et al. have reported increased protein abundance of GLUT3 in human IUGR
placenta samples (Janzen et al., 2013). Importantly, this study did not assess functional
capacity of GLUT3, but it was hypothesized that placental oxidative stress may be
involved in this process.
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1.1.2

The Developmental Origins of Health and Disease
(DOHaD)
The metabolic syndrome refers to a group of physiological symptoms that

increase an individual’s risk for cardiovascular disease and type II diabetes. These
symptoms, including dyslipidemia, obesity, hyperglycemia, and hypertension, are often
assessed independent of each other; however, their simultaneous occurrence is synergistic
toward onset of the metabolic syndrome. It is well known that these symptoms are
influenced by factors such as genetics and lifestyle, but the role of developmental priming
is often overlooked. The developmental origins of health and disease (DOHaD) posits
that there is a relationship between birth weight and long-term metabolic health, as
adverse events in utero may permanently influence the function of metabolic organs. This
is in alignment with the “Predictive Adaptive Response” hypothesis, which states that
environmental cues during periods of developmental plasticity will induce a specific
phenotype in anticipation of the postnatal environment (Bateson et al., 2014). As such, a
mismatch between the pre- and postnatal environment results in short-term adaptations
that have adverse consequences later in life (Hales and Barker, 2001; Bateson et al.,
2014). Infants affected by IUGR exhibit impaired organ growth with metabolic disease in
adulthood, as early epidemiological studies by Sir David Barker and colleagues
determined that low birth weight individuals have high rates of obesity, glucose
intolerance, and coronary artery disease (Ravelli et al., 1976, 1998, 1999). These studies
have since led to widespread investigation of the underlying causes of IUGR, as well as
the metabolic pathologies that arise in response to impaired organ development.

1.1.2.1

Human Evidence of DOHaD

Evidence for DOHaD has been revealed by numerous human studies, many of
which are focused on the role of famine and other nutritional insults during pregnancy.
Barker’s investigations of the Hertfordshire birth cohort are perhaps the best described, as
these studies were among the first to uncover the relationship between impeded fetal
growth and adult offspring health (Osmond et al., 1993). In combination with
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epidemiological studies of famine, the data from this cohort indicate a strong relationship
between birth weight and risk for the metabolic syndrome. In particular, men and women
who were born with low birth weight had increased risk of death from cardiovascular
disease in adulthood, while this was also true of men who were small at one year of age
(Osmond et al., 1993). These studies led to further investigation of the surviving
individuals from the cohort, and it was found that low birth weight was associated with
increased risk for insulin resistance (Barker et al., 1993b), type II diabetes (Fall et al.,
1995), and coronary artery disease (Hales et al., 1991). These men and women also had
increased risk for osteoporosis (Cooper et al., 1997) and sarcopenia (Sayer et al., 1998),
indicating that the effects of small size at birth were not limited to just metabolic organs.
Additional birth cohorts from Brazil, South Africa, and the United States have also
reported similar trends, further solidifying the role of the in utero environment in the
development of metabolic disease (Victora et al., 2003; Musa et al., 2015; Perng et al.,
2016). Finally, rising rates of obesity can be partially explained by developmental
programming, as there is an association between birth weight and adult body
composition. This relationship is U-shaped such that infants born with either IUGR (low
birth weight, <2500 g) or macrosomia (high birth weight, >3500 g) have increased risk
for obesity in adult life compared to those born appropriate for gestational age (Eriksson
et al., 2001).
Barker’s studies of the Dutch famine cohort have brought much attention to the
importance of a high-quality maternal diet in determining offspring metabolic health. The
data, which were collected from individuals born before, during and after the famine of
1944–1945, demonstrated that those exposed to famine during mid to late gestation were
glucose intolerant as adults (Ravelli et al., 1998). Later studies of this cohort found that
exposure to famine at any point during pregnancy also contributed to increased likelihood
of hypertension during adult life (Stein et al., 2006). Furthermore, males exposed to
famine during the first two trimesters were more likely to be obese during adulthood
(Ravelli et al., 1976). Studies of the Chinese famine of 1959–1961 have reported similar
trends, as fetal exposure to famine resulted in elevated fasting plasma glucose in
adulthood (Wang et al., 2016) and high rates of obesity among female adults (Yang et al.,
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2008). Additionally, a retrospective cohort study of Chinese individuals found that risk
for hypertension was increased in offspring exposed to famine exclusively during the first
trimester (Wang et al., 2012). Many studies have determined that exposure during
infancy or childhood appears to play a much greater role in this process (Huang et al.,
2010; Wang et al., 2016), highlighting the importance of the postnatal environment on
offspring metabolic health and the complex relationship between fetal development and
metabolic disease.
Postnatal catch-up growth, or rapid postnatal weight gain, is known to exacerbate
the relationship between birth weight and long-term metabolic health. Barker’s ‘thrifty
phenotype’ hypothesis states that this is because fetal programming adapts in anticipation
of a similar postnatal environment (Hales and Barker, 2001). Of note, circulating and
hepatic lipid levels are highly sensitive to catch-up growth, and there are many studies
illustrating that low birth weight offspring with catch-up growth exhibit dyslipidemia. For
example, preterm infants who undergo catch-up growth following consumption of
nutrient-dense formula have high ratios of low-density lipoprotein (LDL) to high-density
lipoprotein (HDL) during adolescence (Singhal et al., 2004). Cohort studies of Finnish
and Italian infants have also identified an association between birth weight and risk for
non-alcoholic fatty liver disease (NAFLD) during childhood and adult life (Nobili et al.,
2007; Suomela et al., 2016). Alarmingly, obesity and dyslipidemia are risk factors for
insulin resistance and type II diabetes (James et al., 2004), so the increased risk for
NAFLD following catch-up growth may contribute to later onset of insulin resistance and
cardiovascular disease (Anstee et al., 2013). The previously mentioned birth cohorts from
Brazil, South Africa, and the United States have also outlined the role of postnatal catchup growth in elevating the risk for obesity. In these studies, increased weight gain during
childhood was associated with greater fat mass and weight gain during mid-childhood
and adolescence (Victora et al., 2003; Musa et al., 2015; Perng et al., 2016). Importantly,
childhood obesity is further predictive of adult body mass index and body composition
(Salgin et al., 2015); therefore, the battle against obesity and the metabolic syndrome is
lifelong. Overall, these studies warrant the need for clinical preventative strategies in
mediating both fetal and postnatal growth.
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In addition to excess visceral adiposity, impaired liver function contributes to
dyslipidemia. The liver is central in managing systemic levels of nutrients in both the fed
and fasted state, as it coordinates the various metabolic pathways that maintain
appropriate levels of glucose and lipid molecules. Individuals with hepatic dysfunction
exhibit dyslipidemia, which can give rise to fibrosis and eventual cirrhosis of the liver
(Anstee et al., 2013). Again, this may further lead to glucose intolerance and the
development of type II diabetes, indicating the high potential for hepatic dysfunction in
producing widespread metabolic disease (Anstee et al., 2013). IUGR offspring have
impaired liver growth as indicated by decreased abdominal circumference at birth, which
is correlated with elevated levels of total cholesterol, triglycerides, and LDL in adult life
(Barker et al., 1993a; Roberts et al., 1999; Skilton et al., 2011). The strong correlation
between these two variables suggests that long-term hepatic function becomes
compromised following gestational insult. Again, IUGR infants undergo rapid catch-up
growth in early postnatal life, and the undernourished liver stands to gain the most
relative to other organs (Neerhof, 1995; Valsamakis et al., 2006). This is evident in SGA
infants who undergo hypersomatotropism by postnatal day (PND) four, which occurs due
to increased levels of insulin growth factor 1 (IGF-1) in the liver and blood (Deiber et al.,
1989). Keeping with the DOHaD hypothesis, this rapid weight gain is detrimental to
hepatic function and can further exacerbate risk for the metabolic syndrome (Hales and
Barker, 2001).
While the clinical evidence in support of DOHaD is abundant, these studies are
limited in that they provide little insight into the underlying mechanisms linking a poor in
utero environment to postnatal metabolic disease. It is for this reason that animal models
are essential in improving our understanding of how molecular mechanisms contribute to
adverse metabolic outcomes of IUGR offspring. Some of these models will be discussed
in detail in Section 1.2.5.
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1.2 The Liver
1.2.1

Liver Development

Hepatogenesis is a highly complex process that begins during gastrulation. Briefly,
the liver is derived from the anterior portion of the definitive endoderm (Douarin, 1975).
Progenitor hepatoblast cells are in the posterior foregut region of this layer, which
eventually closes to form the hepatic diverticulum (i.e., the hepatic bud; Trefts et al.,
2017). The hepatic diverticulum folds such that it lies proximally to the lateral plate
mesoderm, which secretes key signaling molecules and extracellular growth factors to
induce differentiation of progenitor hepatoblasts (Si-Tayeb et al., 2010). These signaling
molecules include fibroblast growth factors (FGF), bone morphogenic proteins (BMPs),
transforming growth factor beta (TGF-b), Wnt, and NOTCH, while important
transcription factors include those belonging to the FoxA1 and GATA families (Trefts et
al., 2017). In particular, the gradient of TGF-b secreted from the portal vein mesenchyme
(PVM) is necessary for differentiation of hepatoblasts into hepatocytes and
cholangiocytes (Trefts et al., 2017). That is, the fates of these cells are dependent on their
proximity to the PVM. High concentrations of TGF-b pushes these cells towards a
cholangiocyte fate, while lower concentrations of TGF-b promote differentiation of
hepatoblasts into hepatocytes (Trefts et al., 2017). TGF-b is also an inhibitory molecule
of CCAAT/enhancer-binding protein alpha (C/EBPa), which regulates the expression of
hepatocyte-specific co-activators such as hepatocyte nuclear factor 1 homeobox A (HNF1a) and hepatocyte nuclear factor 4 alpha (HNF-4a; Trefts et al., 2017). Specific loss of
HNF-4a from fetal hepatoblasts appears to have significant impact on hepatocyte polarity
and liver structure, indicating that it is essential for the progression of hepatogenesis
(Battle et al., 2006). Additionally, the presence of HNF-4a in the adult liver is important
as it is maintains metabolic function of mature hepatocytes (Hayhurst et al., 2001).
Again, hepatogenesis is highly elaborate and requires synchronized expression of all
these signaling molecules along with numerous others. There appears to be a high degree
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of similarity between human and rodent embryogenesis; however, there are key
distinctions in timing that contribute to structural and functional differences between
these species (Figure 1-1). In humans, terminal differentiation of the liver occurs prior to
birth between gestational weeks 34 and 37 (Trefts et al., 2017). Alternatively, the rodent
liver continues to develop postnatally until days 18–21 of life (Gruppuso and Sanders,
2016; Trefts et al., 2017). Function of the adult liver is also quite different from that of
the fetal liver. Prior to the formation of bone marrow, the developing liver serves as the
site of fetal hematopoiesis. In the final weeks of perinatal development, the liver shifts
towards being a primarily metabolic organ (Trefts et al., 2017). The adult liver is highly
versatile in that it has many functions, which will be expanded upon below in Section
1.2.3.

1.2.2

Anatomical and Cellular Structure

The liver is the largest internal organ in the body, weighing approximately 1500
grams in fully grown adults (Ross and Pawlina, 2011). It is located underneath the
ribcage in the upper right quadrant of the abdomen, and it is divided into two main lobes
(i.e., the left and right hepatic lobes) that are separated by the falciform ligament (Ross
and Pawlina, 2011). The larger right lobe further contains two smaller lobes, the quadrate
and caudate lobes. These lobes are separated into eight functional segments that
correspond to blood supply and biliary drainage (Ross and Pawlina, 2011). Importantly,
anatomical structure of the human liver differs from that of rodents in that it is not further
lobated beyond the left and right lobes (i.e., the rodent liver is a multi-lobated structure;
Kogure et al., 1999). Much like other organs, it is immediately surrounded by a fibrous
connective tissue capsule layer called Glisson’s capsule, which is encapsulated by the
serous visceral peritoneum (Ross and Pawlina, 2011). Glisson’s capsule is continuous
with the internal connective tissue stroma, which contains the blood vessels, lymphatic
vessels, nerves, and bile ducts that enter the liver parenchyma. The liver parenchyma is
made up of stacks of hepatocytes organized into hexagonal-shaped liver lobules, which
are the classic functional unit of the liver (Si-Tayeb et al., 2010). These hepatocyte plates
are separated by sinusoidal capillaries, which drain into the central vein of each lobule
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Figure 1-1. Timing of liver development in the rat and humans.
Major developmental events are marked on timelines representing the gestational and
postnatal periods for rats (top) and humans (bottom). Given the differences in timing of
pregnancy and lifespan, the scale for development in rats is in days, while the scale for
development in humans is in weeks (gestational period) and years (postnatal period).
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(Si-Tayeb et al., 2010). Surrounding each lobule are multiple portal triads, which
consist of a hepatic artery, portal vein, and bile duct (Si-Tayeb et al., 2010). The hepatic
artery and portal vein both open into the sinusoidal capillaries, while the bile ducts drain
into interlobular bile ducts that eventually lead to the larger hepatic duct (Si-Tayeb et al.,
2010). This structural organization is strategic in that it allows for optimal nutrient and
oxygen exchange within the liver, while simultaneously removing waste metabolites and
releasing bile to the gallbladder.
The liver possesses a unique dual blood supply consisting of (1) the venous (portal)
blood supply and (2) the arterial blood supply (Ross and Pawlina, 2011). These vessels
enter the liver at a hilum between the quadrate and caudate lobes. This hilum is the same
location at which the common bile duct and lymphatic vessels exit the liver; that is, blood
travels in the opposite direction as bile and lymph fluid. The hepatic portal vein carries
venous blood to the liver from the intestines, pancreas, and spleen, and it supplies the
liver with approximately 75% of its major blood supply (Ross and Pawlina, 2011).
Although this blood is deoxygenated, it is highly concentrated with nutrients that have
been absorbed along the intestine (Trefts et al., 2017). That said, the liver is also the first
site exposed to toxic substances and metabolites that are absorbed. The hepatic artery is
responsible for carrying oxygen-rich blood that makes up the remainder of the liver’s
blood supply (Ross and Pawlina, 2011). Both the hepatic portal vein and hepatic artery
branch to form the smaller portal vein and arteries that surround the hepatic lobule, and
the blood from both vessels mixes as it enters the sinusoidal capillaries (Trefts et al.,
2017). Because of this, hepatocytes are never exposed to blood that is fully oxygenated.
As blood flows through the sinusoids, gas and nutrient exchange occurs with hepatocytes
and the blood empties into the central vein of the lobule (Trefts et al., 2017). These veins
later join to form multiple sublobular veins, which eventually come together as the larger
hepatic vein that exits the liver (Ross and Pawlina, 2011).
Being one of the most heterogenous tissues in the body, the liver is composed of
numerous cell types that each play a critical role in hepatic physiology. As previously
mentioned, hepatocytes are the main functional cell present in the liver. They make up
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approximately 70–80% of the liver and are responsible for the liver’s regenerative
capacity (Si-Tayeb et al., 2010; Ross and Pawlina, 2011). Hepatocytes are typically
binucleate, and they contain high quantities of mitochondria, rough and smooth
endoplasmic reticulum (ER), Golgi complexes, peroxisomes, and lysosomes (Ross and
Pawlina, 2011). These abundant organelles account for the hepatocyte’s ability to
produce and secrete proteins, along with their proficient metabolism of various
compounds (Si-Tayeb et al., 2010). Additionally, hepatocytes are the major storage site
of glucose and lipids in the liver as they express high levels of GLUT2 and various fatty
acid transporters (Thorens, 1996). The remaining cells of the liver, including
cholangiocytes, hepatic stellate cells, endothelial cells, Kupffer cells, and Pit cells,
comprise a small overall percentage of the liver’s cell population. Cholangiocytes, also
known as bile duct cells, make up the walls of the hepatic bile duct to allow for transport
of bile from the liver to the gallbladder (Si-Tayeb et al., 2010; Trefts et al., 2017). These
cells control the composition and pH of bile as it leaves the liver, as they are capable of
secreting water and bicarbonate (Si-Tayeb et al., 2010). Hepatic stellate cells (HSC) are
mesenchymal cells found within the perisinusoidal space that are responsible for
maintaining extracellular matrix in the liver (Si-Tayeb et al., 2010). These cells are the
primary site of vitamin A storage within cytoplasmic lipid droplets, and they work
alongside hepatocytes to promote hepatic regeneration (Si-Tayeb et al., 2010).
Endothelial cells make up the larger hepatic blood vessels, and are capable of controlling
blood flow much like those found throughout the rest of the body (Si-Tayeb et al., 2010).
Alternatively, liver sinusoidal endothelial cells are specialized endothelial cells that form
the sinusoidal capillaries of hepatic lobules. They allow for the transfer of various
molecules between hepatocytes and blood, while simultaneously having a role in immune
function and blood clotting in the liver (Si-Tayeb et al., 2010). Finally, Kupffer cells and
Pit cells are the immune cells of the liver. Kupffer cells exist within the lining of hepatic
sinusoids, and they are the ‘resident macrophages’ due to their phagocytotic abilities (SiTayeb et al., 2010). These cells are plentiful relative to Pit cells, which are rare natural
killer (NK) cells possessing cytotoxic activity (Si-Tayeb et al., 2010).
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1.2.3

Physiological Function
As mentioned previously, the liver is arguably the most versatile organ in the

body. It possesses both endocrine and exocrine function, making it essential in regulating
metabolism, digestion, production of proteins, immune function, detoxification, and
storage of macromolecules. With respect to exocrine function, the liver produces and
delivers bile to the gallbladder via the hepatic duct. Bile is an aqueous secretion
containing phospholipids, cholesterol, bile salts, bile pigments, and electrolytes (Ross and
Pawlina, 2011). Many of these compounds are also recycled back to the liver via the
hepatic portal circulation. Bile is primarily involved in the emulsification of lipids present
in the duodenum, but it also contributes to maintaining cholesterol, bilirubin, and mineral
(e.g., iron and copper) levels (Si-Tayeb et al., 2010). Moreover, the liver produces many
plasma proteins present in circulation. These include albumins, glycoproteins,
lipoproteins, clotting proteins (e.g., prothrombin and fibrinogen), and non-immune
globulin proteins (e.g., a-globulins and b-globulins; Ross and Pawlina, 2011). Each of
these plasma proteins are involved in either the regulation of fluid balance or the
distribution of molecules in the bloodstream. For example, various vitamins and minerals
(e.g., vitamin A, vitamin D, vitamin K, and iron) require binding to plasma proteins in
circulation before they are either stored at the liver or biochemically modified (Ross and
Pawlina, 2011).
Aside from being the largest internal organ, the liver is also the largest endocrine
gland in the body. It is capable of producing some hormones, including IGF-1 and
angiotensinogen, along with modifying and metabolizing hormones produced by other
organs (Rhyu and Yu, 2021). For example, thyroxine (T4) and vitamin D both require
conversion at the liver to their bioactive forms, while insulin and glucagon are pancreatic
hormones that are primarily degraded at the liver (Rhyu and Yu, 2021). In addition to the
metabolism of hormones, the liver is essential in managing systemic levels of xenobiotics
and macromolecules (Corsini and Bortolini, 2013). Both phase I (oxidation) and phase II
(conjugation) of drug metabolism occurs in the liver, whereby hepatocytes initiate
biochemical reactions to convert drugs into their inactive forms. In phase I metabolism,
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hepatic cytochrome P450 (Cyp) enzymes catalyze the carboxylation or hydroxylation of
drugs at the smooth ER (Corsini and Bortolini, 2013). These modified compounds are
made further water soluble through glucuronidation, acetylation, and sulfation reactions
in phase II before their distribution to the kidney for excretion (Corsini and Bortolini,
2013).
Along with its endocrine and drug detoxification role, the liver controls the numerous
molecular pathways involved in nutrient metabolism. With respect to glucose
metabolism, the liver synthesizes and stores glucose via gluconeogenesis and
glycogenosis. Alternatively, it can metabolize and release glucose by means of glycolysis
and glycogenolysis. In the fasted state, the liver metabolizes glycogen stores in response
to increased levels of plasma glucagon from the pancreas (Jones, 2016). The liver
releases glucose into circulation so that it can be distributed to peripheral tissues,
including skeletal muscle and the brain. In the fed state, glucagon levels subside and the
pancreas releases insulin (Jones, 2016). Hepatic insulin receptors detect this increase in
plasma insulin, thereby signaling the liver to decrease hepatic glucose output and increase
glucose uptake. This allows for replenishment of hepatic glycogen stores such that
glucose is available again later in the fasted state as previously described. Again, the liver
is also a major site of protein synthesis, but it is also capable of digesting proteins and
metabolizing amino acids (Trefts et al., 2017). This process does not produce as much
energy as glucose metabolism, and it requires the removal of nitrogenous waste via the
urea cycle. That said, some amino acids can serve as a substrate for the tricarboxylic acid
(TCA) cycle during gluconeogenesis in the fasted state. Finally, the liver plays a major
role in lipid homeostasis through the synthesis and metabolism of lipids and lipoproteins
(Jones, 2016). This will be discussed in greater detail below (Section 1.2.4).

1.2.4

Hepatic Lipid Biosynthesis and Metabolism
Management of homeostatic lipid levels is an intricate process involving

numerous metabolic pathways. Many of these pathways are controlled by hepatocytes,
which are capable of synthesizing and metabolizing lipids as an energy source (Si-Tayeb

15
et al., 2010). Lipids exist in three different forms, including phospholipids, steroids, and
triglycerides. Phospholipids are amphipathic molecules that make up the lipid bilayer of
cellular membranes; therefore, they have a role in cell signaling and the transport of
various molecules into and out of the cell (Küllenberg et al., 2012). Steroids are unique in
that they have a fused ring structure, and they are key components of the endocrine
system (Borah and Banik, 2020). Cholesterol, which is produced and metabolized in the
liver, serves as a precursor to several steroid hormones (e.g., estrogen and testosterone;
Zampelas and Magriplis, 2019). Cholesterol also helps to maintain the fluidity and
integrity of cell membranes through its presence in the phospholipid bilayer (Zampelas
and Magriplis, 2019). Finally, triglycerides are esters comprised of three fatty acids
bound to a single glycerol molecule (Bayly, 2014). Fatty acids can exist in circulation as
their non-esterified form (i.e., non-esterified fatty acids; NEFAs); however, they must be
bound to albumin due to their hydrophobic nature (Bayly, 2014). NEFAs can be
classified as either ‘unsaturated’ or ‘saturated’ depending on the number of carboncarbon double bonds present in their chemical structure. Unsaturated fatty acids possess
one (monounsaturated fatty acids; MUFAs) or more (polyunsaturated fatty acids; PUFAs)
carbon-carbon double bonds, which further gives rise to cis/trans isomers (Tvrzicka et
al., 2011). Conversely, saturated fatty acids do not possess any carbon-carbon double
bonds (Tvrzicka et al., 2011). Importantly, NEFAs are derived from the breakdown of
dietary triglycerides by lipase or thioesterase enzymes (Nguyen et al., 2008). This
enzyme frees NEFAs from the chylomicron structure, allowing them to be taken up by
hepatocytes.
Lipid biosynthesis occurs in both the liver and adipose tissue, and it begins with
the uptake of NEFAs from the bloodstream. In the liver, transmembrane NEFA transport
occurs via passive diffusion or facilitated transport by fatty acid transporter proteins
(FATPs) and fatty acid translocase (CD36; Nguyen et al., 2008; Pepino et al., 2014).
Once inside the cell, NEFAs bind with fatty acid binding proteins (FABP) and acyl-CoA
synthetases (ACS; Nguyen et al., 2008). FABPs exist within hepatic microsomes and
serve as cytosolic shuttles that mediate NEFA transport (Furuhashi and Hotamisligil,
2008). ACS uses NEFAs as a substrate in generating acyl-CoA, which is further
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metabolized to generate acetyl-CoA (Furuhashi and Hotamisligil, 2008). Both NEFAs
and acyl-CoA have a myriad of cellular fates, including de novo lipogenesis, synthesis of
triglycerides and phospholipids, mitochondrial and peroxisomal b-oxidation, or transport
to the nucleus to interact with various transcription factors (Nguyen et al., 2008).

1.2.4.1

De novo Lipogenesis and Triglyceride Synthesis

De novo lipogenesis (DNL) is the synthesis of novel fatty acids from excess
glucose. Because of this, de novo lipogenesis is highly sensitive to plasma insulin levels.
Insulin resistance promotes increased de novo lipogenesis, often culminating in NAFLD
(Smith et al., 2020). Moreover, the expression of many lipogenic transcription factors are
subsequently regulated by insulin. These include the sterol regulatory-element binding
protein (SREBP) and carbohydrate response element binding protein (ChREBP)
transcription factor families (Matsuzaka and Shimano, 2009). In short, de novo
lipogenesis begins with hepatic glucose uptake at GLUT2 upon signaling from insulin
(Figure 1-2). Following a series of glycolytic reactions in the cytosol, glucose is
converted to pyruvate before its transport into mitochondria through the voltagedependent anion channel (VDAC). Pyruvate undergoes decarboxylation by pyruvate
dehydrogenase (PDH) to generate acetyl Co-A, which must enter the TCA cycle to
produce citrate for export into the cytosol via the mitochondrial citrate transporter. ATP
citrate synthase (ACL) converts citrate back into acetyl Co-A, which is converted to
malonyl Co-A by acetyl-CoA carboxylase alpha (ACCa; Kim, 1997; Jensen-Urstad and
Semenkovich, 2012). Fatty acid synthase (FAS) then uses malonyl Co-A as a substrate to
generate long-chain saturated fatty acids such as palmitic acid (Kim, 1997; Jensen-Urstad
and Semenkovich, 2012). Palmitic acid is further elongated by elongation of long-chain
fatty acids family member 6 (ELOVL6) to produce stearic acid (Matsuzaka and Shimano,
2009), followed by action of stearoyl Co-A desaturase-1 (SCD-1) to generate MUFAs at
the ER (Miyazaki and Ntambi, 2003). These MUFAs are subject to a series of elongation
reactions, and acted on by ACS to produce acyl Co-A. From here, triglyceride synthesis
begins with the acylation of acyl Co-A with glycerol-3-phosphate by glycerol-3phosphate acyltransferase (GPAT) to synthesize lysophosphatidic acid (LPA; Yu et al.,
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Figure 1-2. Overview of de novo lipogenesis and triglyceride synthesis in the liver.
Hepatic lipogenesis is an insulin-sensitive process requiring the coordination of fatty acid
uptake, de novo lipogenesis, and triglyceride synthesis in the hepatocyte. Fatty acids can
undergo cytosolic transport or be used to generate acyl-CoA for triglyceride synthesis or
beta oxidation. NEFA, non-esterified fatty acid; FAT, fatty acid translocase; FATP, fatty
acid transport protein; GLUT2, glucose transporter 2; VDAC, voltage-dependent anion
channel; PDH, pyruvate dehydrogenase; TCA, tricarboxylic acid; MCT, mitochondrial
citrate transporter; ACL, ATP citrate synthase, ACCa, acetyl-CoA carboxylase alpha;
FAS, fatty acid synthase; ELOVL6, elongation of long-chain fatty acids family member
6; SCD-1, stearoyl Co-A desaturase-1, MUFA, monounsaturated fatty acid; ACS, acylCoA synthetase; FABP, fatty acid binding protein; GPAT, glycerol-3-phosphate
acyltransferase; APGAT, 1-acyl glycerol-3-phosphate acyltransferase; PAP, phosphatidic
acid phosphatase; DGAT, diacylglycerol acyltransferase.

18
2018). LPA is converted to phosphatidic acid (PA) by the 1-acyl glycerol-3-phosphate
acyltransferase (APGAT) family of enzymes, and PA is dephosphorylated by
phosphatidic acid phosphatase (PAP) to produce diacylglycerol (DAG; Yu et al., 2018).
Importantly, diacylglycerol acyltransferase (DGAT) catalyzes the conversion of DAG to
triglycerides as the terminal step of triglyceride synthesis (Cases et al., 1998; Smith et al.,
2000). The resulting triglycerides can either be stored in the liver or secreted from
hepatocytes to peripheral tissues as very low density lipoprotein (VLDL; Kawano and
Cohen, 2013).

1.2.4.2

Mitochondrial and Peroxisomal b-Oxidation

Under low glucose conditions, hepatocytes can synthesize energy from lipids via
b-oxidation in peroxisomes and mitochondria. While the goal of mitochondrial boxidation is to satisfy energy needs of the cell through coupling with ATP synthesis,
peroxisomal b-oxidation metabolizes long-chain fatty acids that are too long for handling
by mitochondria (Nguyen et al., 2008). Peroxisomal b-oxidation ultimately produces
hydrogen peroxide, which is broken down into water and oxygen by catalase (Nguyen et
al., 2008). Overall, b-oxidation is an efficient catabolic process that produces ATP from
free fatty acids. Given that the liver stores fatty acids in the form of triglycerides,
lipolysis of stored triglycerides must occur prior to b-oxidation to release fatty acids from
glycerol chains. This reaction is catalyzed by the enzyme lipase, which is regulated by
insulin and glucagon (Nguyen et al., 2008; Trefts et al., 2017). While free glycerol
molecules remain in the liver as a substrate for gluconeogenesis, the resulting fatty acids
either stay in the liver or are distributed to skeletal muscle (Trefts et al., 2017). NEFAs
present in circulation can also be imported into the liver as previously described.
Regardless, all fatty acids must be converted into acyl-CoA by ACS such that they can
undergo mitochondrial transport (Nguyen et al., 2008). Acyl-CoA is further converted to
acylcarnitine by carnitine palmitoyltransferase (CPT)-I at the outer mitochondrial
membrane, allowing for transport into the mitochondrial matrix (Nguyen et al., 2008).
The function of CPT-I is inhibited by malonyl-CoA produced during fatty acid synthesis;
therefore, the anabolism and catabolism of fatty acids cannot occur simultaneously.
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Acylcarnitine is reconverted to acyl-CoA through action of CPT-II in the inner
mitochondrial membrane, allowing for initiation of b-oxidation (Nguyen et al., 2008).
Alternatively, short- and medium-chain fatty acids pass through mitochondrial
membranes freely and are converted to acyl-CoA in the matrix by ACS (Nguyen et al.,
2008). Ultimately, the end goal of reach round of b-oxidation is to produce one molecule
of acetyl-CoA (Talley and Mohiuddin, 2022). Acetyl-CoA can feed into the TCA cycle to
generate ATP, while it can also be used to produce ketone bodies via hepatic ketogenesis
(Nguyen et al., 2008). One round of b-oxidation removes two carbons from the end of a
fatty acid chain, and this process occurs until the entire molecule is broken down.
Because of this, fatty acids of different lengths will produce different amounts of ATP
depending on the number of rounds of b-oxidation that occur. This breakdown is an
oxidative process, and the corresponding reduction produces one molecule of FADH2
(flavin adenine dinucleotide) and one molecule of NADH (nicotinamide adenine
dinucleotide + hydrogen) per round (Talley and Mohiuddin, 2022). NADH and FADH2
are electron carrier molecules; therefore, they consequently donate their electrons to the
electron transport chain for ATP synthesis.

1.2.5

Animal Models Linking Intrauterine Growth Restriction
and Hepatic Dyslipidemia
As outlined in Section 1.1.2.1, evidence in support of the relationship between

birth weight and dyslipidemia is abundant. However, epidemiological studies are limited
in that they provide no insight into the molecular mechanisms by which lipid handling is
affected. It is for this reason that various animal models of IUGR have enhanced our
knowledge of this relationship, along with distinguishing between maternal and fetal
contributions toward metabolic dysfunction. These models include uterine ligation and
ablation, maternal nutrient restriction, maternal protein restriction, and maternal drug
exposure.
Uterine ligation and ablation are surgical interventions used to mimic the effects
of idiopathic placental insufficiency. In this model, fetal nutrient and oxygen transfer
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become reduced such that birth weight and liver to body weight ratio are decreased in the
affected offspring (Yudkin and Stanner, 1998; Ross and Beall, 2009; Elias et al., 2016;
Sarr et al., 2021). This is attributed to decreased expression of hepatic and circulating
IGF-1 in the offspring, which is critical for both fetal growth and postnatal metabolism
(Fu et al., 2015). Offspring born from this model further demonstrate high occurrences of
dyslipidemia, obesity, and type II diabetes in adult life, while these effects are also
transgenerational as they arise in the F2 generation (Ogata et al., 1986; Simmons et al.,
1992; Tran et al., 2013; Goodspeed et al., 2015; Sarr et al., 2021). These metabolic
defects occur due to impaired glucose and fatty acid metabolism in the liver, as
demonstrated by increased expression and activity of hepatic glucocorticoid receptors,
increased glucose production, insulin resistance, increased expression of hepatic GLUT1,
and oxidative stress (Lane et al., 1999, 2002; Baserga et al., 2005; Raab et al., 2009; Sarr
et al., 2021). Interestingly, neonatal administration of Exendin-4, a glucagon-like peptide1 receptor agonist, improves both insulin resistance and oxidative stress in the livers of
these offspring (Raab et al., 2009).
Maternal nutrient restriction (MNR) and maternal protein restriction (MPR) are
models of maternal undernutrition that reduce gestational caloric or protein intake,
respectively. Both models lead to decreased fetal nutrient availability; therefore, MNR
and MPR are useful in studying the impact of maternal malnutrition and placental
insufficiency. Importantly, MPR leads to amino acid deficiencies in the fetus despite no
changes to maternal weight gain or food intake (Desai and Hales, 1997; Sohi et al.,
2015). Amino acids are essential for fetal growth and development (Crosby, 1991), so the
MPR model provides insight into the consequences of fetal amino acid deficiencies
specifically. Both MNR and MPR offspring exhibit asymmetrical IUGR, along with
postnatal catch-up growth resulting in long-term hepatic hyperlipidemia, glucose
intolerance, and insulin resistance. Studies have demonstrated that these effects occur in
response to epigenetic regulation of genes encoding metabolic enzymes. For example,
MNR offspring exhibit decreased methylation within the promoter region of
phosphoenolpyruvate carboxylase (PEPCK), a rate limiting enzyme involved in hepatic
gluconeogenesis (George et al., 2012). Alternatively, MPR offspring with catch-up
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growth have increased methylation and decreased acetylation of histone H3 lysine
residues [K9,14] surrounding the promoter region of Cyp7a1, the major enzyme
responsible for cholesterol catabolism (Sohi et al., 2011). These two histone
modifications result in chromatin silencing, leading to decreased expression of Cyp7a1
and elevated hepatic and circulating cholesterol (Sohi et al., 2011).
Finally, our laboratory has previously implemented a rodent model of maternal
nicotine exposure (MNE) to study the effects of nicotine on postnatal metabolism. With
this model, pregnant dams receive daily subcutaneous injections of saline or nicotine
bitartrate (1 mg/kg/day) up until the point of weaning (Ma et al., 2013). At birth, MNE
offspring are low birth weight, and undergo whole body and hepatic catch-up growth by
three weeks of age (Ma et al., 2013). In adult life, MNE offspring exhibit increased
hepatic triglyceride levels, while male MNE offspring also display increased fasting
serum triglycerides (Ma et al., 2013). Further investigation of male MNE offspring
showed increased transcript abundance of FAS and ACCa in the liver, while FAS protein
abundance was also increased (Ma et al., 2013). Moreover, these changes occurred
alongside increased hepatic protein levels of liver X receptor alpha (LXRα), a
transcription factor involved in the silencing of genes associated with glucose production.
LXRα is known to regulate expression of enzymes that partake in lipid synthesis;
therefore, it is possible that it contributes to the hyperlipidemia observed in MNE male
offspring. Chromatin immunoprecipitation (ChIP) assays revealed an increase in the
acetylation of histone H3 [K9,14] surrounding the LXR binding element (LXRE) on the
proximal promoter of FAS, providing further evidence that lipid synthesis pathways are
sensitive to altered epigenetic mechanisms (Ma et al., 2013).
It’s clear that each of the previously described IUGR animal models have
replicated the metabolic outcomes observed among human cohorts of IUGR individuals.
In addition, they have further provided great insight into the underlying molecular
mechanisms that promote dyslipidemia due to a poor in utero environment and postnatal
catch-up growth. These molecular mechanisms will be expanded upon below in Section
1.3.
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1.3 Molecular Mechanisms Underlying Metabolic Disease
in Growth-Restricted Offspring
Fetal growth and development consist of intricate cellular processes that are
highly sensitive to intra- and extracellular stressors. Because of this, it is plausible that
the presence of metabolic disease in adult IUGR offspring is attributed in part to cellular
stress and programmed cell death. While events of cell stress and cell death are often
protective, they can also be destructive and contribute to the development of metabolic
disease. Studies have demonstrated that a suboptimal prenatal environment initiates cell
stress and cell death in the placenta, giving rise to compromised fetal growth. This may
further lead to different forms of cellular stress, including oxidative stress, mitochondrial
dysfunction, and ER stress. Each of these forms of cell stress can lead to programmed cell
death (i.e., apoptosis and autophagy) when uncontrolled; however, for the sake of this
thesis, I will only discuss the types of cell stress previously mentioned. Moreover,
molecular mechanisms such as epigenetics have a role in this process, including DNA
methylation, post-translational histone modifications, and microRNAs (miRNAs).
Finally, the occurrence of rapid postnatal weight gain (i.e., catch-up growth) in low birth
weight offspring can lead to cellular stress and metabolic disease in an indirect manner.
As such, this section addresses the latest research findings on the various types of cellular
stress and epigenetic mechanisms that are prevalent in IUGR offspring during postnatal
life.

1.3.1

Oxidative Stress and Mitochondrial Dysfunction
Mitochondria are membrane-bound organelles present in most eukaryotic

organisms. Each mitochondrion is composed of an inner and outer mitochondrial
membrane, which separates the mitochondrion into two distinct compartments known as
the intermembrane space and the matrix (McCarron et al., 2013). While most cellular
DNA is present within the nucleus, mitochondria also have their own genome (i.e.,
mitochondrial DNA; mtDNA) that contains genes which are critical for mitochondrial
function (Taanman, 1999). These include genes that control aerobic metabolism, as
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mitochondria are key energy-producing organelles in the cell. Each cell contains an
abundance of mitochondria; however, certain cell types possess greater numbers of
mitochondria due to higher energy requirements. For example, hepatocytes can contain
anywhere from 1000–2000 mitochondria per cell, as they are responsible for regulating
various metabolic pathways (Wiesner et al., 1992). In the presence of oxygen,
mitochondria are capable of producing energy in the form of adenosine triphosphate
(ATP) at much higher levels than anaerobic metabolic processes (i.e., glycolysis) alone
(Naifeh et al., 2022). Aerobic metabolism consists of the TCA cycle and oxidative
phosphorylation, which occur within the mitochondrial matrix (Naifeh et al., 2022).
Following the completion of glycolysis, pyruvate is transported into mitochondria
through the voltage-dependent anion channel (VDAC) present in the outer mitochondrial
membrane (OMM), followed by the mitochondrial pyruvate carrier (MPC) in the inner
mitochondrial membrane (IMM; Zangari et al., 2020). Once present in the matrix,
pyruvate is converted to acetyl Co-A by PDH (Naifeh et al., 2022). This acetyl-CoA
molecule is used as a substrate by the TCA cycle, which consists of a series of oxidative
reactions that produces two molecules of carbon dioxide, three molecules of NADH, one
molecule of FADH2, and one molecule of guanosine triphosphate (GTP) per cycle
(Naifeh et al., 2022). Together with the two NADH molecules generated during
glycolysis, the NADH and FADH2 molecules generated during the TCA cycle can donate
their electrons to oxygen at the electron transport chain. This process is referred to as
oxidative phosphorylation, which involves five cytochrome enzymes present in the inner
mitochondrial membrane (Demirel and Gerbaud, 2019). These enzymes include
complexes I–V, and they are present in series with each other such that they can pass
electrons to each other in a stepwise manner (Demirel and Gerbaud, 2019). As a result,
the complexes become reduced while NADH and FADH2 are oxidized. As electrons are
passed from electron carriers to the ETC, protons are also shuttled across the inner
mitochondrial membrane from the matrix to the intermembrane space (Demirel and
Gerbaud, 2019). This proton gradient is a source of potential energy that fuels complex V
in generating ATP (Demirel and Gerbaud, 2019).
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Pregnancy and early postnatal development are metabolically challenging periods
of growth for both the mother and offspring. Accordingly, IUGR is often associated with
increased stress within mitochondria. Mitochondria utilize oxygen as the terminal
electron acceptor in aerobic respiration; however, the production of damaging reactive
oxygen species (ROS) and ROS by-products is a negative side effect (Cadenas and
Davies, 2000). While low levels of ROS are required for some enzymatic reactions and
signaling pathways, they inflict oxidative damage on macromolecules when present in
excess (Krumova and Cosa, 2016). Oxidative stress arises when there is an imbalance
between ROS production and antioxidant enzymes, which are responsible for the
transformation of ROS into less harmful molecules (Cadenas and Davies, 2000). The
mitochondrial electron transport chain is both a source and target of ROS; therefore,
mitochondrial dysfunction commonly coexists with unabated oxidative stress (Cadenas
and Davies, 2000). Importantly, both oxidative stress and mitochondrial dysfunction are
consistently associated with the IUGR-induced metabolic syndrome. Studies have
revealed that mothers of growth-restricted offspring tend to have increased ROS and
decreased levels of antioxidants in the blood (Karowicz-Bilinska et al., 2002; Gupta et
al., 2004; Biri et al., 2007; Saker et al., 2008), while tissues taken from IUGR offspring
also demonstrate oxidative stress. This includes not only an increase in ROS, but also the
differential expression of antioxidant enzymes, increased lipid peroxidation, and
compromised synthesis of ATP (Rodríguez-Rodríguez et al., 2018) . Collectively, these
trends indicate that oxidative stress is an important contributor to the aberrant metabolism
seen in IUGR offspring.
The liver is highly subjected to oxidative stress given that it is abundant in
mitochondria due to its critical role in nutrient metabolism. Many chronic forms of liver
disease, including non-alcoholic steatohepatitis (NASH) and NAFLD, are characterized
by increased markers of oxidative stress, which is often accompanied by an accumulation
of damaged or dysfunctional mitochondria (Mantena et al., 2008; Rolo et al., 2012;
Begriche et al., 2013; Chen et al., 2020). The IUGR liver is no exception to this, as
numerous studies have found evidence of hepatic oxidative and mitochondrial stress in
growth-restricted offspring. For example, in a porcine model of spontaneous IUGR,
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growth-restricted neonates had increased levels of hepatic alpha-1-acid glycoprotein at
birth, indicating hepatic and systemic oxidative stress (Wang et al., 2008). These
offspring also displayed increased protein levels of complex IV of the electron transport
chain, suggesting that ATP availability may be reduced due to accelerated ATP
hydrolysis (Wang et al., 2008). In a rat model of caloric restriction, a 50% decrease in
maternal caloric intake from gestational day 11 through PND 21 (i.e., the point of
weaning) resulted in increased lipid peroxidation marker 4-hydroxynonenol (4HNE) and
decreased glutathione protein levels at three weeks (Devarajan et al., 2019). Adult
offspring had unaltered 4HNE and antioxidant levels after switching to a control diet at
weaning, suggesting that the caloric restriction itself had caused the oxidative stress
(Devarajan et al., 2019). Many studies using the MPR rat model have also established
that catch-up growth may be of greater detriment to hepatic mitochondrial function rather
than the original in utero nutritional insult. Again, in this model, pregnant rat dams are
fed a low protein diet throughout gestation, thereby inducing fetal protein deficiency and
IUGR. Offspring that are maintained on a low protein diet postnatally (LP1 offspring) do
not undergo catch-up growth and remain small relative to control offspring. These
offspring are metabolically healthy in adult life, while they also exhibit decreased hepatic
ROS production (Sohi et al., 2011; Moraes et al., 2014). Given that LP1 offspring do not
experience a nutritional mismatch between the pre- and postnatal environments, it is
possible that the maintenance of the low protein diet may be protective of mitochondrial
function in the absence of catch-up growth. Alternatively, whole body and hepatic catchup growth is induced by switching offspring to a normal protein diet at weaning (LP2
offspring) or at birth (LP3 offspring; Sohi et al., 2011). We have shown that LP2
offspring exclusively develop hypercholesterolemia, glucose intolerance, and impaired
drug metabolism at four months of age, while LP1 and LP3 offspring appear to be
unaffected (Sohi et al., 2011; Vo et al., 2013). This occurs alongside ER stress, which is
known to exist simultaneously with oxidative stress and mitochondrial dysfunction
(Plaisance et al., 2016). Other studies have also shown that catch-up growth after
weaning results in increased hepatic oxygen consumption, altered antioxidant level and
activity, and decreased mitochondrial DNA-encoded gene expression (Park et al., 2003;
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Theys et al., 2009; Moraes et al., 2014). Again, LP3 offspring do not exhibit these
metabolic and mitochondrial deficits, so the timing of nutritional restoration and catch-up
growth appear to be of importance in initiating oxidative stress as a driver of poor liver
health. By introducing a normal protein diet prior to the completion of hepatic
differentiation, the liver may be protected from the metabolic consequences of oxidative
stress and poor mitochondrial function.

1.3.2

Endoplasmic Reticulum (ER) Stress
As mentioned previously, oxidative stress is also known to occur alongside ER

stress. The mitochondrion and ER are physically connected at sites called the
mitochondrial-associated ER membrane (MAM); these sites can indirectly influence the
production of ATP, and they are responsive to ER signaling during instances of increased
protein folding (Hayashi et al., 2009). When the ER cannot facilitate proper protein
folding, this leads to lumenal accumulation of misfolded or unfolded proteins in the ER
(i.e., ER stress). While ER stress is essential for embryonic development and the
maintenance of pregnancy (Michalak and Gye, 2015), excessive or chronic ER stress
during postnatal life can be triggered by numerous cellular insults. These may include
oxidative stress, diminished calcium homeostasis, decreased supply of amino acids, viral
infection, decreased formation of disulfide bonds, and decreased N-linked glycosylation
(Xu et al., 2005; Wong et al., 2015). Furthermore, postnatal catch-up growth has been
shown to trigger ER stress, specifically in the growth-restricted liver (Sohi et al., 2013).
In the unstressed cell, the chaperone protein Grp78 prevents the activation of ER
transmembrane proteins IRE1, PERK, and Atf6 by binding their N-terminal domains in
the ER lumen (Bertolotti et al., 2000; Hong et al., 2004). Under ER stress, the cell’s
unfolded protein response (UPR) becomes activated via release of these transmembrane
proteins from Grp78 (Bertolotti et al., 2000; Hong et al., 2004). This allows for their
oligomerization and subsequent activation of targets that promote an adaptive phenotype
(Bertolotti et al., 2000). This entails increased transcription of genes that strengthen the
folding capacity of the ER, or protein degradation. If the ER cannot be successfully
relieved of misfolded and unfolded proteins, ER-stress induced cell death is initiated
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through the activation of C/EBP-homologous protein (CHOP; Xu et al., 2005; Wong et
al., 2015). Certain ER stress pathways have been implicated in the onset of various
metabolic diseases (Cnop et al., 2012), so the presence of ER stress in IUGR tissues is
not surprising.
Various animal models have found that hepatic ER stress may serve as an
underlying mechanism for the dysregulated blood glucose and insulin resistance
exhibited by IUGR offspring. Again, the liver regulates metabolic pathways that maintain
blood glucose levels, including gluconeogenesis. Rodent models demonstrate that
activation of the UPR either precedes or occurs simultaneously with accelerated hepatic
gluconeogenesis, and these offspring later exhibit glucose intolerance and impaired
hepatic glycogen storage (Sohi et al., 2013; Vo et al., 2013; Deodati et al., 2018; Liu et
al., 2018). For example, one study showed that uteroplacental insufficiency due to uterine
artery ligation resulted in increased markers of ER stress in the affected pups at birth,
concomitant with increased transcript abundance of gluconeogenic enzymes
Phosphoenolpyruvate Carboxykinase 1 (PCK1) and glucose-6-phosphatase catalytic
subunit (G6Pc; Deodati et al., 2018)) . At PND 105, these male IUGR offspring were
glucose intolerant and still had active markers of ER stress (Deodati et al., 2018). The
UPR is also activated in protein-restricted offspring via upregulation of Atf2, Atf6, and
phosphorylated eukaryotic transcription factor 2 alpha (p-eIF2a) during fetal life,
followed by elevated fasting blood glucose and decreased Periodic acid-Schiff (PAS)
stain (i.e., decreased glycogen storage) at twelve weeks (Liu et al., 2018). Alternatively,
Sohi et al., demonstrated that ER stress occurs exclusively following catch-up growth in
the protein-restricted liver (i.e., LP2 offspring; Sohi et al., 2013). These LP2 offspring
exhibited increased hepatic Grp78, Grp94, p-eIF2a[Ser51], and spliced X box binding
protein 1 (Xbp-1), along with increased protein levels of p85 and decreased
phosphorylation of protein kinase B (Akt1) at serine residue 473 (p-Akt1[Ser473]; Sohi
et al., 2013). Increased p85 and decreased p-Akt1[Ser473] are commonly associated with
impaired insulin signaling, while p-Akt [Ser473] and p-eIF2a[Ser51] are also inversely
related and occur with insulin resistance (Mounir et al., 2011; Sohi et al., 2013). Of note,
offspring that had not undergone catch-up growth (i.e., LP1 offspring) did not exhibit
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indices of ER stress or insulin resistance (Sohi et al., 2013). Protein levels of Grp78 and
Grp94 were also increased at embryonic day (ED) 19; therefore, it is possible that hepatic
ER stress begins in the protein-restricted liver during fetal life and is worsened with
postnatal catch-up growth (Sohi et al., 2013).

1.3.3

Epigenetic Regulation of Gene Expression

Although there are many proposed definitions of epigenetics, it is generally defined as
the study of heritable changes in phenotype without altering the underlying DNA
sequence (Greally, 2018). Importantly, this definition is not meant to encompass all forms
of transcriptional regulation, and rather describes three distinct mechanisms: (1) DNA
methylation, (2) post-translational histone modification, and (3) non-coding RNAs (e.g.,
microRNAs). Given that embryonic and fetal development require careful timing of
changes to gene expression, and epigenetics is highly influenced by environmental
changes, it is not surprising that aberrant epigenetic marks have been documented among
IUGR offspring. That said, much attention has been given to the role of epigenetic
mechanisms in implantation of the blastocyst and development of the placenta rather than
metabolic organs. Here I will outline some of the evidence that does exist in support of
epigenetics as a contributor to postnatal dysmetabolism among IUGR offspring.
DNA methylation is a covalent biochemical modification involving the transfer of a
methyl group to cytosine residues (Schenkel et al., 2017). It most commonly occurs at
cytosine-guanidine (CpG)-rich regions of the genome, particularly at the 5’ end of
promoter regions (Schenkel et al., 2017; Goyal et al., 2019). Methylation of promoter
regions occurs via DNA methyltransferase (DNMT) enzymes, which catalyze the transfer
of methyl groups from S-adenosyl-methionine to cytosine (Schenkel et al., 2017). This
causes the condensation of chromatic structure, thereby leading to transcriptional
repression. Conversely, the removal of methyl groups by enzymes such as the ten-eleven
translocation (TET) methylcytosine dioxygenase family can activate transcription and
upregulate gene expression (Schenkel et al., 2017). As mentioned previously, IUGR
rodent offspring born to dams with uterine ligation or ablation exhibit decreased
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expression of IGF-1; this is partially attributed to altered CpG methylation status, which
is further seen in the F2 generation (Goodspeed et al., 2015). This can be alleviated by
weaning offspring onto an essential nutrient methyl-donor diet (Goodspeed et al., 2015),
which has been shown to reduce accumulation of hepatic triglycerides and NAFLD
(Cordero et al., 2013). In 2005, a study by Lillycrop et al. demonstrated that the CpG
island methylation status of hepatic glucocorticoid receptor (GR) and PPARα promoters
are significantly reduced in protein-restricted offspring, and this hypomethylated state is
associated with increased expression of these genes (Lillycrop et al., 2005). Interestingly,
feeding of a low protein diet in combination with folic acid supplementation prevented
these epigenetic changes, indicating that one-carbon metabolism is essential in preventing
the effects of this maternal insult (Lillycrop et al, 2005). Further studies also confirmed
that this alteration also exemplifies transgenerational effects, as methylation status is
decreased in the F2 generation at postnatal day 80 (Burdge et al, 2007). This is
characteristic of many epigenetic mechanisms, thereby illustrating relevance of perinatal
insult to health outcomes of future generations.
In addition to DNA methylation, chromatic structure is greatly affected by posttranslational histone modifications. Histones are proteins rich in positively charged lysine
and arginine residues that provide structural support to chromosomes. Negatively charged
DNA is wrapped around histone octamers, each consisting of two copies of the H2A,
H2B, H3 and H4 histones (Hong et al., 1993). This makes up the nucleosome core
structure, which is linked to adjacent nucleosomes by stretches of DNA that are less than
100 bp long (Kornberg and Lorch, 1999). These DNA regions are associated with histone
H1 to form higher level chromatic structures, which allows for formation of whole
chromosomes (Kornberg and Lorch, 1999). Because of this structural arrangement,
histones regulate DNA accessibility to replication and transcriptional machinery, and
biochemical modifications to amino acid residues within histones can alter gene
transcription. These modifications include histone acetylation, methylation,
ubiquitination, sumoylation, phosphorylation, and ADP-ribosylation (Schenkel et al.,
2017). Notably, histone acetylation is associated with a euchromatic structure that permits
gene transcription, while histone methylation is associated with heterochromatin and
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transcriptional repression (Schenkel et al., 2017). In addition to altering DNA
methylation status, uterine artery ligation leads to changes in histone H3 acetylation and
methylation at various lysine residues both surrounding the promoter region of IGF-1 and
within the IGF-1 gene itself (Fu et al., 2009). Interestingly, histone modifications were
different between male and female IUGR offspring at specific lysine residues, suggesting
that changes to the IGF-1 ‘histone code’ are sex-specific (Fu et al., 2009). In proteinrestricted offspring, the long-term expression of gluconeogenic enzymes (e.g., G6Pase
and 11β-hydroxysteroid dehydrogenase type I; 11β-HSD1) is increased due to the
histone-mediated silencing of LXRα at four months (Vo et al., 2013). Vo et al.
demonstrated that there is a significant decrease in histone H3 acetylation [K9, 14] at the
transcriptional start site of Lxrα in 4 month recuperated protein-restricted offspring (Vo et
al., 2013). This is concomitant with decreased association of LXRα at the LXR response
element of G6Pase and 11β-HSD1, culminating in glucose intolerance (Vo et al., 2013).
Again, these same offspring also exhibit decreased expression of hepatic Cyp7a1, leading
to hypercholesterolemia in male offspring at three weeks and four months of age (Sohi et
al., 2011). This reduction in enzyme expression is due to epigenetic silencing at the
Cyp7a1 promoter region, as there is increased tri-methylation and decreased acetylation
of histone H3[K9, 14]. It is interesting that female protein-restricted offspring from the
same cohort are protected from these histone modifications in adult life, as they show
complete opposite trends in methylation and acetylation.
Lastly, non-coding RNA molecules have been demonstrated to influence long-term
gene expression as an epigenetic mechanism. These include small interfering RNAs, long
non-coding RNAs, and microRNAs, which will be discussed here. MicroRNAs
(miRNAs) are short RNA molecules that can regulate gene expression by either targeting
DNMTS or acting at specific target genes (Schenkel et al., 2017). Much like other RNA
molecules, miRNA biosynthesis begins with transcription by RNA polymerase II into a
looped, hairpin primary-miRNA structure. This primary-miRNA is cleaved by the
endonuclease Drosha, which results in a stem-loop precursor-miRNA molecule. This
precursor-miRNA undergoes nuclear export through Exportin 5, followed by further
enzymatic cleavage by the endonuclease Dicer. The resulting structure is a mature,
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double-stranded miRNA molecule that binds with the RNA-induced silencing complex
(RISC). The double-stranded miRNA is unwound while attached to RISC, with one
strand being degraded while the other serves as a guide strand in finding target mRNA
molecules. Should a miRNA have extensive complementarity between its 5’ untranslated
region (UTR) and the 3’ UTR of an mRNA, degradation of the target mRNA molecule
will occur. Alternatively, short regions of complementarity result in target transcriptional
repression. Using a guinea pig model of uterine artery ablation, Sarr et al. demonstrated
that growth-restricted offspring have decreased miR-146a transcript abundance in the
liver at five months of age (Sarr et al., 2016). It has been proposed that this miRNA
modulates function of HSCs through targeting of SMAD4, and it is decreased in fibrotic
liver tissues (He et al., 2012). In 2016, Su et al. investigated the role of miR-15b in
pancreatic beta cell proliferation of MPR mouse offspring. It was discovered that miR15b is significantly increased in the pancreatic islets of MPR offspring, accompanied by
reduced expression of cyclin D1 and D2 (Su et al., 2016). Given the role of cyclins in cell
cycle progression, it is believed that downregulation of these molecules contributes to
impaired beta cell function and glucose intolerance. Our own studies of MPR during
pregnancy and lactation have also shown that miR-29 is upregulated in MPR offspring
with postnatal catch-up growth (Sohi et al., 2015). Each isoform of miR-29 (miR29a/b/c) was significantly increased in livers of three week and four month old offspring,
further leading to reduced levels of Igf-1 mRNA (Sohi et al., 2015). With that in mind, it
is possible that the timing of nutritional restoration for IUGR offspring may play a role in
long-term disease via modulation of miRs. Given that miRs also circulate in the blood,
these animal studies could lead to novel therapeutic interventions with the use of miR
inhibitors in neonatal treatment of the metabolic syndrome.

1.4 Rationale and Study Aims
It is widely accepted that growth of the IUGR liver becomes compromised at the
expense of other fetal organs. Studies have established that IUGR offspring have poor
long-term metabolic function of the liver, particularly involving hepatic lipid metabolism
(Sohi et al., 2011; Ma et al., 2013). This is exacerbated with rapid postnatal catch-up
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growth, and our laboratory has shown that various forms of cellular stress occur
exclusively following catch-up growth (Sohi et al., 2013; Barra et al., 2017). That said,
the role of mitochondria in this process remains elusive. Mitochondria are key regulators
of cellular metabolism and oxidative stress, and mitochondrial dysfunction is known to
occur with many metabolic pathologies. Not surprisingly, previous studies have found
that IUGR offspring exhibit indices of mitochondrial dysfunction in metabolic tissues,
including the liver (Park et al., 2003; Moraes et al., 2014; Barra et al., 2017; Woodman et
al., 2018). Despite this, the molecular mechanisms leading to mitochondrial dysfunction
in IUGR offspring remain largely unknown, along with impact of catch-up growth on
mitochondrial function (Figure 1-3). Given that hepatic miRNA expression is altered in
IUGR offspring with catch-up growth (Sohi et al., 2015), it is conceivable that miRNAs
also have a role in this process.
These findings give rise to my overall hypothesis that postnatal catch-up growth
leads to hepatic mitochondrial dysfunction in IUGR offspring as an underlying
mechanism of hyperlipidemia, independent of gestational insult. I further predict that
aberrant expression of miRNAs contributes to hepatic mitochondrial dysfunction
exclusively following catch-up growth. To address my hypothesis, the following specific
aims are proposed:
1) Determination of the role of postnatal catch-up growth in mitochondrial
dysfunction among maternal protein-restricted IUGR rat offspring.
2) Analysis and characterization of hepatic mitochondrial dysfunction in an
alternative model of IUGR with postnatal catch-up growth.
3) Investigation of the relationship between hepatic cellular stress, miRNA
expression, and hepatic hyperlipidemia using an in vitro model.
Significance: My proposed studies will provide novel insight into the mitochondrial
mechanisms that underlie dyslipidemia in IUGR offspring. Overall, these studies will
identify important targets that regulate mitochondrial dysfunction in response to insults
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Figure 1-3. Intrauterine growth restriction (IUGR) leads to mitochondrial
dysfunction and hyperlipidemia in the affected offspring.
Although it has been shown that IUGR offspring exhibit mitochondrial dysfunction in
metabolic organs, the molecular mechanisms by which this occurs have not been studied.
Additionally, the role of postnatal catch-up growth in this process remains unknown.
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during the perinatal period. This research will further improve our understanding of
DOHaD, and it has potential in leading to early life therapeutic strategies that could be
employed to mitigate hepatic dysfunction in IUGR offspring.
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2.1 Introduction
Fetal undernutrition gives rise to intrauterine growth restriction (IUGR), a
condition characterized by low birth weight and reduced organ growth. Epidemiological
studies have established a relationship between birth weight and long-term metabolic
health, as individuals exposed to undernutrition in utero exhibit high rates of the
metabolic syndrome in adult life (Ravelli et al. 1998, Roseboom et al. 2001). This
relationship is further exacerbated by postnatal catch-up growth, whereby the affected
offspring undergo rapid weight gain during critical stages of growth and development.
Collectively, this underlies Barker’s ‘thrifty phenotype’ hypothesis, which states that an
adverse intrauterine environment will cause permanent alterations to physiological
processes in anticipation of a similarly hostile postnatal environment (Hales & Barker
2001). When a mismatch in nutrient availability occurs between the pre- and postnatal
environments, these adaptations become maladaptive and pose risk for development of
the metabolic syndrome (Hales & Barker 2001, Ozanne & Hales 2004, Bieswal et al.
2006, Sohi et al. 2011). While animal studies have revealed the contributions of postnatal
catch-up growth to long-term dysmetabolism, the molecular basis of the relationship
between birth weight and postpartum development remains poorly understood.
There is strong evidence to suggest that the composition of maternal diet during
pregnancy plays a role in fetal health. Given that amino acids are essential for fetal
growth and development (Battaglia & Meschia 1978, Crosby 1991), the maternal protein
restriction (MPR) model of undernutrition has been widely utilized in rodents to
investigate the role of protein availability on postnatal outcomes. We and others have
demonstrated that MPR offspring are low birth weight and exhibit asymmetrical organ
growth, with the fetal liver becoming selectively compromised at the expense of other
organs such as the lungs and the brain (Desai & Hales 1997, Sohi et al. 2011, 2013). Not
surprisingly, MPR offspring undergo hepatic and whole-body catch-up growth when
introduced to a normal protein diet at birth or weaning (Ozanne & Hales 2004, Sohi et al.
2011). Our laboratory has established that these ‘recuperated’ offspring exhibit signs of
impaired hepatic function at adulthood, including hypercholesterolemia, glucose
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intolerance (e.g., increased gluconeogenesis) and accelerated drug catabolism due to
differential abundance of hepatic enzymes (Sohi et al. 2011, 2014, Vo et al. 2013).
Conversely, MPR offspring without catch-up growth have normal cholesterol levels and
drug metabolism later in life, but to date, the mechanisms underlying rapid catch-up
growth and dysmetabolism are unclear (Sohi et al. 2011, 2014).
Mitochondria are intracellular energy producers that are largely responsible in
regulating metabolism and oxidative stress. Moreover, impaired mitochondrial function is
associated with various metabolic pathologies (Petersen et al. 2003, Nojiri et al. 2006,
Ozgen et al. 2012), and a variety of maternal insults have been shown to compromise
mitochondrial function in IUGR offspring (Park et al. 2003, Moraes et al. 2014, Barra et
al. 2017, Woodman et al. 2018). While these studies demonstrate the importance of the
maternal nutrition in mediating mitochondrial function, it remains unknown whether
these abnormalities occur directly due to the maternal insult or due to postnatal catch-up
growth. For example, using a model of maternal nicotine exposure (MNE), we have
previously shown that IUGR offspring have both impeded mitochondrial function and
cardiac dysfunction exclusively after catch-up growth has occurred (Barra et al. 2017).
This may also occur in nutrition-induced IUGR offspring (e.g. MPR); however, the
critical windows of nutrient deprivation leading to impaired mitochondrial function and
metabolic disease remain elusive.
Several studies have implicated the p66Shc adaptor protein in processes
contributing to mitochondrial dysfunction and oxidative stress (Migliaccio et al. 1999,
Orsini et al. 2004, Giorgio et al. 2005, Pinton et al. 2007, Trinei et al. 2013). Upon
cellular stress, cytosolic p66Shc becomes phosphorylated at serine residue 36 (Ser36),
followed by a subsequent conformational change that is initiated by the cis/trans
isomerase PIN1 (Giorgio et al. 2005, Pinton et al. 2007). After dephosphorylation of
Ser36 by PP2A phosphatase, p66Shc undergoes mitochondrial translocation to permit
binding with cytochrome C. This interaction promotes increased production of ROS, as
well as accelerated rates of mitochondrial-induced apoptosis and cellular senescence
(Migliaccio et al. 1999, Giorgio et al. 2005). Studies have shown that activation of
p66Shc also leads to compromised aerobic metabolism, which may further contribute to
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increased reactive oxygen species (ROS) production (Acin-Perez et al. 2010, Lone et al.
2018). While the mechanism by which this occurs is not yet clear, there is evidence to
suggest that increased p66shc activation is linked to metabolic pathologies such as
diabetes and coronary artery disease (Pagnin et al. 2005, Noda et al. 2010). Therefore, the
overall objective of this study was to determine if MPR offspring exhibit hepatic
mitochondrial dysfunction following postnatal catch-up growth, and to define if this was
concomitant with elevated levels of p66Shc and oxidative stress in adulthood.
Furthermore, given that increased p66Shc expression has been associated with
endoplasmic reticulum (ER) stress (Zhang et al. 2013), and MPR offspring with catch-up
growth exhibit hepatic ER stress (Sohi et al. 2013), we further anticipated that ER stress
may mediate any increase in p66Shc expression.

2.2 Materials and Methods
2.2.1

Animals and Dietary Regimes
All procedures were performed according to guidelines set by the Canadian

Council of Animal Care with approval from the Animal Care Committee at The
University of Western Ontario. Male and female Wistar rats (250 g, 8–10 weeks old)
were purchased from Charles River (La Salle, St. Constant, QC) and left to acclimatize to
environmental conditions of the animal care facility for 3 weeks. Upon proestrus, female
rats were placed in cages of male rats for mating, and pregnancy was confirmed the next
morning via presence of sperm in the vaginal smear (gestational day 1). Pregnant dams
were then fed either a normal (20% casein) protein diet or a low (8% casein, LP) protein
diet for the remainder of gestation (Figure 2-1). Diets were made isocaloric with each
other through the addition of carbohydrates (i.e. sucrose) to the LP diet as we have
previously published (Sohi et al. 2015), and food was provided ad libitum throughout
pregnancy. Despite the increased carbohydrate content, the LP diet is not considered to
be high in carbohydrates as the addition of sucrose is modest (i.e., an increase of 13%) in
comparison to decreased total protein (i.e., a decrease of 60%). At birth, litter size was
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reduced to eight animals by selecting pups with birth weight closest to the litter mean.
Offspring born to control diet-fed mothers continued to feed off a control diet for the
remainder of life, while offspring born to LP dams were assigned to one of three LP
groups (Figure 2-1): low protein 1 (LP1), low protein 2 (LP2) or low protein 3 (LP3).
LP1 offspring were fed a LP diet throughout life, while LP2 offspring were introduced to
a normal protein diet at weaning (postnatal day 21). Given that hepatic differentiation in
rats is not complete at birth (Gruppuso & Sanders 2016), the LP2 group of offspring
allows us to examine the effects of protein restriction during the entire perinatal period.
LP3 offspring received a control diet at birth and continued to feed on this diet for the
remainder of life. Necropsy was performed at postnatal days (PND) 21 and 130 to
examine the direct and indirect effects of MPR, respectively. As demonstrated by our
studies and others, PND 130 was chosen given it is the time at which poor metabolic
outcomes (i.e., glucose intolerance and hypercholesterolemia) are manifested in these low
birth weight offspring (Chamson-Reig et al. 2009, Sohi et al. 2011). For the purposes of
this study, male offspring were exclusively selected because female MPR offspring
exhibit less metabolic deficits (i.e., normal cholesterol levels) and to avoid confounding
effects presented by the female estrus cycle (Sohi et al. 2011). The right medial hepatic
lobe was collected and immediately flash-frozen in liquid nitrogen, followed by storage at
−80°C until further use.

2.2.2

Cell Culture and Induction of ER stress
The HepG2 human hepatocellular carcinoma cell line was obtained from the

American Type Culture Collection (ATCC) and cultured in 5% CO2/95% atmospheric air
at 37°C. Cells were maintained in minimum essential medium (MEM; Gibco)
supplemented with 10% fetal bovine serum (FBS; Gibco) and 1% penicillin-streptomycin
solution (10,000 IU and 10,000 μg/mL, respectively; Fisher Scientific). For induction of
ER stress, cells between passages 7 and 10 were seeded at a density of 2.0 × _10

5

cells/well in six-well culture plates (Thermo Scientific) and allowed to proliferate for 24
h prior to treatment. Cells were then treated with 0.5, 1.0 and 2.0 μg/ mL tunicamycin
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Figure 2-1. The maternal protein restriction (MPR) rodent model of undernutrition.
MPR diets differ according to percent protein composition and timing of nutritional
intervention. Pregnant Wistar rat dams were subjected to an 8% protein diet during
gestation, and pups were randomly assigned to one of three postnatal dietary regimens at
birth: 8% protein diet throughout life (LP1), 8% protein diet until three weeks of age +
20% (control) diet after three weeks (LP2), or 20% protein diet throughout life (LP3).
Importantly, liver development continues postnatally in the rat, with terminal hepatic
differentiation occurring between postnatal days 18 and 21.
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(BioShop Canada, Burlington, ON) for 1, 2 and 6 h. Additional cells were treated with a
matching volume of DMSO as a vehicular control for 1, 2 and 6 h. Following treatment,
cells were collected for protein isolation and western immunoblotting as described below.

2.2.3

RNA Isolation and Real-Time PCR Analysis
Total RNA was isolated from PND 21 and 130 livers using the one-step method

of Chomczynski and Sacchi (TRIzol; Invitrogen), followed by RT with a High-Capacity
cDNA RT Kit (Applied Biosystems). Primer sets for gene targets of interest were
designed using the National Center for Biotechnology Information and Ensembl genome
browsers, followed by generation via Invitrogen Custom DNA Oligos (Table 2-1).
Relative transcript abundance was determined via quantitative real-time PCR (qRT-PCR)
as previously published (Barra et al. 2017). Values obtained for all gene targets of
interest were normalized to geometric means of β-Actin and GAPDH, which were
determined to be suitable housekeeping genes by using both the comparative ΔCt method
and algorithms from geNorm, Normfinder and BestKeeper (Vandesompele et al. 2002,
Pfaffl et al. 2004). Relative transcript abundance was calculated for each primer set as
determined by the comparative ΔCt method.

2.2.4

Protein Extraction and Western Immunoblot
Whole-cell protein lysates were isolated from liver segments and HepG2 cells as

previously published (Barra et al. 2017). Protein loading samples were prepared for
western immunoblotting using sample lysates, NuPAGE reducing agent (10×;
Invitrogen), NuPAGE LDS sample buffer (4×; Invitrogen), and deionized water. Loading
samples were heated at 70°C to denature proteins, followed by loading into wells of 4–
12% Bis-Tris gels (Invitrogen). For liver samples, 20 μg of protein was loaded per well,
while cell samples were loaded at 10–12 μg per well. Following separation by gel
electrophoresis, proteins were transferred onto PVDF membranes (Thermo Scientific) at
100 volts for 2 h. Membranes were blocked in 1× _Tris-buffered saline/Tween-20
(TBST) buffer with either 5% non-fat milk (Carnation) or 3% bovine serum albumin
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(BSA; EMD Millipore), followed by probing with primary and secondary antibodies
(Table 2-2). Immunoreactive bands were visualized using either Millipore Immobilon
Forte Western HRP Substrate solution or BioRad Clarity Max Western ECL Substrate
solution and imaged using a BioRad ChemiDoc XRS+ Imaging System. Resulting bands
were analyzed using BioRad Image Lab™ Software, and band intensities of target
hepatic mitochondrial proteins were normalized to those of β-Actin as previously
published (Wei et al. 2009, Zhao et al. 2019). Note that while a sample size of 7–8
offspring per group was used for all experiments, representative immunoblots containing
all experimental groups on one blot are presented with either 4 offspring (PND 130) or 5–
6 offspring (PND 21) per group.

2.2.5

Statistical Analyses
All statistical analyses were performed using GraphPad Prism 8 software. Results

were expressed as means of normalized values ± s.e.m., and the threshold for statistical
significance was set as P < 0.05. As mentioned previously, a sample size of 7–8 offspring
(i.e., litter is the statistical unit) was used for all in vivo experiments, as this provided
enough statistical power to detect significant differences in outcome measures. Again,
immunoblots presented are representative and do not contain all offspring included in
statistical analyses, but are rather presented such that all groups are contained on the same
blot. To ensure that trends were consistent within the control group on blots
used for analysis, data were normalized such that the same control sample was used as an
internal loading control (i.e., the first control sample, present in lane one). Results
obtained from body weight or qRT-PCR were analyzed using one-way ANOVA followed
by Tukey’s multiple comparisons test. Because we were interested solely in the
differences between the control diet and each individual MPR treatment (i.e., the timing
of nutritional intervention), individual Student’s unpaired t-tests were performed on
distinct blots comparing each MPR group to their respective control. All cell culture
experiments were performed in biological replicates of 3, where each replicate represents
an independent experiment using a different frozen cell stock or passage number. These
in vitro data were analyzed at each time point using a Student’s unpaired t-test, as the
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Table 2-1. Forward and reverse sequences for primers used in analysis of mRNA
targets via quantitative real-time PCR.
Gene
pin1

Forward Sequence

nd1

b-Actin
GAPDH

GenBank/
Reference

CAGCTCAGGCCGTGT
CTACTA

p66Shc

Reverse Sequence

TACTTGGTTCGGGTG
AGTGC

TCCGAGATTGGCTG
TGCTTC

GAGCAGGAAGTCC

CCTAAGACACCACC

CAGGTA

AGCATGT

CACAGCTGAGAGGG

TCAGCAATGCCTGG

AAAT

GTAC

AGAGAGAGG

NM_053517.2

CGACAAA

CCGAGAACGCAACT

GGATACTGAGAGCA

NM_001106701.2

TCCTGTTGTTATGG
GGTCTGG

NM_001006972.1

NM_031144
NM_017008.4

62
Table 2-2. Western blot primary and secondary antibodies, dilutions, and
company/catalog information.
Antibody Name
SHC1

Source
Mouse
monoclonal

Pin1 (G-8)

Mouse
monoclonal

4hydroxynonenal

Mouse
monoclonal

Superoxide

Rabbit

dismutase

polyclonal

Dilution

Company (Catalogue No.)

1:1000 Acris Antibodies, Rockville, MD, USA
(AM00143PU-N)
1:1000 Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA (sc-46660)
1:1000 R&D Systems, Oakville, ON, Canada
(MAB3249)
1:1000 Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA (sc-11407)

(SOD)-1 (FL154)
Superoxide

Rabbit

dismutase

polyclonal

1:1000 Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA (sc-30080)

(SOD)-2 (FL222)
Catalase (H-300)

Rabbit
polyclonal

pSer(232)

Rabbit

pyruvate

polyclonal

1:1000 Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA (sc-50508)
1:1000 EMD Millipore, Etobicoke, ON, Canada
(AP1063)

dehydrogenase
Pyruvate
dehydrogenase
LDHa

Rabbit
polyclonal
Rabbit
polyclonal

1:1000 Cell Signaling Technology Inc., Danvers,
MA, USA (2784S)
1:1000 Cell Signaling Technology Inc., Danvers,
MA, USA (2012S)
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Citrate Synthase

Rabbit
polyclonal

OXPHOS rodent
cocktail
TFAM (D5C8)

Mouse
monoclonal
Rabbit
monoclonal

KDEL ER
Marker (10C3)
b-Actin
Peroxidase

Mouse
monoclonal
Mouse
monoclonal

Goat anti-rabbit
IgG HRP-linked

1:1000 Provided by Dr. S. Raha, McMaster
University
1:1000 Abcam Inc., Toronto, ON, Canada
(ab110413)
1:1000 Cell Signaling Technology Inc., Danvers,
MA, USA (8076S)
1:250 Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA (sc-58774)
1:25000 Sigma Aldrich Co., St. Louis, MO, USA
(A3854-200UL)
1:10000 Cell Signaling Technology Inc., Danvers,

N/A

MA, USA (7074P2)

(H+L chain)
Horse anti-mouse
IgG HRP-linked
(H+L chain)

1:10000 Cell Signaling Technology Inc., Danvers,
N/A

MA, USA (7076S)
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purpose of this experiment was to determine if tunicamycin-induced ER stress led to
elevated p66Shc abundance rather than the effects observed with time.

2.3 Results
2.3.1

Restoration of dietary proteins following maternal protein
restriction results in rapid postnatal catch-up growth
We and others have previously shown that MPR causes decreased birth weight,

while the restoration of dietary proteins produces rapid postnatal catch-up growth in the
affected offspring (Hales et al. 1996, Desai & Hales 1997, Sohi et al. 2011). To
determine if MPR offspring used in our study underwent whole body and/or liver catchup growth, body weights and liver weights were recorded at birth and PND 21 and 130
(i.e., 3 weeks and 4 months of age). Using these weights, liver to body weight ratio was
calculated for offspring at each time point. At postnatal day 21, LP1/LP2 offspring had
significantly decreased average bodyweight and liver weight relative to control offspring
(Table 2-3; P < 0.0001), while there were no differences in body weight and liver weight
between LP3 and control offspring. Interestingly, liver to body weight ratios of both
LP1/LP2 and LP3 offspring were significantly lower than those of control offspring at
this time point (Table 2-3; P < 0.01 and P < 0.05, respectively). At 4 months of age, LP1
offspring weighed significantly less than control offspring (Table 2-3; P < 0.05), while
body weights of LP2 and LP3 offspring were not significantly different from those of
control offspring (i.e., postnatal catch-up growth had occurred). There were no significant
differences between liver weights and liver to body weight ratios of control offspring
compared to all groups of MPR offspring at 4 months of age (Table 2-3).
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Table 2-3. Maternal protein restriction followed by restoration of dietary protein
leads to rapid postnatal catch-up growth by four months of age.
d21

d130

Control

48.75 ± 1.06a

544.25 ± 10.30bc

Body Weight

LP1

26 ± 0.53b

467 ± 15.82a

(g)

LP2

N/A

504.38 ± 11.35ab

LP3

46.14 ± 2.97a

602 ± 22.12c

Control

1.91 ± 0.07a

17.16 ± 1.84a

Liver Weight

LP1

0.86 ± 0.001b

15.60 ± 0.84a

(g)

LP2

N/A

16.94 ± 0.79a

LP3

1.65 ± 0.002a

19.30 ± 1.54a

Control

0.04 ± 0.001a

0.031 ± 0.003a

Liver:Body

LP1

0.03 ± 0.001b

0.033 ± 0.001a

Weight Ratio

LP2

N/A

0.033 ± 0.001a

LP3

0.04 ± 0.001b

0.032 ± 0.002a

For offspring at both timepoints, liver growth was assessed by calculating liver to body weight ratio. All
data are expressed as means ± SEM, and dietary effects were determined using one-way ANOVA followed
by Tukey’s multiple comparisons test. Groups labeled with different letters are significantly different from
each other.
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2.3.2

Maternal protein restriction during the perinatal period

leads to increased hepatic p66Shc following postnatal catch-up
growth
Given the strong association between p66Shc and impaired mitochondrial
function (Migliaccio et al. 1999, Orsini et al. 2004, Giorgio et al. 2005, Pinton et al.
2007, Trinei et al. 2013), we first measured the expression levels of hepatic p66Shc in
our MPR offspring. While the steady-state mRNA levels of p66Shc remained unaffected
in all MPR offspring (Figure 2-2A), LP2 offspring demonstrated a significant increase in
p66Shc protein abundance at 4 months of age compared to control offspring (Figure 22D; P < 0.05). Conversely, p66Shc protein levels were significantly decreased in LP1 and
LP3 offspring when compared against that of control offspring (Figure 2-2D; P < 0.05).
These data were consistent with changes in protein abundance of peptidyl-prolyl cis-trans
isomerase NIMA-interacting 1 (PIN1), an isomerase that is essential for translocation of
p66Shc into mitochondria. Transcript abundance of Pin1 remained unchanged across all
groups (Figure 2-2B); however, PIN1 protein abundance was significantly increased in
LP2 offspring at 4 months (Figure 2-2E; P < 0.05). PIN1 protein abundance was not
significantly affected in LP1 or LP3 offspring at this time point (Figure 2-2E).

2.3.3

Maternal protein restriction causes increased oxidative
stress following postnatal catch-up growth
Given that increased expression of p66Shc is indicative of oxidative stress, we

next measured levels of markers of oxidative stress via Western immunoblotting. When
cells exist in a state of oxidative stress, there is increased oxidation of polyunsaturated
fatty acids (PUFAs) resulting in the formation of various lipid hydroperoxides. 4Hydroxynonenal (4-HNE) is among the most bioactive of hydroperoxides produced, and
it is recognized as an indirect marker of mitochondrial-induced oxidative stress when
present at high levels (Liu et al. 2011). Using an antibody specific for 4-HNE adducts of
histidine residues, we determined that all groups of 4-month old MPR offspring (LP1,
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Figure 2-2. Maternal protein restriction (MPR) and postnatal catch-up growth
together increase hepatic p66Shc and PIN1 in 4-month-old male offspring.
Transcript and protein abundances of p66Shc and Pin1 were determined via quantitative
real-time PCR and Western immunoblotting, respectively. Relative transcript abundance
of (A) p66Shc and (B) Pin1 were expressed as means normalized to the geometric mean
of β-actin and GAPDH ± SEM (n = 7–8/group). (C) Representative western immunoblots
for specific targeted protein bands of control, LP1, LP2 and LP3 offspring as detected by
primary antibodies for p66Shc and PIN1. Relative protein abundances of (D) p66Shc and
(E) PIN1 at 4 months of age were expressed as means normalized to β-Actin ± SEM (n =
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7–8/group). All qRT-PCR data were analyzed using a one-way ANOVA and multiple
comparisons test, while protein abundances were compared using a two-tailed unpaired
Student’s t-test. *Significant difference (P < 0.05).
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LP2, and LP3) exhibited significantly increased 4-HNE relative to control offspring
(Figure 2-3B; P < 0.001 [LP1] and P < 0.01 [LP2 and LP3]). To determine if antioxidant
defenses were altered in response to this oxidative stress, we next examined protein
abundance of hepatic superoxide dismutase (SOD) 1, SOD2 and catalase. Immunoblot
analysis revealed that at four months of age, SOD1 and SOD2 were both significantly
increased in LP2 offspring relative to control offspring (Figure 2-3C, D; P < 0.05 and P <
0.01). In contrast, SOD1 and SOD2 protein abundance remained unchanged in LP1
offspring at 4 months of age (Figure 2-3C, D; P = 0.22 and 0.20), as was the case for LP3
offspring (Figure 2-3C, D; P = 0.73 and 0.16). Interestingly, abundance of catalase was
significantly reduced in both LP1 and LP2 offspring (Figure 2-3E; P = 0.02 and P =
0.03), while LP3 offspring were unaffected (Figure 2-3E; P = 0.42).

2.3.4

Maternal protein restriction in combination with postnatal
catch-up growth leads to impaired aerobic respiration at
4 months of age
Because p66Shc has been suggested to mediate mitochondrial respiration through

alterations in oxidative phosphorylation, we next investigated the expression of various
enzymes involved in mitochondrial aerobic respiration (Nemoto et al. 2006, Acin-Perez
et al. 2010, Lone et al. 2018). Following completion of glycolysis, pyruvate
dehydrogenase (PDH) converts pyruvate to acetyl coenzyme-A (acetyl CoA) for use in
the citric acid cycle (TCA). Increased phosphorylation of PDH results in inhibited PDH
activity, thereby promoting increased glycolysis in the presence of oxygen (i.e., aerobic
glycolysis). At 4 months of age, LP2 offspring displayed a significant increase in the ratio
of phosphorylated PDH (p-PDH) to total PDH (Figure 2-4B; P < 0.05), as well as
significantly increased levels of lactate dehydrogenase subunit A (LDHa; Figure 2-4C; P
= 0.03). At this time point, the ratio of p-PDH to total PDH was unchanged in LP1
offspring (Figure 2-4B; P = 0.25), while it was significantly augmented in LP3 offspring
(Figure 2-4B; P < 0.05). Abundance of LDHa was significantly decreased in LP1 and
LP3 offspring (Figure 2-4C; P = 0.02 and P = 0.04).
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Figure 2-3. Maternal protein restriction leads to increased markers of hepatic
oxidative stress at 4 months of age.
(A) Representative Western immunoblots illustrating expression of 4-hydroxynonenal, a
marker of lipid peroxidation, superoxide dismutase (SOD) 1 and SOD2 in LP1, LP2 and
LP3 offspring relative to control diet-fed offspring. Protein abundances of (B) 4HNE, (C)
SOD1, (D) SOD2, and (E) catalase in each group of MPR offspring were each compared
against control offspring. 4HNE abundance was expressed as means normalized to total
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protein abundance ± SEM (n = 7–8/group), while SOD1, SOD2 and catalase abundances
were normalized to β-Actin ± SEM (n = 7–8/group). All protein abundances were
analyzed using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05),
**significant difference (P < 0.01), ***significant difference (P < 0.001).
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Figure 2-4. Maternal protein restriction and postnatal catch-up growth together
lead to aberrant markers of aerobic metabolism at 4 months of age.
(A) Representative Western immunoblots for specific targeted protein bands for control,
LP1, LP2 and LP3 offspring as detected by primary antibodies. Protein abundances of (B)
phosphorylated pyruvate dehydrogenase (PDH) to total PDH, (C) lactate dehydrogenase
subunit A (LDHa), (D) citrate synthase, and (F) mitochondrial transcription factor A
(TFAM) in LP1, LP2 and LP3 offspring were compared against control diet-fed offspring
and expressed as means normalized to β-Actin ± SEM (n = 7–8/group). (E) Transcript
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abundance of NADH:ubiquinone oxidoreductase core subunit V1 (ND1), a marker of
mitochondrial number, was expressed as means normalized to geometric means of βActin and GAPDH ± SEM (n = 7–8/group). All qRT-PCR data were analyzed using a
one-way ANOVA and multiple comparisons test, while protein abundances were
compared using a two-tailed unpaired Student’s t-test. *Significant difference (P < 0.05),
**significant difference (P < 0.01), ***significant difference (P < 0.001).
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Considering the role of the electron transport chain (ETC) in oxidative
phosphorylation, we measured levels of the five protein complexes within the ETC.
While protein abundance of complexes I, III, IV and V were unaffected in LP2 offspring
(Figure 2-5B, D–F), complex II was significantly decreased in LP2 offspring at 4 months
of age (Figure 2-5C; P < 0.0001). In contrast, complex II protein abundance was
unaffected in LP1 and LP3 offspring (Figure 2-5B). Moreover, the expression levels of
mitochondrial complexes I, III, IV and V were also not altered in LP1 and LP3 offspring
(Figure 2-5B, D–F).
Given the perinatal environment could have detrimental effects on mitochondrial
size and abundance, we first assessed citrate synthase (CS) protein levels as a marker of
mitochondrial mass and function. We observed a significant decrease in CS levels of LP2
offspring at 4 months of age relative to control offspring (Figure 2-4D; P < 0.001).
Interestingly, LP1 offspring also displayed a significant decrease in CS levels at this time
point when compared against control offspring (Figure 2-4D; P < 0.05). CS protein levels
of LP3 offspring were unaffected compared to control offspring at 4 months of age
(Figure 2-4D). Since we saw changes in the expression of CS and other mitochondrial
metabolic enzymes, we next sought to determine if this was due to changes in
mitochondrial number. Using qRT-PCR, we measured hepatic transcript abundance of
NADH:ubiquinone oxidoreductase core subunit V1 (ND1) as a marker of mitochondrial
number. At 4 months of age, ND1 mRNA abundance was unchanged in all groups of
MPR offspring (Figure 2-4E). However, immunoblot analysis of mitochondrial
transcription factor A (TFAM), which is critical in activating mitochondrial genome
transcription, revealed a significant decrease in TFAM abundance in LP2 offspring
(Figure 2-4F; P = 0.004). In contrast, TFAM abundance was significantly increased in
LP1 and LP3 offspring (Figure 2-4F; P = 0.002 and 0.008).

2.3.5

Maternal protein restriction alone leads to decreased
p66Shc protein abundance at 3 weeks of age
To distinguish between the direct effects of the MPR diet versus postnatal catch-

up growth, we next evaluated the expression of p66Shc and previously examined
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Figure 2-5. Maternal protein restriction leads to decreased protein levels of complex
II of the mitochondrial electron transport chain at four months of age.
(A) Specific targeted protein bands of control, LP1, LP2, and LP3 offspring as detected by
primary antibodies via western immunoblot. Protein abundances of (B) complex I, (C)
complex II, (D) complex III, (E) complex IV, and (F) complex V protein abundances were
compared in each group of MPR offspring against control offspring. Protein abundances
of all targets were normalized to β-Actin ± SEM (n= 7–8/group). All protein abundances
were analyzed using a two-tailed unpaired Student’s t-test.
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mitochondrial markers at three weeks (i.e., postnatal day 21). Western immunoblots
revealed a significant decrease in p66Shc protein levels in protein-restricted (i.e.,
LP1/LP2) offspring compared to control offspring (Figure 2-6B; P < 0.05), while p66Shc
was unchanged in LP3 offspring (Figure 2-6B). Levels of PIN1, 4HNE, citrate synthase,
and all ETC complexes were unaltered in all MPR offspring relative to controls (Figure
2-6C, D, F and Figure 2-7B–F). While the ratio of p-PDH to total PDH was unchanged in
LP1/LP2 offspring (Figure 2-6E; P = 0.44), LP3 offspring displayed a significant
increase in p-PDH to total PDH (Figure 2-6E; P < 0.01).

2.3.6

Induction of ER stress in vitro promotes increased
abundance of p66Shc
Given that our previous studies of these same MPR offspring revealed that only

LP2 offspring exhibit ER stress (Sohi et al. 2013), and there is an association between
increased ER stress and p66Shc (Zhang et al. 2013), we next investigated if induction of
ER stress in vitro leads to augmented hepatic p66Shc protein levels in short-term cell
culture. HepG2 cells were used for all in vitro experiments given their ability to secrete
proteins that are found primarily in fetal hepatocytes (Maruyama et al. 2007). Cells were
treated with various doses of tunicamycin, a potent inducer of ER stress in HepG2 cells
(Lei et al. 2016), and collected at 1, 2 and 6 h to determine which dose was most effective
in inducing ER stress. A dose of 0.5 μg/mL proved to be most consistent in inducing ER
stress, as evidenced by a trending increase in Grp94 protein levels relative to cells treated
with DMSO vehicular control (Figure 2-8B; P = 0.08 (1 h), 0.10 (2 h), 0.07 (6 h)).
Interestingly, HepG2 cells treated with tunicamycin had a significant increase in p66Shc
protein levels at 1 h and 2 h (Figure 2-8C; P < 0.05).

2.4 Discussion
In this study, we demonstrate that perinatal protein restriction with postnatal
catch-up growth leads to hepatic oxidative stress and mitochondrial dysfunction in adult
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Figure 2-6. Maternal protein restriction does not independently contribute to
increased p66Shc or oxidative stress at 3 weeks of age.
(A) Representative Western immunoblots of specific targeted protein bands for control,
LP1/LP2, and LP3 offspring as detected by primary antibodies. Protein abundances of
(B) p66Shc, (C) PIN1, (D) 4HNE, (E) p-PDH, and (F) citrate synthase were compared in
each group of MPR offspring against control offspring. 4HNE abundance was expressed
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as means normalized to total protein abundance ± SEM (n = 7–8/group), while
abundances of all other targets were normalized to β-Actin ± SEM (n = 7–8/group). All
protein abundances were analyzed using a two-tailed unpaired Student’s t-test.
*Significant difference (P < 0.05), **significant difference (P < 0.01).
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Figure 2-7. Maternal protein restriction does not independently contribute to
altered complex proteins of the mitochondrial electron transport chain at three
weeks of age.
(A) Specific targeted protein bands of control, LP1/LP2, and LP3 offspring as detected by
primary antibodies via western immunoblot. (B) Complex I, (C) complex II, (D) complex
III, (E) complex IV, and (F) complex V protein abundances were compared in each group
of MPR offspring against control offspring. Protein abundances of all targets were
normalized to β-Actin ± SEM (n= 7–8/group). All protein abundances were analyzed
using a two-tailed unpaired Student’s t-test.
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Figure 2-8. Induction of ER stress with tunicamycin results in increased protein
abundance of p66Shc in the HepG2 cell line.
(A) Representative Western blots illustrating protein abundance of GRP94 and p66Shc in
HepG2 cells treated with either DMSO vehicular control for 1 h (V1), 2 h (V2) or 6 h
(V6), or 0.5 μg/mL tunicamycin for 1h (T1), 2h (T2) or 6h (T6). Fold change difference
of (B) p66Shc and (C) GRP94 were expressed as means from three biological replicates
normalized to β-Actin ± SEM, and again normalized to untreated control cells at 0h (V0).
Protein abundances for each time point were analyzed using a two-tailed unpaired
Student’s t-test. *Significant difference (P < 0.05).
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rat offspring. Our results suggest that catch-up growth, rather than the direct low protein
diet, leads to increased expression of mitochondrial stress marker p66Shc and the
cis/trans isomerase PIN1 at 4 months of age. These cellular stresses were exclusive to
LP2 offspring, which experienced catch-up growth after completion of liver
differentiation (i.e, after 3 weeks) in the rat (Gruppuso & Sanders 2016). It is noteworthy
that LP2 offspring are also exposed to the longest period of protein restriction, including
22 days during gestation and 21 days in postnatal life. In addition, LP2 offspring
exhibited long-term hepatic oxidative stress, as observed by the apparent changes in
expression of 4-HNE, SOD1, SOD2, and catalase. Furthermore, these LP2 offspring
display elevated levels of phospho-PDH(Ser232) and LDHa, as well as decreased
abundance of CS and mitochondrial ETC complex II, collectively indicating impaired
mitochondrial metabolism. Finally, we established a direct relationship between ER stress
and hepatic p66Shc expression, thereby uncovering a potential mechanism for increased
hepatic p66shc in these LP2 offspring. Taken together, our in vivo and in vitro results
suggest that the dysmetabolism exhibited by MPR offspring is driven in part by
mitochondrial dysfunction and oxidative stress (Figure 2-9).
While previous studies have verified the significance of oxidative stress and
mitochondrial impairment in metabolic disease (Petersen et al. 2003, Nojiri et al. 2006,
Ozgen et al. 2012), the role of developmental programming in this process remains
largely unknown. In rat offspring, it has been suggested that MPR may be protective
during the first month of life by decreasing production of ROS and promoting increased
coupling between cellular respiration and oxidative phosphorylation (Moraes et al. 2014).
Despite this, adult male offspring have been demonstrated to have increased hepatic
oxygen consumption and markers of oxidative stress, as well as reduced expression of
mitochondrial (mt)-DNA encoded genes (Park et al. 2003, They et al. 2009, Moraes et al.
2014). These data are consistent with human and rodent studies of obesity and
cardiovascular disease, as mitochondrial defects arise with morbid obesity and insulin
resistance (Dobrian et al. 2001, Koliaki et al. 2015).
In many cell types, increased oxidative injury is mediated, in part, by augmented
expression of p66Shc (Orsini et al. 2004, Giorgio et al. 2005, Pinton et al. 2007). This is
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Figure 2-9. Proposed schematic illustrating the effects of perinatal protein
restriction in combination with postnatal catch-up growth on hepatic mitochondrial
health.
In summary, LP2 offspring were the only experimental group subject to MPR that
exhibited increased protein abundance of p66Shc and PIN1. These offspring also
displayed aberrant markers of oxidative stress and metabolism, indicating that
mitochondrial health had become impaired in adulthood following catch-up growth in
early life.
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particularly evident in the diseased liver, which exhibits elevated expression of p66Shc
(Haga et al. 2010, Perrini et al. 2015, Zhao et al. 2019). Using rodent models of various
hepatic pathologies, knockdown of p66Shc prevents liver injury by ameliorating
oxidative stress and mitochondrial dysfunction (Haga et al. 2010, Perrini et al. 2015,
Zhao et al. 2019). Our expression analysis of p66Shc and PIN1 suggests that there may
be increased stabilization of p66Shc in LP2 offspring, thereby accelerating hepatic
mitochondrial ROS generation. Previous findings demonstrate that MPR offspring with
catch-up growth display elevated renal p66Shc much later in life (i.e., 6 months), but this
is already a time of significant aging (Luyckx et al. 2009). In addition, a comparison to
the effects of a low protein cohort (i.e., LP1) were not determined. Conversely, our study
highlights how the timing of postnatal nutritional intervention leads to differential
expression of hepatic p66Shc expression in young adult offspring. Given that LP1
offspring have decreased expression of p66Shc and unchanged levels of PIN1, it is
possible that maintenance of a LP diet in postnatal life may actually protect the adult liver
from mitochondrial dysfunction in absence of catch-up growth. Moreover, decreased
expression of p66Shc in adult LP3 offspring suggests that introduction of a normal
protein diet during lactation, a period of hepatic plasticity, could ‘rescue’ MPR offspring
by preventing mitochondrial stress (Gruppuso & Sanders 2016). LP3 offspring undergo
catch-up growth prior to the completion of hepatic differentiation (Gruppuso & Sanders
2016); therefore, it is possible that earlier nutritional intervention (i.e., <3 weeks
postpartum) allows for recovery from any negative effects of the gestational MPR diet.
Since we observed elevated p66Shc and PIN1 expression in MPR offspring, we
next investigated if this coincided with the presence of hepatic oxidative stress.
Interestingly, our data revealed that LP2 offspring have increased 4-HNE and SODs, but
decreased expression of catalase. Not only does this suggest that LP2 offspring exhibit
the greatest degree of oxidative stress, but also that MPR with catch-up growth likely
triggers the SOD antioxidant response over time. While this may occur as a
compensatory mechanism in response to p66Shc-mediated oxidative stress, it is not
sufficient in overcoming the cumulative oxidative stress that is brought about by other
mechanisms. That said, decreased abundance of catalase in LP2 offspring may contribute
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to the apparent oxidative stress via an inability to decompose hydrogen peroxide in the
liver. Because 4-HNE, SOD1 and catalase are not specific to the mitochondria, the
differential expression of these markers indicates the presence of general cellular
oxidative stress as well. That said, SOD2 is localized to the mitochondria (Weisiger &
Fridovich 1973); therefore, its upregulation, in combination with increased p66Shc and
decreased TFAM, is suggestive of mitochondrial-induced oxidative stress. A previous
report indicates that LP2 adult offspring have increased activity of hepatic SOD activity
at three months of age; however, direct markers of oxidative stress were not measured
(Theys et al. 2009). Furthermore, the authors did not examine how the timing of postnatal
protein restoration may contribute to this antioxidant response (Theys et al. 2009).
Collectively, given LP2 offspring are the only MPR group to exhibit abnormal expression
of both p66Shc and PIN1 along with all examined markers of oxidative stress, it is
conceivable that increased p66shc/PIN1 in these offspring is conducive to oxidative and
mitochondrial damage in the liver.
Studies of aging have uncovered the relationship between oxidative stress and
impaired mitochondrial metabolism, as oxygen-free radicals can cause inactivation of
metabolic enzymes present within the mitochondrion (Cadenas & Davies 2000). More
recently, p66Shc has been demonstrated to cause abnormal aerobic respiration (AcinPerez et al. 2010, Lone et al. 2018); however, the mechanisms by which this occurs
remain relatively unclear. Interestingly, p66Shc stabilization leads to reduced oxygen
consumption rate and reduced production of ATP in vitro (Lone et al. 2018), while its
deficiency can reduce basal and maximal oxygen consumption capacity and increase
production of lactate by LDHa (Nemoto et al. 2006). Moreover, in cultured mouse
embryos, greater total p66shc has been correlated with decreased cellular ATP production
and increased superoxide production (Edwards et al. 2016). Our study determined that
MPR and catch-up growth affects all stages of aerobic respiration, as we observed
increased phosphorylation of PDH along with decreased abundance of citrate synthase
and mitochondrial complex II proteins. Increased p-PDH is indicative of impaired
mitochondrial function, as the cell begins to preferentially convert pyruvate to lactate
rather than acetyl CoA (Lone et al. 2018). This is in agreement with our data concerning
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LDHa, which was upregulated in adult LP2 offspring. With respect to the ETC,
mitochondrial complex II was the only subunit to be influenced by MPR. This is of great
interest considering that decreased activity of complex II can cause elevated ROS
production within the mitochondria (Walker et al. 2006). Citrate synthase, the enzyme
responsible for production of citrate from acetyl CoA and oxaloacetate in the TCA, is
also a prominent marker of mitochondrial biomass. Decreased hepatic citrate synthase
abundance and activity is associated with insulin resistance in male obese rats (Rector et
al. 2010); therefore, the current decrease in hepatic citrate synthase abundance helps
explain the decreased hepatic insulin sensitivity and enhanced gluconeogenesis of LP2
offspring observed in our previous studies (Sohi et al. 2013, Vo et al. 2013). Finally, the
observed decrease in protein levels of TFAM are indicative of reduced mtDNA content.
Suppression of TFAM has been previously associated with altered mitochondrial
function, suggesting that it may have a role in mediating metabolic activity and disease
(Vernochet et al. 2012).
To understand why MPR offspring with catch-up growth might exhibit exclusive
increases in p66shc, we focused our attention of the role of ER stress on the
mitochondria. The ER and mitochondrion are physically connected via sites known as the
mitochondrial-associated ER membrane (MAMs), which are highly concentrated with
calcium transporters and ion channels (Hayashi et al. 2009). These channels can
indirectly alter ATP production in response to protein demands of the ER (Burton et al.
2017), and it has been demonstrated that their activity is influenced by nutrient
availability (Theurey et al. 2016). Upon cellular stress, the presence of misfolded and
unfolded proteins in the ER initiates the unfolded protein response (UPR), leading to
activation of downstream targets that promote an adaptive or apoptotic phenotype (Xu et
al. 2005). Under severe ER stress, the UPR is initiated to promote the transcription of
genes that increase folding capacity of the ER (i.e., Grp94) or protein attenuation (i.e.,
phosphorylation of eukaryotic initiation factor 2 alpha (eIF2α) (Xu et al. 2005). We have
previously demonstrated that the same LP2 offspring examined as part of this study
exhibit elevated phosphorylated eIF2α _and higher expression of chaperone proteins in
the liver (Sohi et al. 2013). Given that these findings are exclusive to LP2 offspring, it
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appears that catch-up growth is implicated in onset of hepatic ER stress. Our in vitro
studies in HepG2 liver cells directly linked ER stress with increased protein abundance of
p66Shc, consequently implicating this process as a potential instigator of augmented
hepatic p66Shc expression in LP2 offspring. It is noteworthy that in a model of
intermittent hypoxia, p66Shc has been associated with increased ER stress in the rat
testes; however, the direct role of ER stress on p66Shc was not investigated (Zhang et al.
2013). Because we saw an increase in p66Shc as early as 1 h after tunicamycin treatment,
as well as an increase only in p66Shc protein but not mRNA in vivo, it is possible that ER
stress may regulate p66Shc expression via post-transcriptional mechanisms. P66Shc has
been demonstrated to be subject to post-transcriptional regulation (Kumar et al. 2017);
therefore, future in vitro studies will investigate this relationship in efforts of elucidating
the molecular mechanisms by which ER stress may regulate p66Shc in vivo.
In summary, our data indicate that postnatal catch-up growth plays a direct role in
the mitochondrial function of adult MPR offspring. We are the first to demonstrate that
the timing of nutritional insult can modify expression of hepatic p66Shc, an important
modulator of mitochondrial-induced oxidative stress. Protein deficiency exclusively
during the perinatal period appears to be most detrimental to hepatic mitochondrial
function, while restoration of a normal protein diet at birth shows promise in ameliorating
oxidative stress and mitochondrial defects. While these outcomes may be mediated by
hepatic ER stress, future studies are warranted in determining the exact mechanism by
which this occurs. Overall, our study provides further support for the main tenet of
Barker’s ‘thrifty phenotype’ hypothesis, as it highlights the importance of the nutritional
environment in developing organ systems and risk for the adult metabolic syndrome.
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to postnatal catch-up growth and hepatic mitochondrial
dysfunction in the adult rat
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3.1 Introduction
Cannabis is the most commonly used recreational drug among individuals of
reproductive age. In 2019, the Canadian Cannabis Survey found that approximately 21%
of female adolescents and young adults self-reported daily or almost daily use of
cannabis, while 40% reported monthly use (‘Canadian Cannabis Survey 2019 - Summary
- Canada.ca’). The American College of Obstetricians and Gynecologists has further
found that 2–5% of individuals use cannabis during pregnancy, and this was increased to
15–28% among young women who lived in urban settings and whom were
socioeconomically disadvantaged (‘Marijuana use during pregnancy and lactation’,
2017). Along with the recent legalization of recreational cannabis in Canada and select
American states, the use of cannabis during pregnancy has become increasingly popular
despite limited evidence of its safety. Many pregnant individuals use cannabis to diminish
nausea, anxiety and depression, as they believe it to be a ‘safe’ and natural alternative to
prescription medications (Westfall et al., 2006; Brown et al., 2019; Chang et al., 2019).
Alarmingly, gestational exposure to cannabis can increase the risk for adverse neonatal
outcomes, including low birth weight and preterm delivery (English et al., 1997; Conner
et al., 2016; Gunn et al., 2016). However, these studies are confounded by that fact that
cannabis users are more likely to concurrently abuse other drugs, such as alcohol and
tobacco (Michalski et al., 2020), highlighting the need for animal studies that focus on
the effects of specific constituents of cannabis (i.e., Δ9-tetrahydrocannabinol [Δ9-THC]
and cannabidiol [CBD]) on short- and long-term maternal-fetal outcomes (Michalski et
al., 2020).
Cannabis is composed of several distinct compounds that stimulate the
endocannabinoid system via the interaction with cannabinoid receptor type 1 (CB1R) and
CB2R. These receptors are highly expressed throughout the central nervous system
(CNS). Therefore, their activation by cannabinoids has a profound effect on mood, pain,
memory and appetite (Silvestri and Di Marzo, 2013). At the same time, CB1R and CB2R
are localized in peripheral metabolic tissues, suggesting that the endocannabinoid system
has additional roles outside of neurocognitive function (Bouchard et al., 2003; Sun and
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Dey, 2012; Malenczyk et al., 2015; Ramírez-López et al., 2016). Many cannabinoids are
also lipophilic and able to cross the placental barrier, thereby entering fetal circulation
and allowing for activation of CB1R and CB2R (Maia et al., 2019). While the activation
of the endocannabinoid system is essential for the maintenance of pregnancy, the
presence of exogenous cannabinoids can also directly interfere with fetal growth and
development through the disruption of endocannabinoid signaling. Gestational exposure
to D9-THC, the principal psychoactive component of cannabis, has been demonstrated to
promote placental insufficiency and symmetrical intrauterine growth restriction (IUGR)
in rodents, characterized by low birth weight and reduced neonatal organ weight
(Harbison and Mantilla-Plata, 1972; Fried, 1976; Hurd et al., 2005; Benevenuto et al.,
2017; Chang et al., 2017; Natale et al., 2020). Notably, the liver-to-body weight ratio is
reduced in D9-THC offspring, followed by rapid catch-up growth in the first three weeks
of life (Natale et al., 2020). While the developmental origins of health and disease
(DOHaD) postulates that there is a relationship between birth weight and metabolic
health, the role of gestational D9-THC exposure on postnatal hepatic function has not yet
been investigated.
The liver has a critical role in controlling lipid metabolism, which involves the
synthesis and degradation of structural and functional lipid molecules. Naturally,
impaired liver function leads to dyslipidemia, whereby triglycerides and cholesterol
become elevated in the liver and plasma. Dyslipidemia is a well-characterized attribute of
the metabolic syndrome that often accompanies obesity. Therefore, individuals with
either of these conditions exhibit an increased risk for developing diabetes and
cardiovascular disease (James et al., 2004). Moreover, epidemiological studies have
identified that low birth weight individuals with decreased liver-to-body weight ratio are
more likely to be obese and have non-alcoholic fatty liver disease (NAFLD) during
childhood and adult life (Ravelli et al., 1976; Barker et al., 1993; Eriksson et al., 2001;
Nobili et al., 2007; Yang et al., 2008; Faienza et al., 2013; Suomela et al., 2016). Similar
trends have been found in studies of rodent IUGR offspring. We previously shown that
maternal nicotine exposure leads to elevated hepatic and circulating triglycerides in adult
male offspring, while protein-restricted adult males have increased hepatic and
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circulating cholesterol (Sohi et al., 2011; Ma et al., 2013). Hepatic hyperlipidemia often
occurs due to divergent synthesis and metabolism of free fatty acids, which can be of
dietary, circulating or de novo origin (Jensen-Urstad and Semenkovich, 2012). In
particular, de novo lipogenesis is a highly regulated, multi-step process that involves the
esterification of fatty acids to triglycerides through the action of numerous enzymes.
Initially, acetyl-coA carboxylase (ACCα) catalyzes the carboxylation of acetyl-coA to
malonyl-coA, which acts as a substrate for fatty acid synthase (FAS) in generating
saturated fatty acids (Kim, 1997; Jensen-Urstad and Semenkovich, 2012). Stearoyl-coA
desaturase-1 (SCD-1) then converts these saturated fatty acids into monounsaturated fatty
acids (MUFAs), which undergo various elongation reactions to generate the long chain
fatty acids that feed into triglyceride synthesis pathways (Miyazaki and Ntambi, 2003).
The cytosolic transport of these long chain fatty acids is mediated by various fatty acid
binding proteins (FABPs), which are highly expressed in tissues that control lipid
metabolism. Importantly, the diacylglycerol acyltransferase (DGAT) enzyme catalyzes
the terminal step of triglyceride synthesis (Cases et al., 1998; Smith et al., 2000). Studies
of the growth-restricted liver demonstrate that many of these enzymes are particularly
sensitive to developmental reprogramming, as their abundance and activity levels change
with exposure to a variety of gestational insults leading to long-term dyslipidemia
(Yamada et al., 2011; Ma et al., 2013; Deodati et al., 2018; Cheng et al., 2020). That
said, the underlying mechanisms linking a poor in utero environment to these metabolic
deficits remain elusive.
Oxidative stress and mitochondrial dysfunction occur with many metabolic
pathologies, including hepatic hyperlipidemia. Many studies have shown that growthrestricted offspring exhibit oxidative stress and impaired mitochondrial metabolism in the
liver (Park et al., 2003; Wang et al., 2008; Theys et al., 2009; Moraes et al., 2014;
Devarajan et al., 2019; Oke et al., 2019). Therefore, it is possible that mitochondrial
dysfunction precedes dyslipidemia in IUGR offspring. This may be mediated, in part, by
the adaptor protein p66Shc, which is known to accelerate the mitochondrial production of
ROS (Giorgio et al., 2005). Human and animal studies indicate that the p66Shc-induced
oxidative signal is involved in the accumulation of intracellular lipids, leading to obesity
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and NAFLD (Berniakovich et al., 2008; Tomita et al., 2012). Not surprisingly, growthrestricted offspring display increased levels of p66Shc in the liver, kidney, and pancreas
at birth and in postnatal life (Luyckx et al., 2009; Oke et al., 2019; Raez-Villanueva et
al., 2022). Furthermore, using a rodent model of maternal protein restriction, we have
also shown that adult male offspring have increased hepatic protein abundance of p66Shc
following postnatal catch-up growth (Oke et al., 2019). These same offspring also have
aberrant expression of various microRNAs (miRs) in the liver, so it is possible that the
expression of genes involved in de novo lipogenesis and mitochondrial function may be
regulated via epigenetic mechanisms (Sohi et al., 2015). Based on the fact that gestational
exposure to D9-THC leads to compromised liver growth, the present study investigates
the effects of D9-THC on hepatic lipid metabolism in the exposed offspring. Given the
role of mitochondria in metabolic disease and the growth-restricted liver, we
hypothesized that D9-THC-exposed offspring would exhibit oxidative stress and
mitochondrial dysfunction, along with aberrant expression of miRs that are known to
result in dysmetabolism.

3.2 Materials and Methods
3.2.1

Animals and Experimental Handling
All procedures were performed according to guidelines set by the Canadian

Council of Animal Care, and the animal use protocol was approved by the Animal Care
Committee at The University of Western Ontario (AUP #2019-126, January 2019). All
investigators understood and followed the ethical principles outlined by Grundy (Grundy,
2015), and the study design was informed by ARRIVE guidelines (Kilkenny et al., 2010).
Pregnant female Wistar rats were purchased from Charles River (La Salle, St. Constant,
QC, Canada). Dams arrived at the animal care facility at gestational day 3 (GD3) and
were left to acclimatize to environmental conditions for three days. All animals were
maintained at 22 °C on a 12:12 h light-dark cycle in the animal care facility, while food
and water were provided ad libitum for the entire duration of the experimental protocol.
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Dams were randomly assigned to receive daily intraperitoneal (i.p.) injection of either
vehicular control (1:18 cremophor:saline) or 3 mg/kg D9-THC (Sigma-Aldrich, St. Louis,
MO, USA) from E6.5 to E22 (n = 14, where litter is the statistical unit) as previously
performed (Natale et al., 2020). This dose of D9-THC was selected as it results in rodent
plasma concentrations (8.6–12.4 ng/mL) that are reflective of those found in human
recreational cannabis smokers (using 6% D9-THC) 0–22h post-inhalation (13–63 ng/mL),
as well as in the aborted fetal tissues of pregnant cannabis users (4–287 ng/mL; Klein et
al., 2011; Schwope et al., 2011; Falcon et al., 2012). This dose and method of delivery
has also been demonstrated to have no impact on maternal or litter outcomes in rats
(Mato et al., 2004; Tortoriello et al., 2014; Natale et al., 2020). An oral route of
administration was not chosen as to avoid the poor bioavailability and slowed adsorption
of D9-THC when ingested with food, and as edibles are the least popular route of
administration of cannabis among pregnant women (Dinieri and Hurd, 2012; Chang et
al., 2019). Injections were initiated at E6.5 because D9-THC can interfere with
implantation of the blastocyst and induce spontaneous abortion (Dinieri and Hurd, 2012).
Maternal food intake and body weight were monitored daily throughout the entire
gestational period. Dams were allowed to deliver normally, and all pups were weighed at
birth. Litters were randomly culled to eight offspring per litter to ensure uniformity of
litter size between treatment groups. As previously reported, we and others have found
the selected dose of D9-THC has no impact on maternal or litter outcomes (Mato et al.,
2004; Tortoriello et al., 2014; Chang et al., 2017; Natale et al., 2020). Liver weights of
culled offspring were recorded and compared to body weight as a measure of fetal growth
restriction and postnatal catch-up growth (Natale et al., 2020). The food intake of these
offspring was monitored by measuring their daily food consumption from PND50-60, as
previously published (Sohi et al., 2015). The remaining offspring were fasted for 24 h
before being euthanized via i.p. injection of 100 mg/kg pentobarbital at either postnatal
day (PND) 21 or six months of age (n = 8 males/8 females per group), followed by
necropsy to examine the effects of D9-THC on metabolic and molecular outcomes. The
right medial hepatic lobe was collected and immediately flash-frozen in liquid nitrogen,
followed by storage at −80 °C until further use. Visceral fat was also weighed and
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compared to body weight at six months as a measure of obesity. Blood was also
collected, centrifuged, and stored at −80 °C.

3.2.2

Hepatic Triglyceride Measurements
Circulating and hepatic triglyceride and cholesterol measurements were detected

using the Cobas® Mira S analyzer as previously published (Ma et al., 2013). For
triglyceride measurements, triglycerides were hydrolyzed by lipoprotein lipase to
glycerol and fatty acids. Glycerol was then phosphorylated to glycerol-3-phosphate by
ATP in a reaction catalyzed by glycerol kinase (GK). The oxidation of glycerol-3phosphate was catalyzed by glycerol phosphate oxidase (GPO) to form dihydroxyacetone
phosphate and hydrogen peroxide (H2O2). In the presence of peroxidase, H2O2 alters the
oxidative coupling of 4-chlorophenol and 4-aminophenazone to form a red-colored
quinoneimine dye, which was measured at 512 nm. The increase in absorbance is directly
proportional to the concentration of triglycerides in the sample. For cholesterol
measurements, cholesterol esterase cleaved cholesterol esters, which then were converted
to choleste-4-en-3-one and H2O2 by cholesterol oxidase. Cholesterol levels were
quantified using a colorimetric assay that measured the breakdown of H2O2 via the
Trinder reaction as previously described (Sohi et al., 2011).

3.2.3

RNA Isolation and Quantitative Real-Time PCR Analysis
MicroRNAs were isolated from frozen liver samples using a miRNeasy kit

(QIAGEN Inc., Toronto, ON, Canada), followed by spectrophotometric analysis with a
Nanodrop 2000. 0.5 µg of each miRNA sample was then reverse transcribed into cDNA
using a miScript II RT kit (QIAGEN Canada) and stored at −20 °C. Forward sequence
primers for miR-203a-3p, miR-29a, miR-29b, and miR-29c were purchased (QIAGEN
Canada), while a universal reverse sequence primer for miRNAs was used as part of a
miScript SYBR green PCR kit (QIAGEN Canada). MiRNA transcripts were amplified
via quantitative real-time PCR (qRT-PCR) using the Bio-Rad CFX384 Real Time
System, using cycling conditions as previously published (Sohi et al., 2015). Cq values
obtained for miRs of interest were normalized to that of a miRNA standard control
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(Ctrl_miRTC_1; QIAGEN Canada), and relative transcript abundance was calculated for
each target using the comparative DCt method.

3.2.4

Protein Extraction and Western Immunoblot
Whole-cell protein lysates were isolated using the protocol, previously described

by Barra et al. (Barra et al., 2017) Prior to western immunoblotting, loading samples were
prepared using sample lysates, NuPAGE reducing agent (10×; Invitrogen, Waltham, MA,
USA), NuPAGE LDS sample buffer (4X; Invitrogen), and deionized water. Loading
samples were heated at 70 °C to denature proteins, while a separate set of loading mixes
were kept unheated for mitochondrial OXPHOS immunoblots. Samples were loaded into
wells of 4–12% Bis-Tris gels (Invitrogen) at 20–30 µg per well (n = 8/group), followed
by separation via gel electrophoresis. Proteins were transferred onto PVDF membranes
(Thermo Scientific, Waltham, MA, USA) at 75 V for two hours, followed by one hour of
blocking in 1X Tris-buffered saline/Tween-20 (TBST) buffer with either 5% non-fat milk
(Carnation) or 3% bovine serum albumin (BSA; Fisher Scientific, Ottawa, ON, Canada).
Membranes were probed with primary antibodies overnight, followed by probing with
secondary antibodies for one hour (Table 3-1). To avoid the excessive use of PVDF
membranes, multiple targets of interest were detected on each membrane by cutting the
membrane according to molecular weight and probing with the appropriate primary
antibodies in separate tubes. In the case that a membrane was reused, the primary
antibody was removed with stripping buffer (ThermoFisher Scientific, Waltham, MA,
USA), followed by incubation with secondary antibody and re-imaging to ensure that the
initial antibody was removed. Immunoreactive bands were visualized using BioRad
Clarity Max Western ECL Substrate solution (Bio-Rad Laboratories Canada Ltd,
Mississauga, ON, Canada) and imaged using a BioRad ChemiDoc XRS+ Imaging
System. Resulting bands were analyzed using BioRad Image LabTM Software. Band
intensities of target proteins were normalized to β-Actin, as previously published (Oke et
al., 2019), with the exception of 4-hydroxynonenol which was normalized to total protein
content detected with Ponceau staining (Hayes et al., 2012; Oke et al., 2019). Signals for
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Table 3-1. Western blot primary and secondary antibodies, dilutions and
company/catalogue information.

Antibody Name
ACCa (H-76)

Source

Dilution

Rabbit

1:500

polyclonal
FAS (C20G5)

Rabbit

Rabbit
polyclonal

FABP1 (D2A3X)

Rabbit
monoclonal

DGAT1
DGAT2 (4C1)

Rabbit

1:1000 Cell Signaling Technology Inc.,

dehydrogenase
Pyruvate dehydrogenase

Santa Cruz, CA, USA (sc-30081)
1:1000 Cell Signaling Technology Inc.,
Danvers, MA, USA (#13368)
1:1000 Novus Biologicals, Centennial, CO,
1:1000 Santa Cruz Biotechnology Inc.,

Mouse
Rabbit
Rabbit
polyclonal
Rabbit
polyclonal

LDHa

Santa Cruz Biotechnology Inc.,

Mouse

monoclonal
pSer(232) pyruvate

1:250

USA (NB110-41487)

monoclonal
TFAM (D5C8)

Danvers, MA, USA (#3180)

polyclonal
monoclonal
SHC

Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA (sc-30212)

monoclonal
SCD (H300)

Company (Catalogue No.)

Rabbit
polyclonal

Santa Cruz, CA, USA (sc-293211)
1:1000 BD BioSciences, San Jose, CA,
USA (610879)
1:1000 Cell Signaling Technology Inc.,
Danvers, MA, USA (8076)
1:1000 EMD Millipore, Etobicoke, ON,
Canada (AP1063)
1:1000 Cell Signaling Technology Inc.,
Danvers, MA, USA (2784)
1:1000 Cell Signaling Technology Inc.,
Danvers, MA, USA (2012)
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Citrate Synthase

Rabbit
polyclonal

Catalase (H-300)

Rabbit
polyclonal

Superoxide dismutase
(SOD)-1 (FL-154)
Superoxide dismutase

Rabbit
polyclonal
Rabbit

1:1000 Provided by Dr. S. Raha, McMaster
University
1:1000 Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA (sc-50508)
1:1000 Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA (sc-11407)
1:1000 Santa Cruz Biotechnology Inc.,

(SOD)-2 (FL-222)

polyclonal

4-hydroxynonenal

Mouse

1:1000 R&D Systems, Oakville, ON,

monoclonal

Canada (MAB3249)

OXPHOS rodent
cocktail
b-Actin Peroxidase

Mouse
monoclonal
Mouse
monoclonal

Goat anti-rabbit IgG
HRP-linked (H+L

Santa Cruz, CA, USA (sc-30080)

1:1000 Abcam Inc., Toronto, ON, Canada
(ab110413)
1:25000 Sigma Aldrich Co., St. Louis, MO,
USA (A3854-200UL)
1:10000 Cell Signaling Technology Inc.,

N/A

Danvers, MA, USA (7074P2)

chain)
Horse anti-mouse IgG
HRP-linked (H+L
chain)

1:10000 Cell Signaling Technology Inc.,
N/A

Danvers, MA, USA (7076S)
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proteins that were detected on the same membrane were normalized to that of β-Actin
from the same membrane.

3.2.5

Statistical Analyses
At each timepoint, the selected offspring were taken from separate litters to avoid

litter bias (i.e., n = 1 represents pups from a single dam), where a sample size of n = 7–8
was used for each sex per group. This sample size was chosen based on our previous
studies to achieve a statistically significant difference with an expected standard deviation
of 15% or less (Beamish et al., 2017; Gillies et al., 2020). All statistical analyses were
performed using GraphPad Prism 9 software. The results were expressed as means of
normalized values ± SEM, and the threshold for significance was set as p < 0.05. Organ
and body weight data were analyzed using Student’s two-tailed unpaired t-test when
examining both sexes together (e.g., PND1), while sex-specific effects were analyzed by
two-way ANOVA followed by a Holm-Sidak-corrected multiple comparisons test. All
immunoblot data were analyzed using Student’s two-tailed unpaired t-test. Triglyceride
and cholesterol measurements obtained from lipid analyses were analyzed by two-way
ANOVA, followed by Holm-Sidak-corrected multiple comparisons test between D9-THC
offspring and their sex-matched controls. Grubbs’ test was utilized to detect any
statistical outliers.

3.3 Results
3.3.1

Gestational exposure to D9-THC leads to hepatic catchup growth by three weeks of age
At birth (i.e., PND 1), D9-THC-exposed offspring exhibited decreased liver to

body weight ratio compared to control offspring (Table 3-2; p < 0.05). It should be noted
that in this same cohort of vehicle and D9-THC offspring, we have published that D9THC exposure during pregnancy did not lead to changes in maternal food intake,
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Table 3-2. Gestational exposure to D9-tetrahydrocannabinol (D9-THC) leads to
hepatic catch-up growth by three weeks and increased visceral adiposity in adult
life.
Treatment
Group

Sex

Birth

Male
Control
Liver to
Body
Weight
Ratio

Female
Both sexes
Male

D9-THC

Female
Both sexes
Male

Control
Female
Adipose
to Body
Weight
Ratio

0.0392# ±
0.0039

Both sexes
Male
D9-THC

Female
Both sexes

0.0293¨ ±
0.0018

Three Weeks

Six Months

0.0458a ±
0.0026
0.0445a ±
0.0017
0.0451# ±
0.0011
0.0459a ±
0.0010
0.0437a ±
0.0009
0.0445#± 0.0020

0.0319a ±
0.0024
0.0354a ±
0.0034
0.0333# ±
0.0020
0.0350a ±
0.0017
0.0351a ±
0.0022
0.0351# ±
0.0014
0.01685a ±
0.0015
0.0202a ±
0.0025
0.01828# ±
0.0014
0.0207a ±
0.0020
0.0234a ±
0.0022
0.0223¨±
0.0015

Liver growth and visceral adipose deposition were assessed for all offspring by calculating liver to
body weight ratio and adipose to body weight ratio. All data are expressed as means ± SEM (n = 7–
18/sex/group). The effects of D9-THC on liver to body weight ratio and visceral adipose to body
weight ratio were determined via Student’s two-tailed unpaired t-test. Sex-specific differences in liver
to body weight ratio were assessed using a two-way ANOVA followed by a Holm-Sidak-corrected
multiple comparisons test. Groups labelled with different letters or symbols are significantly different
from each other.
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maternal weight gain, litter size or gestational length (Natale et al., 2020). By three weeks
of age, these offspring had exhibited hepatic catch-up growth, as there were no significant
differences between liver to-body-weight ratios of D9-THC-exposed offspring and
control offspring (Table 3-2). This is consistent with other rodent models of IUGR,
including maternal nicotine exposure and maternal protein restriction, whereby growthrestricted offspring also undergo catch-up growth by three weeks (Sohi et al., 2011; Barra
et al., 2017). At three weeks of age, there were also no differences in liver-to-body weight
ratios between male and female offspring of either treatment group (Table 3-2),
indicating that there were no sex-specific effects of gestational D9-THC with respect to
hepatic catch-up growth. At six months of age, liver to body weight ratio remained equal
between both groups and sexes (Table 3-2). It should also be noted that gestational
exposure to D9-THC did not significantly affect postnatal food intake (PND50–60) in
either males (vehicle, 19.3 ± 1.5 g food/day/offspring; D9-THC, 15.1 ± 2.1 g
food/day/offspring) or females (vehicle, 17.7 ± 1.6 g food/day/offspring; D9-THC, 20.0 ±
1.9 g food/day/offspring.

3.3.2

Adult D9-THC-exposed offspring exhibit elevated
visceral adiposity and hepatic hyperlipidemia
As mentioned previously, adult IUGR offspring are vulnerable to the development

of obesity and hepatic pathologies involved in lipid storage and metabolism. Given that
D9-THC induces symmetrical IUGR (Natale et al., 2020), we were interested in
comparing the levels of visceral adipose tissue and hepatic lipids between control and D9THC-exposed offspring during adult life. At six months, offspring exposed to gestational
D9-THC exhibited increased visceral adipose to body weight ratio (Table 3-2; p < 0.05),
suggesting dyslipidemia in these animals. That said, this was true only when examining
both sexes together, as there were differences in visceral adipose to body weight ratio
when examining each sex individually. To explore this further, we measured hepatic and
circulating triglyceride and cholesterol levels of each sex for both groups at six months of
age. While both hepatic and circulating triglyceride and cholesterol levels of D9-THC-
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exposed female offspring remained unchanged at six months (Figure 3-1A–D), hepatic
triglycerides were elevated in D9-THC-exposed males in comparison to control males and
all females (Figure 3-1A; p < 0.05). Interestingly, hepatic cholesterol was unaltered in
six-month old male offspring exposed to gestational D9-THC, as were circulating
triglycerides and cholesterol (Figure 3-1B–D). Since the differences in lipid content were
observed exclusively in livers of male offspring, we further quantified hepatic
triglycerides and cholesterol in male offspring at an earlier timepoint. At three weeks of
age, hepatic triglycerides and cholesterol were not significantly altered between control
and D9-THC-exposed male offspring (Figure 3-1E,F).

3.3.3

Elevated hepatic triglyceride levels coincide with
increased diglycerol acyltransferase and p66Shc protein
levels in the livers of adult male D9-THC-exposed
offspring
To gain insight on possible mechanisms involved in the elevation of hepatic

triglycerides among adult male D9-THC-exposed offspring, we performed western
immunoblotting for enzymes involved in the triglyceride synthesis pathway. D9-THCexposed males exhibited increased DGAT1 (Figure 3-2F; p < 0.05) and DGAT2 (Figure 32G; p < 0.05) in the liver at six months of age, while there were no significant differences
in hepatic ACCα, FAS, SCD, or FABP1 (Figure 3-2B–E). Adult female D9-THC-exposed
offspring also demonstrated a significant increase in DGAT2 (Figure 3-2N; p < 0.05)
relative to female controls, while all other enzymes involved in triglyceride synthesis were
unchanged (Figure 3-2I–M). As p66Shc is linked to the accumulation of intracellular lipids
(Berniakovich et al., 2008), we further quantified the relative abundance of p66Shc protein
in control and D9-THC-exposed offspring. Adult male offspring exposed to gestational D9THC demonstrated increased hepatic p66Shc protein abundance at 6 months compared to
control male offspring (Figure 3-2H; p < 0.05), while p66Shc was unchanged in adult
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Figure 3-1. The effects of gestational D9-tetrahydrocannabinol (D9-THC) on
triglyceride and cholesterol levels in the liver and plasma of exposed offspring at three
weeks and six months of age.
At six months of age, hepatic triglycerides (A) and cholesterol (B) were assessed
in both male and female offspring (mg of lipid/g of tissue), along with circulating levels
of triglycerides (C) and cholesterol (D; mmol/L). Hepatic triglycerides (E) and
cholesterol (F) were also quantified in three-week old male offspring. Data are expressed
as the mean ± SEM. The effects of D9-THC in three-week old male offspring were
determined via Student’s two-tailed unpaired t-test, while six-month old offspring results
were analyzed using a two-way ANOVA followed by a Holm-Sidak-corrected multiple
comparisons test. Groups labelled with different letters are significantly different from
each other (p < 0.05), while groups labelled ‘ns’ were non-significant from each other.
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Figure 3-2. Gestational exposure to 9-tetrahydrocannabinol (D9-THC) leads to
upregulation of lipogenic enzymes in male offspring at six months of age.
(A) Representative western immunoblots illustrating hepatic expression of acetyl-coA
carboxylase (ACCα), fatty acid synthase (FAS), stearoyl-coA desaturase (SCD), fatty
acid binding protein 1 (FABP1), diacylglycerol acyltransferase (DGAT) 1, DGAT2, and
p66Shc in male and female offspring at six months of age. Protein abundances of each
enzyme for male offspring (B–H) and female offspring (I–O) were normalized to β-Actin
± SEM (n = 7–8/group). All protein abundances were analyzed using a two-tailed
unpaired Student’s t-test. * Significant difference (p < 0.05).
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female offspring (Figure 3-2O). Again, because changes were observed in hepatic lipid
content exclusively in adult male offspring, we further examined the expression of these
enzymes in males at three weeks of age. At three weeks, D9-THC-exposed male offspring
had increased protein abundance of ACCα, SCD, FABP1, and DGAT2 (Figure 3-3B, D,
E, and F; P < 0.05). However, protein levels of FAS, DGAT1, and p66Shc were unchanged
in male offspring at three weeks of age (Figure 3-3B–D,F,H).

3.3.4

Gestational exposure to D9-THC does not affect protein
levels of enzymes involved in aerobic metabolism at six
months of age
Given that male offspring exhibit altered lipid metabolism and increased p66Shc,

which are both implicated in mitochondrial dysfunction (Ipsen et al., 2018; Lone et al.,
2018), we then assessed protein levels of enzymes involved in aerobic metabolism. At six
months, the abundance of mitochondrial transcription factor A (TFAM), a protein that is
essential in activating mitochondrial genome transcription, was unaltered in both male
and female offspring exposed to gestational D9-THC (Figure 3-4B,F). Furthermore, male
offspring exhibited no changes in the ratio of phosphorylated pyruvate dehydrogenase at
serine residue 232 (p-PDH[Ser232]) to the total PDH, lactate dehydrogenase subunit A
(LDHa), or citrate synthase (Figure 3-4C–E). Interestingly, six-month female offspring
exposed to gestational D9-THC displayed a decrease in the ratio of p-PDH[Ser232] to
total PDH (Figure 3-4G), while protein levels of LDHa and citrate synthase were
unchanged (Figure 3-4H,I). However, at three weeks of age, male D9-THC offspring
exhibited increased levels of TFAM (Figure 3-5B; p < 0.01) and LDHa (Figure 3-5D; p <
0.01), while the ratio of p-PDH[Ser232] to total PDH and levels of citrate synthase were
unchanged (Figure 3-5C,E).
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Figure 3-3. Three-week old male offspring exhibit increased lipogenic enzyme
expression in the liver following gestational exposure to D9-tetrahydrocannabinol
(D9-THC).
(A) Representative western immunoblots illustrating hepatic expression of acetyl-coA
carboxylase (ACCα), fatty acid synthase (FAS), stearoyl-coA desaturase (SCD), fatty
acid binding protein 1 (FABP1), diacylglycerol acyltransferase (DGAT) 1, DGAT2, and
p66Shc in male offspring at three weeks of age. Protein abundances of (B) ACCα, (C)
FAS, (D) SCD, (E) FABP1, (F) DGAT1, (G) DGAT2 and (H) p66Shc were normalized
to β-Actin ± SEM (n = 7–8/group). All protein abundances were analyzed using a twotailed unpaired Student’s t-test. * Significant difference (p < 0.05), ** significant
difference (p < 0.01), *** significant difference (p < 0.001).
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Figure 3-4. Gestational exposure to D9-tetrahydrocannabinol (D9-THC) does not
impair aerobic metabolism in male or female offspring at six months of age.
(A) Representative western immunoblots illustrating hepatic expression of mitochondrial
transcription factor A (TFAM), phosphorylated pyruvate dehydrogenase (PDH) to total
PDH, lactate dehydrogenase subunit A (LDHa), and citrate synthase in male and female
offspring at six months of age. Protein abundances of each enzyme for male offspring
(B–E) and female offspring (F–I) were normalized to β-Actin ± SEM (n = 7–8/group).
All protein abundances were analyzed using a two-tailed unpaired Student’s t-test. *
Significant difference (p < 0.05).
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Figure 3-5. Three-week old male offspring exposed to D9-tetrahydrocannabinol (D9THC) in utero have increased mitochondrial transcription factor A (TFAM) and
lactate dehydrogenase subunit A (LDHa).
(A) Representative western immunoblots illustrating hepatic expression of mitochondrial
transcription factor A (TFAM), phosphorylated pyruvate dehydrogenase (PDH) to total
PDH, lactate dehydrogenase subunit A (LDHa), and citrate synthase in male and female
offspring at six months of age. Protein abundances of (B) TFAM, (C) pPDH[Ser232]/PDH, (D) LDHa and (E) citrate synthase were normalized to β-Actin ±
SEM (n = 7–8/group). All protein abundances were analyzed using a two-tailed unpaired
Student’s t-test. ** Significant difference (p < 0.01).
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3.3.5

Gestational exposure to D9-THC leads to altered hepatic
protein levels of superoxide dismutase 1 in adult male
offspring
Given that the increased p66Shc is also associated with oxidative stress(Giorgio et

al., 2005), we further analyzed the abundance of antioxidant enzymes that are critical in
combatting the damaging effects of ROS. Male offspring demonstrated decreased protein
levels of SOD1 at six months of age (Figure 3-6C; p < 0.05), while catalase and SOD2
remained unchanged at this time point (Figure 3-6B,D). Lipid peroxidation was also
unaffected at six months of age in male offspring exposed to D9-THC, as indicated by
levels of 4-hydroxynonenol (4HNE; Figure 3-6E). At three weeks, male D9-THCexposed offspring did not exhibit any changes in catalase, superoxide dismutase (SOD) 1
or SOD2 protein levels (Figure 3-6F–H). However, hepatic lipid peroxidation was
increased as indicated by elevated levels of 4HNE (Figure 3-6I; p < 0.05).

3.3.6

Mitochondrial electron transport chain complexes are
increased in male offspring at six months and three
weeks of age following gestational exposure to D9-THC
The mitochondrial electron transport chain is known to have significant

contribution to the production of ROS, particularly through the activity of complexes I
and III (Brand, 2010). Given we observed changes in antioxidant and mitochondrial
proteins in D9-THC offspring, we next quantified protein levels of each subunit of the
electron transport chain. At six months, male offspring exposed to gestational D9-THC
exhibited increased abundance of complexes I, III, and V (Figure 3-7B,D,F; p < 0.05),
while levels of complexes II and IV were unchanged (Figure 3-7C,E). While adult female
offspring demonstrated an increase in the protein abundance of complex I (Figure 3-7G; p
< 0.01), the expression of all other subunits remained unchanged (Figure 3-7H–K). At
three weeks, male D9-THC-exposed offspring also demonstrated increased levels of
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Figure 3-6. Gestational exposure to D9-tetrahydrocannabinol (D9-THC) results in
hepatic oxidative stress within male offspring at three weeks and six months of age.
(A) Representative western immunoblots illustrating hepatic expression of catalase,
superoxide dismutase (SOD) 1, SOD2 and 4-hydroxynonenol (4HNE) in male offspring
at three weeks and six months. Protein abundance of catalase (B,F), SOD1 (C,G), and
SOD2 (D,H) were normalized to β-Actin ± SEM (n = 7–8/group), while 4HNE
abundance (E,I) was expressed as means normalized to total protein abundance ± SEM (n
= 7–8/group). All protein abundances were analyzed using a two-tailed unpaired
Student’s t-test. * Significant difference (p < 0.05).
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Figure 3-7. Gestational exposure to D9-tetrahydrocannabinol (D9-THC) leads to
increased complexes I, III and V of the electron transport chain in male offspring at
six months of age.
(A) Representative western immunoblots illustrating hepatic expression of complexes I–
V of the electron transport chain in male and female offspring at six months of age.
Protein abundances of each enzyme for male offspring (B–F) and female offspring (G–
K) were normalized to β-Actin ± SEM (n = 7–8/group). All protein abundances were
analyzed using a two-tailed unpaired Student’s t-test. *Significant difference (p < 0.05),
**significant difference (p < 0.01).
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complexes I and III (Figure 3-8B,D; p < 0.05), while all other complexes were unchanged
(Figure 3-8C,E,F).

3.3.7

Adult male offspring exposed to gestational D9-THC
exhibit decreased hepatic transcript levels of miR-203a3p and miR-29a/b/c
Various miRs are known to be dysregulated with metabolic disease, and we have

previously shown that IUGR offspring with postnatal catch-up growth exhibit altered
expression of miRs, specifically, miR-29a/b/c (Sohi et al., 2015). To better understand
the potential mechanisms behind the increase in p66Shc protein levels among adult male
D9-THC-exposed livers, we first investigated whether hepatic transcript abundance of
miR-203a-3p, which silences p66shc (Wang et al., 2020), was altered in these same
offspring. As expected, transcript abundance of miR-203a-3p was significantly decreased
in the livers of adult male offspring with gestational exposure to D9-THC (Figure 3-9A; p
< 0.001). Furthermore, livers from three-week old male D9-THC-exposed offspring
displayed a trending increase in miR-203a-3p transcript abundance, but this change was
not significant (Figure 3-9E). Similar to miR-203a-3p, hepatic transcript abundances of
miR-29a/b/c was also decreased in six-month old male offspring exposed to gestational
D9-THC (Figure 3-9B–D), while the expression of each isoform was unchanged at three
weeks of age (Figure 3-9F–H).

3.4 Discussion
Impairments in the hepatic lipogenic pathway promote excessive production and
storage of intracellular triglycerides, leading to the development of obesity and the
metabolic syndrome (James et al., 2004). In the current study, we demonstrate that
gestational exposure to D9-THC leads to increased adipose to bodyweight ratio at six
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Figure 3-8. Gestational exposure to D9-tetrahydrocannabinol (D9-THC) leads to
increased complexes I and III of the electron transport chain in male offspring at
three weeks of age.
(A) Representative western immunoblots illustrating hepatic expression of complexes I–
V of the electron transport chain in male offspring at three weeks of age. Protein
abundances of complex I (B), II (C), III (D), IV (E) and V (F) were normalized to βActin ± SEM (n = 7–8/group). All protein abundances were analyzed using a two-tailed
unpaired Student’s t-test. * Significant difference (p < 0.05).
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Figure 3-9. Quantitative RT-PCR analysis of miR-203a-3p and miR-29a/b/c in the
livers of male offspring at six months (A–D) and three weeks (E–H) following
gestational exposure to D9-tetrahydrocannabinol (D9-THC).
Relative amounts of all miRs were normalized to that of miRNA standard control. Data
are expressed as means ± SEM (n = 7–8/group). Groups at each time point were
compared using Student’s two-tailed unpaired t-test. * Significant difference (p < 0.05),
** significant difference (p < 0.01), *** significant difference (p < 0.001).
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months of age, along with elevated hepatic triglyceride levels in adult male offspring. The
observed hyperlipidemia coincides with increased hepatic expression of lipogenic
enzymes at three weeks and six months of age, culminating in accelerated de novo
lipogenesis during adult life. Our results suggest that these changes in lipid metabolism
occur in a sex-specific manner, as hepatic triglyceride levels were unchanged in adult
female offspring exposed to gestational D9-THC. Livers taken from three-week old D9THC-exposed male offspring also showed increased 4HNE abundance, suggesting that
hepatic lipid peroxidation and oxidative stress first occurs in early life. Furthermore,
oxidative stress and mitochondrial dysfunction appear to persist into adulthood when
hepatic triglycerides are increased. Last, our study provides insight into the epigenetic
mechanisms that may underly hepatic hyperlipidemia in growth-restricted offspring, as
adult male offspring exposed to gestational D9-THC exhibited decreased expression of
miR-203a-3p and miR-29a/b/c, all involved in mitochondrial homeostasis in the liver.
As mentioned previously, there is a relationship between birth weight and longterm metabolic health. We have reported that gestational exposure to D9-THC leads to
symmetrical IUGR in rodent offspring, followed by whole body and hepatic catch-up
growth by three weeks of age (Natale et al., 2020). The occurrence of catch-up growth, or
rapid postnatal weight gain, is believed to further exacerbate the risk for metabolic
diseases, such as obesity, as seen in birth cohorts studying growth-restricted infants from
South Africa, Brazil, and the Unites States (Victora et al., 2003; Musa et al., 2015; Perng
et al., 2016). Here we show that D9-THC-exposed offspring display increased visceral
adipose to body weight ratio at six months of age, indicating the development of obesity
in adult life. This is consistent with our previous studies of rodent offspring born from
models of maternal nicotine exposure and maternal protein restriction, whereby visceral
obesity was observed in adult offspring following postnatal catch-up growth (Gao et al.,
2005; Guan et al., 2005). Clinically, obese individuals exhibit hypertriglyceridemia in the
liver and plasma, often culminating in hepatic steatosis and later NAFLD (Riediger and
Clara, 2011). In our model, gestational exposure to D9-THC led to an increase in hepatic
triglycerides exclusively in male offspring at six months of age. Interestingly, there were
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no differences in the levels of circulating triglycerides among male offspring, while
circulating and hepatic cholesterol levels of both sexes were also unaffected. We have
previously reported that female D9-THC exposed offspring exposed to gestational D9THC do not exhibit differences in circulating estrogen or testosterone relative to control
female offspring, so this protective effect cannot be attributed to changes in the
circulating levels of androgenic hormones (Gillies et al., 2020). However, the differences
in steroid receptor (i.e., androgen receptor/estrogen receptor) signaling in the liver might
be involved (Park et al., 2011; Villa et al., 2012). Overall, there is great evidence to
suggest that men are more susceptible than women to the development of hepatic
steatosis and NAFLD (Browning et al., 2004; Hamaguchi et al., 2005; Suzuki et al.,
2005; Tsuneto et al., 2010; Sung et al., 2012). Studies of healthy men and women
demonstrate that men exhibit higher rates of de novo lipogenesis and decreased dietary
fatty acid oxidation; therefore, the sexual dimorphism observed among D9-THC-exposed
offspring may be attributed to changes in lipogenesis and lipolysis (Tran et al., 2010;
Pramfalk et al., 2015).
Given the sex-specific differences in hepatic triglyceride content of D9-THCexposed offspring, we next investigated the relative protein abundance of lipogenic
enzymes among male and female adult offspring. At six months of age, male offspring
exposed to gestational D9-THC exclusively displayed increased levels of both DGAT1
and DGAT2, along with an increase in the mitochondrial adaptor protein p66Shc.
Deletion of DGAT and p66Shc are both independently associated with reduced
intracellular accumulation of triglycerides (Berniakovich et al., 2008; Leamy et al.,
2016). Therefore, the upregulation of both DGAT1/2 and p66Shc in the current study
likely mediates the increase in hepatic triglycerides of male D9-THC exposed offspring.
While adult female D9-THC exposed offspring demonstrated increases in DGAT2, this
may not be sufficient in promoting increased de novo lipogenesis in the liver. Instead, a
synergistic interaction of multiple enzymes is necessary to elicit changes in lipid
metabolism. Since we observed lipogenic changes in male offspring exposed to
gestational D9-THC in adulthood, we further assessed whether this occurred earlier (e.g.,
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three weeks) coinciding with the completion of hepatic catch-up growth. D9-THC
exposed male offspring exhibited increased abundance of ACCα, SCD, FABP1 and
DGAT2 at three weeks of age, suggesting that catch-up growth may instigate de novo
lipogenesis. Incidentally, recent studies have determined that FABP1 is an important
regulator of D9-THC hepatic transport and biotransformation (Elmes et al., 2015, 2019).
Many hepatic pathophysiologies, including NAFLD, are associated with increased
expression of FABP1, while its knockdown reduces hepatic triglyceride accumulation
and lipid peroxidation (Mukai et al., 2017). This is consistent with our current study, as
three-week old male offspring displayed increased abundance of 4HNE (i.e., a marker of
lipid peroxidation) concomitant with elevated FABP1. Since FABP1 is involved in D9THC metabolism, it is possible that these offspring have altered expression of FABP1 in
response to exposure to D9-THC in utero. Mice with knockdown of hepatic FABP1 also
exhibit decreased expression of DGAT1 and DGAT2 in the liver (Mukai et al., 2017);
therefore, early elevation of FABP1 in D9-THC-exposed male offspring could be
involved in the upregulation of DGAT and de novo lipogenesis later in life.
Oxidative stress and mitochondrial dysfunction are highly prevalent among
metabolic diseases involving the liver. Elevated reactive oxygen species (ROS) and
mitochondrial abnormalities are implicated in the pathogenesis of NAFLD. However, the
mechanisms by which this occurs are not completely understood (Mantena et al., 2008;
Rolo et al., 2012; Begriche et al., 2013; Chen et al., 2020). In vitro studies have
established that ROS are detrimental to hepatic lipid metabolism and mitochondrial
function, as treatment of HepG2 cells and primary hepatocytes with hydrogen peroxide
promotes the accumulation of triglycerides and cholesterol (Seo et al., 2019).
Additionally, lipid-induced elevation of ROS has been shown to impair mitochondrial
function in the human hepatoblastoma C3A cell line, along with increased
gluconeogenesis and ketogenesis (Lockman et al., 2012). Numerous animal models have
also found that IUGR offspring exhibit indices of hepatic oxidative stress (e.g., increased
lipid peroxidation and ROS; altered expression and activity of antioxidant enzymes) and
impaired mitochondrial function (e.g., aberrant expression and activity of pyruvate
dehydrogenase, citrate synthase, and complexes of the electron transport chain; disrupted
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ATP synthesis) during neonatal and adult life (Wang et al., 2008; Theys et al., 2009;
Moraes et al., 2014; Devarajan et al., 2019; Oke et al., 2019). In particular, we have
shown that hepatic p66Shc is elevated in adult male offspring subject to maternal protein
restriction attributed to postnatal catch-up growth (Oke et al., 2019). P66Shc is a key
regulator of cellular redox state, lifespan, and mitochondrial metabolism, as it interacts
with cytochrome C under conditions of cell stress to stimulate the production of ROS
(Giorgio et al., 2005). This mitochondrial-induced oxidative stress often leads to
apoptosis, cellular senescence and compromised aerobic metabolism (Migliaccio et al.,
1999; Orsini et al., 2004; Giorgio et al., 2005; Trinei et al., 2013), making p66Shc an
attractive target in mitigating metabolic disease. Again, studies have also postulated that
p66Shc is involved in the accumulation of intracellular lipids (Berniakovich et al., 2008).
Here, we found that adult male offspring exposed to gestational D9-THC have increased
protein abundance of p66Shc in the liver, concomitant with decreased abundance of
SOD1. While we did not directly measure hepatic ROS, these results suggest that
oxidative stress occurs in the liver following exposure to gestational D9-THC and catchup growth. To investigate this further, we assessed the levels of proteins involved in
mitochondrial function and aerobic metabolism (i.e., TFAM, p-PDH[Ser232], LDHa,
citrate synthase, and complexes of the electron transport chain). While the expression of
TFAM, p-PDH[Ser232], LDHa and citrate synthase was unchanged in adult male
offspring, they did have increased amounts of complexes I, III and V. This is noteworthy
as increases in complexes I and III are associated with elevated superoxide production via
increased flow of electrons through the subunits of these enzymes (Brand, 2010). These
data, in combination with our p66Shc and SOD1 findings, further support the idea that
these offspring exhibit hepatic oxidative stress and altered oxidative phosphorylation.
Complexes I and III also increased in three-week old male offspring, suggesting that
oxidative stress occurs in early life following D9-THC exposure and catch-up growth.
To date, little is known about the epigenetic mechanisms underlying metabolic
diseases in IUGR offspring. One such mechanism is miRs, which are small, non-coding
RNA molecules that silence target genes through mRNA degradation or repressed protein
translation. Numerous miRs have been demonstrated to have aberrant postnatal
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expression in growth-restricted offspring, leading to cellular stress that precedes impaired
function of metabolic organs (Sohi et al., 2015; Firmin et al., 2018; Zinkhan et al., 2019;
Saget et al., 2020). Recent studies found that the translation of p66Shc protein is directly
inhibited by miR-203a-3p, leading to the attenuation of liver injury and fibrosis in mice
(Wang et al., 2020). Here, we observed robust decreases in the expression of miR-203a3p in the livers of male offspring exposed to gestational D9-THC, but only at six months
of age. This is consistent with the observed increase in p66Shc protein levels at this time
point, indicating that miR-203a-3p may be implicated in the development of oxidative
stress and de novo lipogenesis in these offspring. We further quantified the expression of
miR-29, as we have found this miR family to be altered in the livers of adult male
protein-restricted offspring following catch-up growth (Sohi et al., 2015). Similar to our
findings of miR-203a-3p, adult male D9-THC-exposed offspring exhibited decreased
hepatic expression of all three isoforms of miR-29 at six months of age. This is of great
interest as miR-29 expression is downregulated in patients with advanced liver fibrosis
and cirrhosis (Roderburg et al., 2011). Conversely, when present at high levels, miR-29
can alleviate hepatocellular steatohepatitis, fibrosis and cirrhosis in mice (Roderburg et
al., 2011; Lin et al., 2019; Yang et al., 2019). Collectively, given that each of these miRs
were down-regulated exclusively during adult life, it is conceivable that early catch-up
growth of the liver culminates in long-term oxidative stress and impaired hepatic lipid
metabolism through epigenetic regulation of gene expression. Future in vitro studies are
warranted to investigate this relationship further to reveal additional metabolic targets
that become dysregulated with altered expression of miR-203a-3p and miR-29a/b/c in the
liver.
In summary, this study demonstrates for the first time that gestational exposure to
D9-THC leads to hepatic hyperlipidemia in adult male offspring. We postulate that this
occurs as a result of accelerated triglyceride synthesis (i.e., de novo lipogenesis) in the
liver, as multiple lipogenic enzymes are elevated at both three weeks and six months of
age. Given that FABP1 is involved in the metabolism and transport of D9-THC, it is
possible that gestational exposure to D9-THC in combination with catch-up growth leads
to early elevation of FABP1 in the livers of male offspring. This may further contribute to
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the observed increase in lipid peroxidation and lipogenic enzyme expression in male
offspring at three weeks of age. Hepatic lipid overload is known to further increase
oxidative stress and mitochondrial dysfunction. Therefore, this process may occur in a
cyclical manner as indicated in Figure 3-10. Altered expression of miRs may also
contribute to these molecular changes, as we have indicated that miR-203a-3p and miR29a/b/c are downregulated in response to D9-THC exposure and catch-up growth.
Additional long-term studies will be important in determining if this later culminates in
hepatic pathologies such as NAFLD and cirrhosis of the liver. Given that D9-THC
interacts with both the CB1 and CB2 receptors of the endocannabinoid system, it is also
possible that differences in the expression of these receptors may exist upstream of the
observed physiological and molecular effects. That said, the current study is somewhat
limited in that we did not examine the expression of either CB1R or CB2R. While much
remains unknown about the role of prenatal cannabinoids on offspring outcomes, it is
clear that long-term metabolic health becomes compromised as a result. We have
previously shown that exposure to D9-THC specifically has effect on glucose tolerance
and cardiovascular function (Gillies et al., 2020; Lee et al., 2021), and our current study
demonstrates that it further contributes to hyperlipidemia. Overall, these data provide
great insight into the effects of gestational D9-THC exposure on the development and
function of the liver, as well as the fundamental molecular mechanisms that underlie the
metabolic dysfunction of growth-restricted offspring.
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Chapter IV

4

Oxidative stress and endoplasmic reticulum stress
promote increased expression of hepatic miR-29 and
fatty acid translocase in vitro

This chapter is a version of a manuscript under preparation entitled “Oxidative stress and
endoplasmic reticulum stress promote increased expression of hepatic miR-29 and fatty
acid translocase in vitro”.
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4.1

Introduction

Intrauterine growth restriction (IUGR) is a pathological condition characterized
by low birth weight and reduced organ growth. Several extrinsic risk factors are known to
contribute to the etiology of IUGR, including maternal undernutrition, maternal drug
exposure, maternal obesity, and placental insufficiency. Epidemiological studies have
identified a relationship between birth weight and long-term metabolic health, and this is
further exacerbated by postnatal catch-up growth (i.e., rapid postnatal weight gain). This
relationship is best explained by the Developmental Origins of Health and Disease
(DOHaD) hypothesis, which proposes that adverse events in utero promote changes to
fetal programming that are detrimental to offspring health. It is widely accepted that this
occurs, in part, due to abnormal transcriptional regulation; however, little is known about
the epigenetic mechanisms that contribute to this relationship. Epigenetics refers to
molecular mechanisms that produce stable, heritable phenotypic changes without altering
the underlying DNA sequence (Zhang et al., 2020). Importantly, epigenetic mechanisms
describe a higher level of transcriptional regulation that are separate from common
transcription factors (Greally, 2018). These mechanisms include DNA methylation, posttranslational histone modifications, and microRNAs. While each of these mechanisms
have been implicated in IUGR, here we focus on the role of microRNAs in postnatal
metabolism of the IUGR liver.
MicroRNAs (miRNAs) are small, non-coding RNA molecules that act via
silencing of target genes through mRNA degradation or inhibition of protein translation.
High sequence complementarity between the 5’ untranslated region (UTR) of miRNAs
and the 3’ UTR of target mRNAs results in mRNA degradation via enzymatic cleavage
(Hammond, 2015). Alternatively, sequence mismatch between miRNAs and mRNA
targets results in translational repression through the recruitment of proteins that block
access of translational machinery (Hammond, 2015). Given the potential impact on gene
expression, there has been some investigation into the role of miRNAs in the onset of
metabolic disease of IUGR offspring. This includes our own work focused on the
maternal protein restriction (MPR) rodent model of undernutrition, which identified that
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hepatic miR-29a/b/c is upregulated in adult male offspring exclusively following
postnatal catch-up growth (Sohi et al., 2015). This was concomitant with decreased
expression of hepatic insulin-like growth factor 1 (IGF-1), a hormone that is critical for
fetal growth and development (Sohi et al., 2015). These MPR offspring with catch-up
growth further exhibit hepatic endoplasmic reticulum stress (Sohi et al., 2013), along
with mitochondrial dysfunction via aberrant markers of oxidative stress and aerobic
metabolism in the liver (Oke et al., 2019). Interestingly, we have recently demonstrated
that adult male offspring with gestational exposure to D9-tetrahydrocannabinol (D9-THC,
the psychoactive component of cannabis), display decreased hepatic transcript levels of
miR-29 and miR-203a-3p at six months of age (Oke et al., 2021). Again, this only
occurred following catch-up growth, suggesting that rapid postnatal weight gain may
influence miR expression. Importantly, male offspring from both the MPR model and
the gestational D9-THC model exhibit hepatic hyperlipidemia in adult life (Sohi et al.,
2011; Oke et al., 2021).These findings are of great interest, as the abnormal expression of
miRNAs often precedes impaired function of metabolic organs and concomitant with
cellular stress (Sohi et al., 2015; Firmin et al., 2018; Zinkhan et al., 2019; Saget et al.,
2020). That said, further research is warranted to determine (1) the mechanisms that lead
to altered expression of hepatic miR-29a/b/c, and (2) if miR-29a/b/c directly contributes
to hepatic hyperlipidemia among IUGR offspring.
Although miR-29 and miR-203a-3p target different mRNA transcripts, there is
evidence to suggest that both of these miRNAs are involved in the regulation of lipid
biosynthesis and metabolism. Using the HepG2 cell line, miR-29a has been demonstrated
to directly target the 3’ UTR of fatty acid translocase, also known as CD36 (Lin et al.,
2019). Upregulation of hepatic CD36 is associated with poor hepatic lipid metabolism
and elevated body adiposity in rodents with non-alcoholic fatty liver disease (NAFLD;
Wang et al., 2019), while its knockdown in vitro and in vivo shows promise in alleviating
hepatic lipid accumulation and increasing fatty acid oxidation (Wilson et al., 2016; Li et
al., 2019). Considering that miR-29a suppresses the expression of CD36, these studies
seem to be in favour of miR-29 as a protective agent against the metabolic consequences
of various liver pathologies. Alternatively, miR-203a-3p has been demonstrated to
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directly inhibit the translation of p66Shc protein in the human LX2 hepatic stellate cell
line (Wang et al., 2020). P66Shc is an adaptor protein that undergoes mitochondrial
translocation under cell stress, and its activation further contributes to accelerated
production of mitochondrial reactive oxygen species (ROS) and poor aerobic metabolism
(Migliaccio et al., 1999; Orsini et al., 2004; Giorgio et al., 2005). Additional studies
suggest that p66Shc-induced ROS leads to the accumulation of intracellular lipids, giving
rise to metabolic pathologies such as NAFLD and obesity (Berniakovich et al., 2008;
Tomita et al., 2012).
Taking these observations into account, the role of hepatic miR-29 and miR-203a3p in metabolic dysfunction of IUGR offspring seems promising. Given we have
previously observed that IUGR offspring with catch-up growth exhibit ER stress,
oxidative stress, and mitochondrial dysfunction (Sohi et al., 2015; Oke et al., 2019,
2021), the objective of this study was to determine if these forms of cellular stress
directly lead to altered hepatic expression of miR-29 and miR-203a-3p in HepG2 cells.
This cell line was selected because HepG2 cells are capable of producing and secreting
proteins that are expressed in fetal hepatocytes, making them an appropriate in vitro
model for the neonatal liver (Maruyama et al., 2007). Furthermore, we intended to clarify
the directionality in which expression of these miRNAs are changed in response to cell
stress. To address this, we pharmacologically induced oxidative stress and ER stress
separately in the HepG2 cell line. We hypothesized that both oxidative stress and ER
stress would lead to altered expression of miR-29 and miR-203a-3p, independent of the
pharmacological agent applied. We further anticipated that expression of hepatic p66Shc
and CD36 would be altered in response to miR-29 and miR-203a-3p.

4.2 Materials and Methods
4.2.1

Animal Care and Dietary Regimen
All procedures were performed according to guidelines set by the Canadian

Council of Animal Care (CCAC), with approval from the Animal Care Committee at The
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University of Western Ontario. Male and female Wistar rats were purchased from Charles
River (La Salle, St. Constant, QC), and allowed three weeks to acclimatize to
environmental conditions of the animal care facility. Female rats were placed in cages
with male rats upon proestrus, and pregnancy was confirmed via the presence of sperm in
the vaginal smear (gestational day 1). Pregnant dams were fed either a control (20%
casein) diet or a low (8% casein; LP) diet throughout gestation. Food was provided ad
libitum throughout pregnancy, while diets were made isocaloric through the addition of
sucrose to the LP diet (Sohi et al., 2015). As previously reported, the addition of sucrose
to the LP diet is considered a modest increase in carbohydrate content relative to the
decrease in dietary protein (Oke et al., 2019). Litter size was reduced to eight offspring
per litter at birth by selecting pups with birth weights closest to the litter mean. Offspring
born to control diet-fed dams were fed a control diet for the entire postnatal period.
Alternatively, offspring born to protein-restricted dams were assigned to one of three
dietary regimes (i.e., low protein 1, low protein 2, or low protein 3; LP1, LP2, LP3). LP1
offspring received the LP for their entire lives, while LP2 offspring received the LP diet
until three weeks of age before being switched to the control diet. LP3 offspring were fed
the control diet for the entire postnatal period; that is, they were switched to the control
diet immediately at birth. These three LP groups allow us to examine the effects of the
low protein diet and catch-up growth separately, as hepatic differentiation is not complete
until three weeks of age in the rat (Gruppuso and Sanders, 2016). Offspring were
euthanized and necropsy was performed at four months of age (i.e., postnatal day 130).
This age was selected because it is the time at which IUGR offspring begin to exhibit
metabolic dysfunction, as demonstrated by our own studies and others (Chamson-Reig et
al., 2009; Sohi et al., 2011). All molecular analyses were performed using the right
medial hepatic lobe, which was flash frozen in liquid nitrogen and stored long-term at -80
°C. Importantly, the offspring used here are the same as those used in Chapter II.

4.2.2

Cell Culture and Induction of Cellular Stress
The HepG2 human male hepatocellular carcinoma cell line was acquired from the

American Type Culture Collection (ATCC). Cells were thawed and maintained at 37 °C
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and 5% CO2/95% atmospheric air. Cells were cultured in minimum essential medium
(MEM; Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco) and 1%
penicillin-streptomycin solution (10 000 IU and 10 000 µg/mL, respectively; Fisher
Scientific). All cells were passaged at least twice prior to plating for experimental
treatment. Cells between passages 5 and 12 were seeded in six-well culture plates
(Thermo Scientific) at a density of 2.0 x 105 cells/well and allowed to proliferate to
approximately 80% confluency. To induce oxidative stress, cells were treated with either
hydrogen peroxide solution (H2O2; 100, 200, or 400 µM; Millipore-Sigma) or rotenone
solution (25, 50, or 100 µM; Millipore-Sigma), and allowed to proliferate for 6 and 24
hours in the presence of FBS. These concentrations and length of treatment were selected
based on previous studies that reported successful induction of oxidative stress without
affecting cell viability (Siddiqui et al., 2013; Jiang et al., 2014). Hydrogen peroxide is a
reactive oxygen species (ROS) produced by numerous cellular organelles. Studies have
found that hydrogen peroxide has an important role in cell signaling; however, high
levels of hydrogen peroxide are cytotoxic as it can easily break down into hydroxyl
radicals (Clarkson and Thompson, 2000; Jiang et al., 2014). Because of this, hydrogen
peroxide is commonly used to study the effects of oxidative stress in vitro. Alternatively,
rotenone is a neurotoxic insecticide that inhibits complex I of the mitochondrial electron
transport chain (ETC; Siddiqui et al., 2013). By blocking the transfer of electrons from
complex I to ubiquinone, rotenone increases the production of mitochondrial ROS
(Radad et al., 2006). Because of this, rotenone can be used to target mitochondria directly
rather than inducing general oxidative stress.
To induce ER stress, cells were treated with either tunicamycin (1, 2, or 5 µg/mL;
Millipore-Sigma) or thapsigargin (1, 2, or 5 µM; Millipore-Sigma) for 6 and 24 hours in
the presence of FBS. Again, these concentrations and times were chosen based on
previous studies of a similar nature (Naem et al., 2013; Oke et al., 2019). Tunicamycin
induces ER stress by inhibiting enzymes that catalyze N-linked glycosylation during
glycoprotein synthesis (Lei et al., 2016). Our previous experiments found that treatment
of HepG2s with 0.5 µg/mL of tunicamycin induces ER stress and increased p66Shc
protein levels as early as one hour post-exposure (Oke et al., 2019). Alternatively,
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thapsigargin acts through inhibition of the sarcoplasmic/endoplasmic reticulum bound
Ca2+-ATPase (SERCA), thereby interfering with homeostasis of calcium levels within the
ER (Naem et al., 2013).
Cells treated with rotenone, tunicamycin, or thapsigargin were also treated with
concentration-matched doses of dimethylsulfoxide (DMSO; Fisher Scientific) vehicular
control. For each technical replicate, one well was left untreated. For each time point (i.e.,
6h and 24h), cells were collected for RNA isolation and quantitative real-time PCR (qRTPCR) as described below.

4.2.3

RNA Isolation and Quantitative Real-Time PCR Analysis
Total RNA was isolated from liver tissue and HepG2 cells using the one-step

method of Chomczynski and Sacchi (TRIzol; Invitrogen). For miRNA targets, cDNA
template was synthesized using Qiagen’s miRCURY LNA RT kit, then diluted with
nuclease-free water to 1:60 for use with qRT-PCR. For mRNA targets, cDNA template
was synthesized using a High-Capacity cDNA RT kit (Applied Biosystems), then diluted
with nuclease-free water to 1:40 for use with qRT-PCR. All cDNA template samples
were stored long-term at -20 °C. For quantification of miR-29a/b/c and miR-203a-3p,
primer assays were purchased from Qiagen (Table 4-1). Primer sets for mRNA targets of
interest were designed using the National Center for Biotechnology Information and
Ensembl genome browsers, followed by generation via Invitrogen Custom DNA Oligos
(Table 4-2). Relative transcript abundances for all gene targets were determined via
qRT-PCR as previously published (Barra et al., 2017). Cq values obtained for miRNA
targets were normalized to those of U6 snRNA control (Qiagen; Table 4-1), while Cq
values for mRNA gene targets were normalized to geometric means of b-Actin and
GAPDH (Table 4-2). Relative transcript abundance for all targets was calculated using
the comparative DCt method.
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Table 4-1. GeneGlobe Catalog Numbers for Qiagen miRCURY LNA miRNA
primer assays used for quantitative real-time PCR.

MicroRNA

GeneGlobe (Catalog) Number

HSA-MIR-29A-3P

YP00204698

HSA-MIR-29B-3P

YP00204679

HSA-MIR-29C-3P

YP00204729

HSA-MIR-203A-3P

YP00205914

U6 SNRA

YP0020390
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Table 4-2. Forward and reverse primer sequences for primers used in analysis of
mRNA targets via quantitative real-time PCR.

Gene

Species

Human
p66Shc
Rat

Human
cd36
Rat

Human
GAPDH
Rat

Human
b-Actin
Rat

Primer Sequences (5’–3’)
F: AAGTACAATCCACTCCGG
AATGA
R: GGGCCCCAGGGATGAAG
F: TACTTGGTTCGGGTGAGTGC
R: GAGCAGGAAGTCCCGAC
AAA
F: GTTGAGAGCCTGTGCCT
CAT
R: TGGTTTCTACAAGCTCTGG
TTCTTA
F: CAGTTTTGGATCTTTGAC
GTGC
R: TGCTGCTATTCTTTGCCAC
TT
F: ATGGCATCAAGAAGGTG
GTG
R: CATACCAGGAAAATGAGC
TTG
F: GGATACTGAGAGCAAGA
GAGAGG
R: TCCTGTTGTTATGGGGTC
TGG
F: CACCAACTGGGACGACAT
R: ACAGCCTGGATAGCAACG
F: CACAGCTGAGAGGGAAAT
R: TCAGCAATGCCTGGGTAC

GenBank/
Reference
NM_183001.5

NM_053517.2

NM_001371075.1

XM_039108092.1

NM_001357943.2

NM_017008.4

NM_001101.5
NM_031144
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4.2.4

Statistical Analyses
Statistical analyses were performed using GraphPad Prism 9 software. Results

were expressed as means of normalized values ± S.E.M. (standard error of the mean), and
the threshold for statistical significance was set as P < 0.05. Cell culture experiments
were performed and analyzed in technical replicates of 3 (i.e., n=3/group), where each
replicate represents an independent set of experiments using a different frozen cell stock
or passage number. Ex vivo results for protein-restricted offspring were analyzed using a
One Way ANOVA with Tukey’s multiple comparisons test. In vitro results were
analyzed using individual Student’s unpaired t-tests; that is, each experimental group was
compared to the untreated control group to determine if transcript abundance was
significantly different. This statistical test was used rather than a one-way ANOVA
because the purpose of these experiments was to determine if induction of oxidative
stress or ER stress leads to altered miRNA expression, rather than to assess the effects of
these drugs regarding time or concentration. Values obtained for cells treated with DMSO
vehicular control were also compared to those of untreated cells to ensure that there were
no adverse effects of DMSO.

4.3 Results
4.3.1

Adult male protein-restricted offspring exhibit increased
hepatic transcript levels of miR-203a-3p following
postnatal catch-up growth
Given we observed a significant decrease in hepatic miR-203a-3p and miR-29a/b/c

transcript levels among adult male offspring with catch-up growth following gestational
exposure to D9-THC (Oke et al., 2021), we followed up with analysis of miR-203a-3p
expression in the livers of adult male protein-restricted offspring with (i.e. LP2/LP3
offspring) and without (e.g. LP1 offspring) postnatal catch-up growth. Our laboratory has
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previously demonstrated that these MPR offspring with catch-up growth exhibit
significantly increased hepatic transcript abundance of miR-29a/b/c (Sohi et al., 2015).
Moreover, we have demonstrated that these same offspring exhibit elevated markers of
oxidative stress and aberrant aerobic metabolism in (Oke et al., 2019). Interestingly, we
found that miR-203a-3p was increased exclusively in the livers of LP3 offspring (Figure
4-1; P < 0.05). While this group of offspring is protein-restricted throughout gestation, they
also undergo the greatest degree of catch-up growth given that they are switched to a
control diet at birth. Of note, miR-203a-3p transcript levels were not significantly altered
in LP1 or LP2 offspring relative to that of the control group (Figure 4-1).

4.3.2

MiR-203a-3p transcript is undetectable in the HepG2 cell
line
Following the collection of each treatment group, we began by measuring

transcript levels of miR-203a-3p in HepG2 cells. We first performed qRT-PCR
experiments to measure this miRNA in the untreated control group and hydrogen
peroxide-treated groups for each technical replicate; however, we found that the resultant
Cq values were very high (i.e., > 39). This indicated that miR-203a-3p was poorly
expressed, and it suggests that the HepG2 cell line is not an ideal in vitro model in
studying this miRNA. We further attempted to measure miR-203a-3p in all samples
treated with tunicamycin to ensure that ER stress did not induce its expression, and we
again found that it was undetectable.

4.3.3

Short-term (6-hour) treatment with pharmacological
inducers of oxidative stress and ER stress has no effect
on miR-29 transcript abundance
To determine if miR-29 expression is upregulated following short-term oxidative

stress or ER stress, we performed qRT-PCR in HepG2 cells following 6h treatment with
hydrogen peroxide, rotenone, tunicamycin, or thapsigargin. Because miR-29 has three
isoforms, we measured the relative transcript abundance for each of miR-29a, -29b, and –
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Figure 4-1. Maternal protein restriction (MPR) followed by postnatal catch-up
growth leads to upregulation of miR-203a-3p in the livers of male offspring at four
months of age.
Quantitative RT-PCR analysis of miR-203a-3p was performed following necropsy of
livers from control and MPR Wistar rat offspring. Relative amounts of miR-203a-3p
were expressed as means normalized to U6 miRNA control ± SEM (n=8/group).
Transcript abundances for each individual group were analyzed using One Way
ANOVA and Tukey’s multiple comparisons test. Groups marked with different
letters are significantly different (P<0.05).
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29c. Our analyses showed that each of the three isoforms remained unchanged following
6h treatment with any drug (data not shown), suggesting that exposure to these drugs was
too acute to influence miR-29 expression. While we did not directly measure markers of
oxidative or ER stress, the drug concentrations used in this study have previously been
shown to successfully induce oxidative stress or ER stress in HepG2 cells without having
drastic effects on cell viability (Naem et al., 2013; Siddiqui et al., 2013; Jiang et al.,
2014; Oke et al., 2019). That said, many studies indicated a treatment length of 24h;
therefore, it is possible that a 6h exposure was too acute to cause oxidative or ER stress.

4.3.4

24-hour treatment of HepG2 cells with hydrogen
peroxide does not influence miR-29 expression
Given we did not observe significant changes in miR-29 expression following 6h

treatment, we next performed qRT-PCR for samples exposed to each drug for 24h. We
began by assessing levels of miR-29a/b/c in cells treated with hydrogen peroxide. As
mentioned previously, hydrogen peroxide treatment has been used to induce oxidative
stress in HepG2 cells, while its effects are ameliorated by co-treatment with N-AcetylSerotonin (NAS; Jiang et al., 2014). Interestingly, treatment of primary rat vascular
smooth muscle cells with 200 µM hydrogen peroxide has been shown to result in
decreased miR-29b transcript (Lin et al., 2009). Nonetheless, the effects of hydrogen
peroxide on miR-29 expression in HepG2s have not been investigated. In the current
study, we found that all three isoforms of miR-29 were unchanged following 24h
treatment with all three doses of hydrogen peroxide (Figure 4-2).

4.3.5

MiR-29 is elevated in HepG2 cells following 24-hour
exposure to rotenone, an inhibitor of complex I
To ensure that the effects observed on miR-29 expression are not drug-specific,

we next measured levels of miR-29 in cells treated with rotenone for 24h. Again,
rotenone-induced oxidative stress is of mitochondrial origin via targeting of complex I in
the ETC. Here we discovered that 24h treatment of HepG2s with 25 µM and 50 µM
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Figure 4-2. Induction of oxidative stress with hydrogen peroxide does not influence
transcript abundance of miR-29a/b/c in the HepG2 cell line following 24h treatment.
Cells were plated in a six-well plate at 2 x 105 cells/well and let grown to 80%
confluency. Cells were then treated for 24h with either 100 µM, 200 µM, or 400 µM of
hydrogen peroxide. RNA was collected from each group, followed by qRT-PCR analysis
with the complementary cDNA template. Fold change difference of (A) miR-29a, (B)
miR-29b, and (C) miR-29c were expressed as means from three biological replicates
normalized to U6 miRNA control ± SEM. Transcript abundances for each individual
point were analyzed using a two-tailed unpaired Student’s t-test and compared to the
untreated control group. n.s.= non-significant (P < 0.05)
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rotenone led to increased miR-29a and miR-29c transcript (Figure 4-3A, C; P < 0.05),
and treatment with 25 µM, 50 µM, and 100 µM rotenone led to increased miR-29b
(Figure 4-3A-C; P < 0.05). Since we did not see changes in miR-29 expression following
exposure to hydrogen peroxide, these results suggest that miR-29 may be specifically
influenced by mitochondrial-induced oxidative stress rather than cytosolic oxidative
stress.

4.3.6

24-hour treatment of HepG2 Cells with thapsigargin, but
not tunicamycin, leads to increased miR-29 transcript
abundance
Because we have previously found that protein-restricted offspring display hepatic

ER stress coinciding with increased expression of miR-29 (Sohi et al., 2013), we next
quantified levels of miR-29 transcript in HepG2 cells treated with tunicamycin or
thapsigargin for 24h. Our results here showed that the expression of each miR-29 isoform
was unchanged following treatment with each dose of tunicamycin (Figure 4-4).
Conversely, treatment with thapsigargin resulted in increased levels of miR-29b and miR29c; these isoforms exhibited a trending increase after treatment with 1 µM and 5 µM
(Figure 4-5B,C), while treatment with 2 µM resulted in a significant increase (Figure 45B,C; P < 0.05). Abundance of miR-29a transcript was unaffected by treatment with
thapsigargin (Figure 4-5A).

4.3.7

HepG2 cells treated with rotenone and thapsigargin
have increased transcript abundance of fatty acid
translocase (CD36)
To follow up with our analyses of miR-29 expression corresponding to its

proposed targets, we next assessed transcript levels of p66Shc for each of the cellular
treatment groups. We did not observe changes in p66Shc expression following treatment
with rotenone, tunicamycin or thapsigargin (Figures 4-6C, E, G). This is in alignment
with our previous studies where we showed that p66Shc protein, but not transcript levels,
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Figure 4-3. Induction of oxidative stress with complex I inhibitor rotenone results in
increased transcript abundance of miR-29a/b/c in the HepG2 cell line following 24h
treatment.
Cells were plated in a six-well plate at 2 x 105 cells/well and let grown to 80%
confluency. Cells were then treated for 24h with either 25 µM, 50 µM, or 100 µM of
rotenone. RNA was collected from each group, followed by qRT-PCR analysis with the
complementary cDNA template. Fold change difference of (A) miR-29a, (B) miR-29b,
and (C) miR-29c were expressed as means from three biological replicates normalized to
U6 miRNA control ± SEM. Transcript abundances for each individual point were
analyzed using a two-tailed unpaired Student’s t-test and compared to the untreated
control group. Groups marked with different letters are significantly different (P<0.05).
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Figure 4-4. Induction of endoplasmic reticulum (ER) stress with tunicamycin has no
effect on transcript abundance of miR-29a/b/c in the HepG2 cell line following 24h
treatment.
Cells were plated in a six-well plate at 2 x 105 cells/well and let grown to 80%
confluency. Cells were then treated for 24h with either 1, 2, or 5 µg/mL of tunicamycin.
RNA was collected from each group, followed by qRT-PCR analysis with the
complementary cDNA template. Fold change difference of (A) miR-29a, (B) miR-29b,
and (C) miR-29c were expressed as means from three biological replicates normalized to
U6 miRNA control ± SEM. Transcript abundances for each individual point were
analyzed using a two-tailed unpaired Student’s t-test and compared to the untreated
control group. n.s.= non-significant (P < 0.05)
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Figure 4-5. Induction of endoplasmic reticulum (ER) stress with thapsigargin leads
to increased miR-29 transcript abundance in the HepG2 cell line following 24h
treatment.
Cells were plated in a six-well plate at 2 x 105 cells/well and let grown to 80%
confluency. Cells were then treated for 24h with either 1, 2, or 5 µM of thapsigargin.
RNA was collected from each group, followed by qRT-PCR analysis with the
complementary cDNA template. Fold change difference of (A) miR-29a, (B) miR-29b,
and (C) miR-29c were expressed as means from three biological replicates normalized to
U6 miRNA control ± SEM. Transcript abundances for each individual point were
analyzed using a two-tailed unpaired Student’s t-test and compared to the untreated
control group. Groups marked with different letters are significantly different (P<0.05).
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Figure 4-6. 24-hour exposure to rotenone or thapsigargin leads to increased
expression of fatty acid translocase (CD36) in the HepG2 cell line.
Cells were plated in a six-well plate at 2 x 105 cells/well and let grown to 80%
confluency. Cells were then treated for 24h with hydrogen peroxide (100, 200, 400 µM),
rotenone (25, 50, 100 µM), tunicamycin (1, 2, 5 µg/mL), or thapsigargin (1, 2, 5 µM).
RNA was collected from each group, followed by qRT-PCR analysis with the
complementary cDNA template. Fold change difference of p66Shc (A, C, E, G) and
CD36 (B, D, F, H) were expressed as means from three biological replicates normalized
to the geometric means of GAPDH and b-Actin ± SEM.
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are altered with tunicamycin treatment. These results suggest that p66Shc may be
regulated at the level of protein translation rather than gene transcription (Oke et al.,
2019). At the same time, 24h treatment with 400 µM hydrogen peroxide led to increased
p66Shc mRNA abundance (Figure 4-6A; P < 0.05). Exposure to 100 µM and 200 µM
hydrogen peroxide for 24h did not significantly alter p66Shc levels (Figure 4-5A). Given
that miR-29a is known to target fatty acid translocase (CD36), we also measured levels of
CD36 transcript in each group of cells. Not surprisingly, treatment with hydrogen
peroxide and tunicamycin did not induce changes in expression of cd36 after 24h
(Figures 4-6B, F). Conversely, cells treated with 25 µM and 50 µM rotenone exhibited
increased transcript abundance of CD36 (Figures 4-6B; P < 0.05). This was surprising as
we saw increased levels of miR-29 with these concentrations; however, it also suggests
that hepatic lipid metabolism was altered through means other than miR-29. Treatment
with 2 µM thapsigargin also produced increased levels of CD36 transcript (Figure 4-6H;
P < 0.0001), which is interesting as this group also expressed increased miR-29b/c.

4.3.7

Adult male offspring subject to maternal protein
restriction have decreased transcript abundance of fatty
acid translocase (CD36) following postnatal catch-Up
growth
Finally, we came full circle by measuring levels of CD36 in our in vivo liver

samples taken from the MPR rodent model. We have previously reported that these
offspring do not exhibit changes in p66Shc transcript at four months of age; however,
LP2 offspring display increased p66Shc protein at this age (Oke et al., 2019). As
expected, there were no significant differences between any of the LP groups and the
control group regarding p66Shc transcript levels (Figure 4-7A). Interestingly, LP3
offspring did exhibit increased p66Shc mRNA relative to LP1 and LP2 offspring (Figure
4-7A; P < 0.05). Given that these offspring also have increased miR-29 expression in the
liver, we next quantified mRNA levels of CD36. Our analyses found that each LP group
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showed decreased levels of CD36 mRNA relative to the control group (Figure 4-7B; P <
0.05), while there were no significant differences in CD36 levels between the LP groups.

4.4

Discussion

Here we demonstrate that induction of oxidative stress and ER stress via rotenone
and thapsigargin, respectively, each lead to increased expression of hepatic miR-29.
Induction of general oxidative stress via hydrogen peroxide does not influence miR-29
expression but does contribute to increased transcript levels of p66Shc at high
concentrations. Conversely, inhibition of complex I with rotenone leads to increased
miR-29 alongside increased CD36 mRNA. While induction of ER stress with
tunicamycin does not affect miR-29 expression or that of its downstream targets,
treatment with thapsigargin increases miR-29 in a dose-dependent manner with a
simultaneous increase in CD36 transcript levels. Our previous studies demonstrate that
miR-29 is upregulated in the livers of adult male protein-restricted offspring following
catch-up growth (Sohi et al., 2015). Here we show that these offspring also exhibit
decreased mRNA expression of its constitutive target, CD36, regardless of whether catchup growth had occurred. While we have further found that miR-203a-3p is altered in
livers of IUGR offspring (Oke et al., 2021), the current study identifies that this miRNA
is poorly expressed in hepatocytes. Collectively, our results suggest that mitochondrialinduced oxidative stress and ER-stress may be important in regulating miR-29 expression
as an underlying mechanism of hepatic lipid transport, particularly in hepatocytes of
growth-restricted offspring.
Studies have demonstrated that growth of the fetal liver is compromised at the
benefit of other organs; therefore, the liver stands to gain the most weight during
postnatal life (Desai and Hales, 1997). This is concerning because postnatal catch-up
growth is further detrimental to offspring metabolism, particularly in regard to lipid
handling. Using multiple models of IUGR, we have shown that hepatic lipid biosynthesis
and metabolism is greatly impacted following catch-up growth of the liver (Sohi et al.,
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Figure 4-7. Maternal protein restriction leads to decreased transcript abundance of
fatty acid translocase (CD36) in the livers of male offspring at four months of age.
Pregnant dams were subjected to an 8% protein diet during gestation, and pups were
randomly assigned to one of three postnatal dietary regimens at birth: 8% protein diet
throughout life (LP1), 8% protein diet until three weeks of age + 20% (control) diet after
three weeks (LP2), or 20% protein diet throughout life (LP3). Following necropsy, RNA
was isolated from livers of each group and qRT-PCR analysis was performed with the
complementary cDNA. Fold change difference of (A) p66Shc and (B) CD36 were
expressed as means normalized to the geometric means of GAPDH and b-Actin ± SEM
(n=8/group). Transcript abundances for each individual group were analyzed using One
Way ANOVA and Tukey’s multiple comparisons test. Groups marked with different
letters are significantly different (P<0.05).
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2011; Ma et al., 2013; Oke et al., 2021). Our studies have further implicated oxidative
stress, mitochondrial dysfunction, and ER stress in this relationship (Barra et al., 2017;
Oke et al., 2019, 2021), each of which occur with various metabolic pathologies. While
these forms of cell stress have been associated with altered levels of miR-29 and miR203a-3p in the liver, it remains unknown whether they directly influence hepatic miRNA
expression as a contributor to abnormal hepatic function. Here we show that oxidative
stress and ER stress each give rise to elevated miR-29 expression in HepG2 cells, but
only following treatment with rotenone or thapsigargin. Notably, the mechanism of action
for these drugs is associated with mitochondrial function. While rotenone interferes
directly with mitochondrial metabolism by inhibiting complex I of the ETC, the effects of
thapsigargin are more indirect through interference with calcium signaling. Mitochondrial
calcium influx occurs at mitochondrial-associated ER membranes (MAMs), which are
sites along the ER that permit physical attachment to mitochondria (Hayashi et al.,
2009). Exposure to thapsigargin results in slow, sustained influx of calcium from the ER
to mitochondria, leading to increased mitochondrial membrane potential and apoptosis
(Deniaud et al., 2008). Both rotenone and thapsigargin have been demonstrated to
accelerate mitochondrial ROS production in HepG2 cells, leading to mitochondrialinduced apoptosis (Siddiqui et al., 2013; Wang et al., 2016). Given that we observed
changes in miR-29 expression with exposure to these drugs, but not hydrogen peroxide or
tunicamycin, it seems plausible that oxidative stress and mitochondrial dysfunction act as
a signal in triggering changes to hepatic miR-29 expression. This is in alignment with our
animal studies, as oxidative stress, mitochondrial dysfunction, and altered miR-29
expression occur together following catch-up growth (Sohi et al., 2015; Oke et al., 2019).
That said, we have not directly measured ROS or performed functional assays of
mitochondrial function in the current study. Completion of these experiments would be
necessary to validate that oxidative stress and mitochondrial dysfunction are in fact
occurring, which could be done easily through use of the Seahorse XFe24 Extracellular
Flux Analyzer (Agilent).
In recent years, miR-29 has been investigated as a possible non-invasive
biomarker for the progression of various liver diseases. Not surprisingly, numerous
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studies have identified miR-29 as being pleiotropic in nature. Many target genes of miR29, including CD36, are involved in pathways affecting hepatic function (e.g., nutrient
transport and metabolism, oxidative stress, inflammation, and programmed cell death;
Wilson et al., 2016; Li et al., 2019; Lin et al., 2019; Wang et al., 2019). Each of these
pathways are known to promote non-alcoholic steatohepatitis (NASH), hepatocellular
carcinoma (HCC), liver fibrosis, and cirrhosis (Lin et al., 2020). However, there is no
clear consensus on the directionality of miR-29 expression which impact hepatic
function. We have previously found that male MPR offspring exhibit increased hepatic
miR-29 expression following catch-up growth (Sohi et al., 2015), while male offspring
exposed to gestational D9-THC display decreased hepatic miR-29 (Oke et al., 2021).
Patients with advanced liver fibrosis and cirrhosis have been shown to exhibit decreased
expression of miR-29 (Roderburg et al., 2011), while high miR-29 expression is also
believed to have a protective effect against NASH, fibrosis and cirrhosis in mice
(Roderburg et al., 2011; Lin et al., 2019; Yang et al., 2019). Notably, these studies
suggest that miR-29 may mitigate oxidative stress in a murine model of NASH (Yang et
al., 2019). This could explain our in vitro data, as miR-29 may be upregulated to combat
the negative effects of rotenone and thapsigargin. Since we saw changes in miR-29
expression at 24h but not 6h, it is plausible that initiation of this process does not occur
immediately. This may also explain why CD36 transcript levels are elevated alongside
miR-29 at 24h rather than being suppressed, while additional culture time may be
necessary in allowing for mRNA degradation to occur. Instead, protein translation of
CD36 may also be affected by miR-29, as miRNAs can act through mRNA degradation
or translational repression. Ultimately, the contrasting expression patterns of miR-29
observed in our own studies and those of others may occur due to timing and severity of
insult.
In addition to measuring levels of miR-29, we investigated the effects of oxidative
stress and ER stress on miR-203a-3p expression. As stated, translation of the adaptor
protein p66Shc is repressed by miR-203a-3p (Wang et al., 2020). Elevated p66Shc is
associated with oxidative stress, poor aerobic metabolism, and the accumulation of
intracellular lipids (Migliaccio et al., 1999; Orsini et al., 2004; Giorgio et al., 2005;
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Berniakovich et al., 2008; Tomita et al., 2012); therefore, it’s not surprising that p66Shc is
elevated in livers affected by non-alcoholic steatohepatitis (NASH), NAFLD, and fibrosis
(Tomita et al., 2012; Zhao et al., 2019). P66Shc knockdown in rodents with these diseases
helps to alleviate oxidative damage and mitochondrial function, thereby preventing disease
progression (Haga et al., 2010; Zhao et al., 2019). Additionally, targeting of p66Shc by miR203a-3p specifically has been shown to attenuate liver injury in rodent models (Wang et al.,
2020). Here we saw a significant increase in hepatic miR-203a-3p abundance among MPR
offspring that had been switched to a control diet at birth. Our previous studies have shown
that these same offspring have decreased p66Shc protein abundance (Oke et al., 2019), which
may occur due to increased miR-203a-3p. While we had intended to examine miR-203a-3p
expression alongside miR-29 in our in vitro model, we discovered that miR-203a-3p is poorly
expressed in the HepG2 cell line. These data are in agreement with a previous study that

found miR-203a-3p to be poorly expressed in HepG2 cells due to hypermethylation
within its promoter region (Diao et al., 2014). With this in mind, it seems that miR-203a-3p
is expressed exclusively in hepatic stellate cells (HSCs). The liver is an incredibly
heterogeneous organ made up of multiple cell types; however, hepatocytes and HSCs are the
major two cell types that are involved in the progression of NASH and NAFLD. While
hepatocytes are responsible for regulating hepatic metabolism, HSCs are mesenchymal cells
that maintain extracellular matrix (ECM) in the liver (Si-Tayeb et al., 2010). Chronic
activation of HSCs leads to increased production of ECM proteins such as collagen, thereby
leading to fibrosis of the liver (Si-Tayeb et al., 2010). Our analysis of hepatic miR-203a-3p in
MPR offspring utilized whole-liver samples; therefore, it’s likely that we were able to detect
this miRNA in the HSCs of each sample. Isolation of primary hepatocytes and HSCs from
MPR offspring would be necessary to confirm this finding, as we could compare the
expression of miR-203a-3p in each cell type. Overall, future in vitro studies using cell lines
should avoid using HepG2 cells to study miR-203a-3p in any capacity.
In summary, this study demonstrates that expression of miR-29 in the liver may be
regulated by oxidative stress and ER stress. We are the first to demonstrate that this
relationship may be mediated by mitochondria, as miR-29 upregulation occurred exclusively
following treatment with drugs known to influence mitochondrial function. This is in
agreement with our studies of protein-restricted offspring, which have shown that catch-up
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growth leads to increased miR-29 alongside oxidative stress, ER stress, and mitochondrial
dysfunction in the adult liver. As mentioned, one limitation of our study is that we did not
directly investigate levels or localization of ROS in vitro or in hepatic tissue ex vivo.
Additional studies are necessary to determine if ROS production is heightened in cells with
elevated miR-29 abundance, along with supplementary measures of mitochondrial function.
Moreover, it would be interesting to assess whether increased abundance of miR-29 leads to
accumulation of intracellular lipids. This would further support the involvement of miR-29
as an underlying mechanism of NASH and NAFLD. Given that we saw increased expression
of CD36 at 24h in vitro, long-term studies could also determine if CD36 levels become
repressed by miR-29 as seen in adult protein-restricted offspring. Overall, these data are
important not only in understanding the progression of metabolic disease in IUGR offspring,
but also the general mechanisms underlying health and disease across all populations.
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Chapter V
5

Discussion and Conclusions

5.1 Discussion and Significance of Research
The Developmental Origins of Health and Disease (DOHaD) hypothesis outlines
a relationship between birth weight and long-term metabolic health. Epidemiological and
animal studies have demonstrated that the fetal liver is particularly compromised due to
intrauterine growth restriction (IUGR), while hepatic postnatal catch-up growth
exacerbates the hyperlipidemia observed in adult life. While these studies have
highlighted the consequences of postnatal catch-up growth, the underlying molecular
mechanisms remain poorly understood. This includes mitochondrial dysfunction, which
has been shown to occur among IUGR offspring in postnatal life (Park et al., 2003;
Moraes et al., 2014; Barra et al., 2017; Woodman et al., 2018). Mitochondria are energyproducing organelles that are essential in regulating metabolism, but cellular stress (e.g.,
oxidative stress and ER stress) can interfere with mitochondrial function and produce a
variety of metabolic pathologies. Epigenetic mechanisms such as microRNAs have also
been implicated in IUGR; therefore, it is plausible that epigenetic regulation of gene
expression may influence any mitochondrial dysfunction observed.
The overall hypothesis of my thesis is that independent of gestational insult, postnatal
catch-up growth leads to hepatic mitochondrial dysfunction in IUGR offspring,
culminating in hyperlipidemia. The main findings that support this hypothesis are:
1) Postnatal catch-up growth disrupts hepatic lipid biosynthesis and mitochondrial
function across multiple models of IUGR, particularly in a sex-specific manner.
2) Postnatal catch-up growth has an indirect effect on the regulation of miR-29
expression due to impairment of mitochondrial function.
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Overall, my work provides insight into the molecular consequences of catch-up
growth in the IUGR liver. These studies advance our understanding of mitochondrial
dysfunction in response to catch-up growth, along with the basic molecular mechanisms
by which hepatic miR-29 expression is regulated. We have demonstrated that IUGR in
combination with catch-up growth is detrimental to hepatic lipid handling, and that
mitochondria are particularly susceptible to cellular stress following the completion of
hepatic differentiation. Taken together, these results could lead to the development of
therapeutic strategies in clinical practice during both the prenatal and postnatal period.

5.1.1

Postnatal catch-up growth disrupts hepatic biosynthesis
and mitochondrial function in a sex-specific manner

Epidemiological studies indicate that low birth weight offspring with catch-up growth
are at high risk for hepatic pathologies in adulthood, including non-alcoholic fatty liver
disease (NAFLD) and diabetes (Ravelli et al., 1998; Nobili et al., 2007; Suomela et al.,
2016). In Chapters II and III, I investigated the contribution of catch-up growth upon
hepatic mitochondrial function as an underlying cause of hyperlipidemia in IUGR
offspring. To do this, we investigated two different rodent models of IUGR: (1) the
maternal protein restriction (MPR) model of undernutrition, and (2) gestational exposure
to D9-tetrahydrocannabinol (D9-THC).

5.1.1.1

Chapter II: Outcomes

In Chapter II, I performed molecular techniques (i.e., western immunoblotting and
qRT-PCR) to investigate markers of mitochondrial function in the livers of male
offspring born from the MPR model. In this model, pregnant dams are randomly
assigned to a normal (20%) protein diet, or a low (8%; LP) protein diet. Offspring born to
LP dams are further assigned to one of three dietary regimens: (1) LP for all life (LP1),
(2) LP until three weeks of age + normal protein for the remainder of life (LP2), or (3)
normal protein for all life (LP3). This model beneficial in that it provides an in-depth
look at how the liver responds to catch-up growth both before and after it is fully
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developed. While the human liver is fully developed at term (i.e., gestational week 37),
the rodent liver does not complete hepatic differentiation until three weeks of age
(Gruppuso and Sanders, 2016). By switching protein-restricted offspring to a normal
protein diet at different developmental time points, we can directly influence the timing
of catch-up growth in rodents such that it reflects the human scenario. For example,
administration of a low protein diet until three weeks of age in rodents is physiologically
relevant to human development, as this marks the end of liver development in rodents.
Our laboratory has previously demonstrated that male LP2 offspring display
hypercholesterolemia at four months of age (Sohi et al., 2011). In Chapter II, I discovered
that these offspring further exhibit hepatic oxidative stress and poor aerobic metabolism.
At four months of age, livers from LP2 males have elevated markers of oxidative stress
(increased p66Shc, 4-hydroxynonenol, and superoxide dismutase; decreased catalase) and
aberrant makers of aerobic metabolism (increased p66Shc, phosphorylated pyruvate
dehydrogenase [Ser232], lactate dehydrogenase subunit alpha; decreased complex II,
citrate synthase, and mitochondrial transcription factor A). Again, these changes occur
exclusively in adult life among male offspring that experienced catch-up growth
following the perinatal period (i.e., the completion of hepatic differentiation). The
impairments in mitochondrial function may also underlie some of the hepatic endocrine
deficits (e.g., decreased IGF-1, decreased pAkt [Ser473]) and aberrant drug metabolism
(e.g., increased Cyp3A and Cyp2c11 activity) exhibited exclusively by LP2 offspring
(Sohi et al., 2011, 2013, 2014, 2015). Conversely, LP1 and LP3 offspring do not display
oxidative stress or mitochondrial dysfunction at three weeks of age or during adult life.
This is consistent with our previous studies and those of others, which suggest that LP1
and LP3 offspring are metabolically healthy (Hales et al., 1996; Sohi et al., 2011). My
data is further supportive of the DOHaD hypothesis, which states that a ‘mismatch’ in
nutrient availability gives rise to alterations in fetal programming such that long-term
metabolic function is negatively impacted (Hales and Barker, 2001). Because LP1
offspring remain on a LP diet during postnatal life, they do not experience this mismatch
and are spared the adverse molecular changes. Although LP3 offspring do undergo a
switch in protein content, it is possible that dietary intervention prior to the point of
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terminal differentiation can rescue the liver from the detrimental effects of IUGR with
catch-up growth. Taken together, these data suggest that the IUGR liver is particularly
vulnerable to catch-up growth after it is fully developed.

5.1.1.2

Chapter II: Clinical significance

From a clinical perspective, the results observed in the MPR model are highly
informative as they reinforce that care should be taken to avoid postnatal catch-up
growth. Again, many human cohorts have demonstrated that postnatal catch-up growth in
low birth weight offspring leads to dyslipidemia, as in a study by Singhal et al. on
preterm infants who were formula-fed after birth (Singhal et al., 2004). As adolescents,
individuals who were fed nutrient-dense formula exhibited high ratios of low-density
lipoprotein (LDL) to high-density lipoprotein (HDL), indicative of increased risk for
cardiovascular disease and stroke (Singhal et al., 2004). They further displayed high
serum concentrations of C-reactive protein (CRP), a measure of inflammation that is
associated with atherosclerosis (Singhal et al., 2004). Interestingly, preterm infants who
were fed banked breastmilk had lower levels of LDL to HDL and CRP relative to those
who were formula-fed (Singhal et al., 2004). While these results do highlight the
importance of breastfeeding, they more importantly elucidate the significance of catch-up
growth on long-term metabolism. Here I show that maintenance on a LP diet during the
entire postnatal period (LP1) does not lead to mitochondrial dysfunction in MPR
offspring, while our previous work has found these offspring to have normal hepatic
function as adults (Sohi et al., 2011; Oke et al., 2019). Each of these studies agree with
the main principle of DOHaD, as the mismatch in nutrient availability between prenatal
and postnatal life leads to hepatic hyperlipidemia. This information could influence how
healthcare professionals counsel patients both during and after pregnancy, as they should
emphasize the importance of a balanced prenatal and postnatal diet in optimizing health
throughout the lifespan. Moreover, the identification of mitochondrial targets could lead
to therapeutic interventions during postnatal life as a means of mitigating the effects of
catch-up growth.
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5.1.1.3

Chapter III: Outcomes

In Chapter III, I used an alternative model of IUGR to validate my findings from the
MPR model. That is, I sought to confirm that IUGR in combination with postnatal catchup growth has a negative effect on hepatic lipid metabolism and mitochondrial function,
irrespective of the type of gestational insult. In our model of gestational D9-THC
exposure, offspring exhibit symmetrical IUGR followed by whole body and hepatic
catch-up growth by three weeks of age (Natale et al., 2020). Here I demonstrate that male
D9-THC-exposed offspring exhibit hypertriglyceridemia in the liver at six months of age,
while hepatic triglyceride levels were unchanged in female offspring and three-week old
male offspring. By three weeks, male offspring have an increased abundance of enzymes
involved in lipid transport and biosynthesis (e.g., fatty acid binding protein 1, acetyl-CoA
carboxylase alpha, stearoyl-CoA desaturase, and diacylglycerol acyltransferase). This
occurred alongside increased hepatic 4-hydroxynonenol, p66Shc, complex I, and
complex III at three weeks, suggesting that oxidative stress and impaired aerobic
metabolism had again occurred with catch-up growth in this model of IUGR. Since
hepatic triglyceride levels were not yet affected at this time point, I propose that this early
incidence of mitochondrial dysregulation instigates the increased hepatic de novo
lipogenesis at six months. Adult male D9-THC-exposed offspring continued to exhibit
oxidative stress and mitochondrial dysfunction (increased p66Shc, complex I, III and V;
decreased SOD1) at six months, which could be both a contributing factor and a
consequence of hepatic hyperlipidemia. To determine if catch-up growth is indeed the
primary causative factor, it would be interesting to repeat these analyses in D9-THCexposed offspring at birth prior to catch-up growth. This would provide us with a greater
overall understanding of the direct effects of specific gestational insults independent of
catch-up growth.

5.1.1.4

Chapter III: Clinical significance

In addition to validating the detriments of catch-up growth, the information gained
here from our gestational D9-THC rodent model illustrates the hepatic consequences of
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maternal cannabis use during pregnancy. Despite the legalization of cannabis in Canada
and select American states, very little is known about the safety of maternal cannabis use
with respect to its effects on fetal development and postnatal metabolism. Not
surprisingly, our laboratory’s research has identified that gestational exposure to D9-THC
compromises fetal growth (Natale et al., 2020), while my postnatal studies have
expanded upon its consequences on offspring liver function and obesity in adult life (Oke
et al., 2021). Because dyslipidemia and obesity are risk factors for type II diabetes and
cardiovascular disease, my data may explain the glucose intolerance and impaired cardiac
function that is also observed in D9-THC-exposed offspring (Gillies et al., 2020; Lee et
al., 2021). These data may also provide some context to the human scenario, as a recent
study based out of Colorado established that fetal exposure to cannabis leads to a 2.6%
increase in adiposity (i.e., fat mass) and elevated fasting glucose and insulin levels during
childhood (mean age=4.7 years; Moore et al., 2022). Collectively, data from this model
could again influence how healthcare professionals counsel their patients during
pregnancy, and it may encourage patients to deter cannabis use during pregnancy in
protection of the fetus.

5.1.1.5

The sex-specific effects of postnatal catch-up growth

Overall, these data indicate that male offspring with catch-up growth are more
susceptible to hepatic hyperlipidemia and mitochondrial dysfunction than female
offspring. In both the MPR and D9-THC models, adult male offspring experience hepatic
hyperlipidemia while females are unaffected. I further demonstrated that oxidative stress
and mitochondrial dysfunction occur exclusively in male offspring from both models
(Table 5-1), suggesting that these forms of cell stress may contribute to the male-specific
progression of hyperlipidemia (Sohi et al., 2011; Oke et al., 2019). This is in alignment
with human studies of healthy men and women, whereby men have higher rates of de
novo lipogenesis and decreased fatty acid oxidation (Tran et al., 2010; Pramfalk et al.,
2015). Of note, my studies determined that hepatic p66Shc protein levels were increased
in male offspring with catch-up growth from both models, suggesting that this protein
may have an important role in establishing the sex-specific mitochondrial dysfunction of
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Table 5-1. Summary of protein markers of oxidative stress and mitochondrial
dysfunction analyzed in offspring born from rodent models of Maternal Protein
Restriction and Gestational D9-THC.

Protein Marker

Maternal Protein

Gestational D9-THC

Restriction
P66Shc

↑

↑

Pin1

↑

n.s.

4-HNE

↑

n.s.

SOD1

↑

↓

SOD2

↑

n.s.

Catalase

↓

n.s.

p-PDH

↑

n.s.

LDHa

↑

n.s.

Citrate synthase

↓

n.s.

Electron transport chain

↓ complex II

↑ complexes I, III, V

TFAM

↓

n.s.

Protein markers labelled with ↑ were significant increased, while those with ↓ were significantly decreased
(P < 0.05). n.s.= non-significant.
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IUGR offspring. It has also been proposed that differences in androgenic hormone levels
(i.e., estrogen and testosterone) are protective against the development of liver
pathologies in females compared to males (Szafran and Smielak-Korombel, 1998; Ozaki
et al., 2001). Studies have demonstrated that estrogen actually potentiates mitochondrial
ROS production (Felty et al., 2005; Tian et al., 2016), but this has been disputed by
studies of C57Bl/6J mice showing that males and females exhibit similar production of
mitochondrial ROS and lifespan despite females having higher estrogen levels (Sanz et
al., 2007). It has also been shown that estrogen levels are not altered in male or female
MPR offspring in adult life, while similar data were observed in D9-THC-exposed adult
females (Chamson-Reig et al., 2009; Gillies et al., 2020). Alternatively, activation of
estrogen receptors has been shown to maintain lipid and glucose metabolism in male
mice (Qiu et al., 2017). Given that estrogen receptors have been identified in
mitochondria (Yager and Chen, 2007), it is possible that activation of these receptors by
estrogen leads to altered transcription of mtDNA. Many mitochondrial proteins involved
in aerobic metabolism are mitochondrial-encoded; therefore, their expression may be
affected by estrogen receptor activation and subsequently influence lipid handling. Given
that male MPR offspring have been shown to exhibit decreased serum testosterone levels
at four months of age due to enhanced metabolic activity of hepatic Cyp3A and Cyp2c11
(Chamson-Reig et al., 2009; Sohi et al., 2014), it’s plausible that testosterone signaling
may have a role in promoting mitochondrial dysfunction instead of estrogen.

5.1.2

Postnatal catch-up growth likely has an indirect effect of
the regulation of miR-29 expression through interference
with mitochondrial function
In Chapters II and III, oxidative stress and mitochondrial dysfunction were

investigated as major drivers of hepatic hyperlipidemia in IUGR offspring with catch-up
growth. Importantly, our laboratory has shown that MPR offspring exclusively with
catch-up growth also exhibit endoplasmic reticulum (ER) stress (i.e., higher peIF2α,
Grp94) in adult life (Sohi et al., 2013). MPR offspring with catch-up growth also have
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aberrant expression of hepatic miRNAs, including miR-29a/b/c (Sohi et al., 2015).
However, it remains unknown whether this occurs due to oxidative stress, ER stress, or
mitochondrial dysfunction. In Chapters III and IV, I characterized the expression of miR29 and miR-203a-3p in male IUGR offspring from the MPR and D9-THC models.
Suppression of miR-29 and miR-203a-3p have been shown to contribute to dyslipidemia
through elevation of their targets, including fatty acid translocase (CD36) and p66Shc,
respectively (Roderburg et al., 2011; Tomita et al., 2012; Yang et al., 2019; Zhao et al.,
2019; Wang et al., 2020). As outlined in Chapters I and IV, CD36 permits
transmembrane NEFA transport; therefore, increased levels of CD36 have been
associated with hepatic lipid accumulation and poor lipid metabolism (Lin et al., 2019).
Transgenic mice with constitutive expression of hepatic miR-29 do exhibit decreased
levels of CD36, but this is counteracted by feeding of a high fat diet and suggests that
CD36 expression is more responsive to nutrient availability rather than miR-29
expression (Lin et al., 2019). Similarly, elevated p66Shc leads to increased lipid
accumulation and oxidative stress (Berniakovich et al., 2008; Wang et al., 2020). While
we have already shown that hepatic miR-29 is increased in MPR offspring with catch-up
growth (Sohi et al., 2015), analyses of miR-203a-3p abundance showed that only LP3
offspring have increased miR-203a-3p at four months (Chapter IV). Conversely, hepatic
expression of both miR-29 and miR-203a-3p was decreased in D9-THC-exposed males
(Chapter III). Although there are discrepancies in miR expression between these two
models, this may be attributed to heterogeneity of the liver. MiR-29 and miR-203a-3p
have vastly different expression profiles across liver cell types (e.g., hepatocytes versus
HSCs; Roderburg et al., 2011; Kogure et al., 2012; Diao et al., 2014), so it is possible
that different cell populations are affected by catch-up growth and cell stress in these two
models of IUGR.
In Chapter IV, I studied the direct effects of oxidative stress and ER stress on
miR-29 and miR-203a-3p in vitro. We have previously observed changes in hepatic
miRNAs among adult male MPR offspring with catch-up growth (Sohi et al., 2015);
however, it is unclear from this in vivo data whether oxidative stress or ER stress have
impact on miRNA expression. In vitro studies were therefore necessary to determine if
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miR-29 and miR-203a-3p are affected by these forms of cell stress, and to investigate
which type of cell stress has greater influence on miRNA expression. To do this, I used
pharmacological inducers of oxidative stress (hydrogen peroxide and rotenone) and ER
stress (tunicamycin and thapsigargin) in HepG2 cells, followed by quantification of
miRNAs and their target mRNAs via qRT-PCR. The human male HepG2 cell line is an
appropriate in vitro model for studying the neonatal liver, as these cells produce and
secrete proteins that are exclusive to fetal hepatocytes (Maruyama et al., 2007). While 6h
exposure to each drug did not elicit changes in miRNA expression, miR-29 was increased
in response to treatment with rotenone and thapsigargin for 24h. Surprisingly, cells
treated with rotenone and thapsigargin for 24h further exhibited heightened transcript
abundance of CD36, indicating that lipid transport may be increased and lead to
intracellular lipid accumulation. Given that CD36 is a target of miR-29, we were
surprised to see that rotenone and thapsigargin increased CD36; however, it is
conceivable that oxidative stress may instigate other transcriptional and/or epigenetic
changes enhancing CD36 transcription. My analyses of miR-203a-3p expression in
HepG2 cells revealed that this miRNA is poorly expressed in hepatocytes; therefore,
alternative cell lines should be used to examine miR-203a-3p in the liver. Previous
studies of hepatic miR-203a-3p have focused on its expression in HSCs of the diseased
liver and the human LX-2 HSC line, suggesting that miR-203a-3p may have a role in
regulating extracellular matrix production rather than metabolism (Wang et al., 2020).
My in vitro experiments further demonstrated that miR-29 and CD36 are
increased in response to treatment with rotenone and thapsigargin, but not hydrogen
peroxide or tunicamycin. Importantly, rotenone and thapsigargin are known to influence
mitochondrial function, albeit through different mechanisms. Rotenone is an inhibitor of
complex I of the electron transport chain (Siddiqui et al., 2013), while thapsigargin acts
through interference with calcium signaling (Deniaud et al., 2008; Naem et al., 2013).
Both drugs have been shown to increase mitochondrial production of ROS in HepG2
cells, ultimately resulting in apoptosis (Siddiqui et al., 2013; Wang et al., 2016). It is for
this reason that the evidence for miR-29 being directly increased by ER stress is
inconclusive, as it is not known whether thapsigargin acted through oxidative stress or
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ER stress. Nonetheless, since miR-29 expression was increased exclusively following
treatment with these two drugs, it seems plausible that miR-29 expression is primarily
regulated by mitochondrial dysfunction (Figure 5-1). Taken together, these data provide
further evidence for the role for mitochondrial dysfunction in determining the fate of
hepatic lipids.

5.2 Limitations
While this thesis has greatly advanced our understanding of DOHaD, it also
contains several limitations that should be addressed. Throughout the entirety of this
thesis, my main objective was to characterize the role of postnatal catch-up growth across
various models of IUGR. In the MPR model, the numerous timepoints of dietary
intervention (i.e., LP1 vs. LP2 vs. LP3) allow for analyses of mitochondrial markers in
offspring both with and without catch-up growth. However, the studies performed as part
of Chapter II only included male offspring. This was intentional to avoid any
confounding effects of the female estrus cycle, and because female MPR offspring do not
exhibit hepatic hyperlipidemia in adult life (Sohi et al., 2011; Oke et al., 2019). That said,
livers from female offspring should be further analyzed to conclude that these
mitochondrial deficits are truly sex specific. Additionally, in Chapter III, I performed
experiments using livers of D9-THC-exposed offspring at three weeks and six months of
age only. Given that catch-up growth is complete by three weeks in these offspring, my
studies have quantified markers of mitochondrial dysfunction and hepatic lipid
metabolism exclusively after catch-up growth. To confirm that catch-up growth is indeed
responsible for the mitochondrial dysfunction and hepatic hyperlipidemia observed in this
model, I would need to perform additional experiments in newborn offspring at postnatal
day one, prior to the initiation of catch-up growth. Should these protein markers and
hepatic triglyceride levels be unchanged at birth, I could conclude that catch-up growth is
at fault for the mitochondrial and metabolic deficits observed following gestational
exposure to D9-THC.
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In Chapters II and III, I performed molecular techniques on ex vivo, whole liver
samples from our rodent models of IUGR. I found that adult male offspring from both
models exhibit oxidative stress and mitochondrial dysfunction following catch-up
growth, and I used the HepG2 cell line to assess the direct effects of cell stress on
epigenetic mechanisms. While these data are informative and supportive of the DOHaD
hypothesis, it is difficult to discern the effects of catch-up growth on individual cell types
in the liver. As mentioned previously, the liver is a heterogeneous organ with cell types of
varying functions. Each hepatic cell type has a unique genetic (and epigenetic) profile
that regulates various developmental pathways, as seen in my in vitro studies of miR-29
and miR-203a-3p in the HepG2 cell line. Therefore, it is likely that each cell type in the
IUGR liver is affected differently by catch-up growth. To address this, multiple cell lines
representing the various types of liver cells are necessary to distinguish the effects of cell
stress on hepatic miRNA expression. For example, the LX2 human immortalized cell line
could be used as a model for HSCs, as done in studies by Wang et al. (Wang et al.,
2020). Additionally, while we have established that miR-29 expression is influenced by
mitochondrial dysfunction, it remains unanswered if aberrant miRNA expression can also
induce mitochondrial dysfunction. This classic ‘chicken and egg’ scenario could be
addressed through transfection of miR-29 mimics and inhibitors, followed by analyses of
the same mRNA and protein markers examined in Chapters II and III.

5.3 Future Directions
This thesis investigated the role of postnatal catch-up growth on mitochondrial
function in growth-restricted offspring. We implemented two rodent models of IUGR to
interpret the molecular mechanisms by which mitochondrial dysfunction leads to hepatic
hyperlipidemia in adult life. Supplementary in vitro studies allowed us to further
elucidate these mechanisms, but future studies are warranted to better understand the
effects of catch-up growth on mitochondrial function in the liver.
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Figure 5-1. Mitochondrial dysfunction leads to increased miR-29 as an underlying
mechanism of hepatic hyperlipidemia in adult growth-restricted offspring with
postnatal catch-up growth.
Offspring affected by intrauterine growth restriction (IUGR) exhibit low birth weight and
reduced organ to body weight ratios, followed by rapid postnatal weight gain (i.e., catchup growth) after birth. This catch-up growth leads to oxidative stress and ER stress during
postnatal life, thereby promoting mitochondrial dysfunction in the liver. As a result,
hepatic miR-29 becomes increased in IUGR offspring with catch-up growth, which may
serve as an underlying mechanism of hyperlipidemia observed in adult life. Together, it
appears that mitochondrial dysfunction is a critical source of metabolic dysfunction in
growth-restricted offspring exclusively following postnatal catch-up growth.
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First, there are many avenues by which we could follow up with our studies of
gestational exposure to D9-THC. In Chapter III, I investigated mitochondrial dysfunction
and hepatic hyperlipidemia in offspring at three weeks and six months of age. At six
months, male D9-THC-exposed offspring exhibited increased hepatic triglyceride levels
and elevated adipose to body weight ratio (Oke et al., 2021). As these animals age, it is
possible that they develop NAFLD and cardiovascular disease. By returning to this model
and allowing male offspring to age beyond six months, we could assess the progression
of NAFLD and cardiovascular disease through histopathological and biochemical
analyses. These would include immunohistochemical analyses of liver, skeletal muscle,
and cardiac tissues with Masson trichrome stain (for connective tissue deposition) and Oil
Red O (for intracellular lipid accumulation). Measures of cardiac function, including
echocardiogram assessment, could also be performed in adult offspring as done
previously by our lab for offspring at three weeks of age (Lee et al., 2021). Gestational
D9-THC exposure and catch-up growth led to increased thickness of the left ventricle
anterior wall, along with decreased cardiac output at this time point. Again, since
dyslipidemia is a risk factor for cardiovascular disease, it’s likely that these impairments
in cardiac function are worsened with age due to poor lipid metabolism.
Given that my interests lie in the role of mitochondria in hepatic lipid metabolism,
specific isolation of primary hepatocytes from IUGR offspring in either model would
allow us to perform in vitro functional assays measuring oxidative stress and aerobic
metabolism. These experiments would be performed using cells isolated from newborn,
three-week old, and adult offspring to investigate the effects of catch-up growth on
cellular metabolism. The Seahorse XFe24 Extracellular Flux Analyzer (Agilent) in our
laboratory could be used to measure oxygen consumption rate (OCR) and extracellular
acidification (ECAR) rate in IUGR primary hepatocytes, both before and after catch-up
growth. These in vitro assays can be used to measure basal levels of OCR and ECAR in
response to fatty acid substrates and inhibitors of mitochondrial enzymes. In addition to
these metabolic studies, RNA-sequencing (RNA-seq) could be further utilized to address
issues arising from liver heterogeneity and sex-specificity. In doing so, these studies
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would provide a better understand of how mitochondrial dysfunction in hepatocytes
contributes to the progression of hyperlipidemia.
Mitochondrial dysfunction is a multifaceted cellular phenotype with a wide range
of molecular consequences. Here I have only scratched the surface in how mitochondria
are affected by catch-up growth, and there are many directions in which we could
advance these studies. There is evidence to show that mitochondrial dynamics (i.e.,
fission and fusion) is highly sensitive to cell stress and nutrient status, particularly
through signaling via the AMP-activated protein kinase (AMPK) and mammalian target
of rapamycin (mTOR) pathways. Nutrient deprivation has been demonstrated to cause
mitochondrial elongation and a preference for fatty acid oxidation over glucose
metabolism (Yu and Pekkurnaz, 2018). Conversely, nutrient overload leads to
mitochondrial fragmentation and inefficient bioenergetics (Yu and Pekkurnaz, 2018).
During my studies of MPR offspring, I found that transcript abundance for markers of
both mitochondrial fusion (Opa1 and Mfn1) and fission (Drp1) are upregulated in livers
of adult males with catch-up growth (Figure B-1, Appendix B). Given the connection
between mitochondrial dynamics and metabolism, it would be valuable to pursue these
preliminary data further by directly assessing mitochondrial morphology. This would
again require isolation of primary hepatocytes before and after catch-up growth, followed
by electron microscopy to clarify whether mitochondrial fission or fusion occurs.
Furthermore, it would be interesting to determine the effects of catch-up growth on
mitophagy, a specialized form of autophagy that removes damaged or dysfunction
mitochondria from the cell. Much like mitochondrial dynamics, mitophagy is regulated
by nutrient sensing pathways via AMPK and mTOR signaling. Interestingly, there are
reports indicating that successful mitophagy also relies on mitochondrial fission. To
investigate autophagy, either electron microscopy or fluorescence microscopy could
monitor the formation of autophagosomes. Given that offspring with catch-up growth
prioritize anabolic pathways over energy catabolism, and they exhibit mitochondrial
dysfunction, I predict that catch-up growth leads to both mitochondrial fission and
mitophagy in the IUGR liver.
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Finally, it would be interesting to explore the therapeutic potential of oxidative stress
and ER stress inhibitors in either the MPR or D9-THC model. With a ‘proof-of-principle’
approach, these models would be repeated exactly as before; however, inhibitors of
oxidative stress or ER stress would be administered either gestationally or postnatally.
Administration of these inhibitors only during pregnancy or postnatal life would determine
if postnatal intervention in the offspring is sufficient (e.g., exclusively during lactation), or
if perinatal intervention is necessary. Indeed, there are many pharmaceutical and dietary
interventions that have already been investigated as mitigators of oxidative stress or ER
stress. For oxidative stress, various antioxidant compounds are of interest because of their
ability to inhibit lipid peroxidation and scavenge free radicals. For example, vitamins C
and E, resveratrol, melatonin, and pyrroloquinoline quinone (PQQ), are antioxidants that
can be ingested through the diet. To date, there is some existing research on dietary
supplementation of these antioxidants during pregnancy, but their success in preventing
IUGR is inconclusive (Chen et al., 2006; Poston et al., 2006; Ornoy et al., 2009; Bourque
et al., 2012; Lemley et al., 2012; Wood, 2021). That said, postnatal administration of these
compounds in IUGR offspring could still help to prevent the oxidative stress caused by
catch-up growth and stop the progression of metabolic disease later in life. Since oxidative
stress and ER stress often occur together, it would be interesting to assess the effects of
these oxidative stress inhibitors on ER stress as well. Alternatively, administration of
tauroursodeoxycholic acid (TUDCA) could be used to directly target ER stress. TUDCA
is a naturally occurring bile acid produced by intestinal bacteria, and it has been shown to
alleviate ER stress by improving the protein folding capabilities of the ER (Omura et al.,
2013). In addition, it is a known anti-apoptotic agent as it can stabilize intrinsic
mitochondrial pathways that lead to oxidative stress and apoptosis (Vang et al., 2014). It
is for these reasons that TUDCA has been previously studied as potential treatment for
many neurodegenerative and metabolic diseases, making it an attractive candidate for
postnatal treatment in IUGR offspring.
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5.4 Summary
Intrauterine growth restriction (IUGR) is a pathological condition characterized
by low birth weight and compromised organ development. Epidemiological studies of
gestational famine suggest a relationship between birth weight and long-term metabolic
dysfunction, while the occurrence of postnatal catch-up growth can exacerbate this
detrimental relationship. In this thesis, I present the novel discovery that catch-up growth
promotes oxidative stress and mitochondrial dysfunction in the growth-restricted liver.
This occurs across multiple rodent models of IUGR, suggesting that the combination of
IUGR and catch-up growth has greater impact on mitochondrial function than the type of
gestational insult. These trends occur exclusively among male IUGR offspring, leading to
hepatic hyperlipidemia during adult life. Epigenetic mechanisms appear to have a role in
this process, as hepatic expression of miR-29 is altered following catch-up growth. In
vitro experiments further suggest that alterations in miR-29 expression may be
mitochondrial-driven. Collectively, my data suggest that hepatic catch-up growth has
great impact on mitochondrial function and lipid handling in growth-restricted offspring,
and that this occurs in a sex-specific manner. Again, this could contribute to the
development of postnatal therapies among IUGR offspring, thereby leading to decreased
incidence of the metabolic syndrome.
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Appendix B: Preliminary Data for Future Studies

Figure B-1. Maternal protein restriction leads to upregulated markers of
mitochondrial fusion and fission in livers of offspring with postnatal catch-up growth.
Pregnant dams were subjected to an 8% protein diet during gestation, and pups were
randomly assigned to one of three postnatal dietary regimens at birth: 8% protein diet
throughout life (LP1), 8% protein diet until three weeks of age + 20% (control) diet after
three weeks (LP2), or 20% protein diet throughout life (LP3). Following necropsy, RNA
was isolated from livers of each group and qRT-PCR analysis was performed with the
complementary cDNA. Fold change difference of (A) opa1, (B) mfn1, (C) drp1, and (D)
fis1 were expressed as means from normalized to the geometric means of GAPDH and bActin ± SEM (n=8/group). Transcript abundances for each individual point were
analyzed using a two-tailed unpaired Student’s t-test and compared to the untreated
control group. Groups marked with different letters are significantly different (P < 0.05).
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